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General introduction, outline and aims of the thesis 
INTRODUCTION
Growth during the earliest stages of life is an important determinant of an individual’s 
later health and risk of chronic disease(1). Substantial evidence shows that growth in the 
first 2 years of life, especially high early weight gain, is associated with adverse health 
outcomes later in life, including increased blood pressure (2), increased weight gain 
and body fat deposition (3-6) and increased risk of diabetes (7). Higher protein intake 
for infants who are formula fed may play a role with these health outcomes because 
formula-fed children reach a higher body weight and weight for length at one year of 
age compared to those fed breast milk (8). A lower protein intake in infant formula is 
associated with lower weight up at 2 years of age (9) which might be beneficial because 
the slower pattern of growth in breastfed infants might be protective for the develop-
ment of the metabolic syndrome (10). In preterm infants, however, a higher protein 
intake in the first month of life correlates with improved neurodevelopment (11, 12). 
Preterm infants have higher protein turnover rates and protein losses than terms and 
thereby higher protein requirements (13, 14). Excessive intake of amino acids has been 
shown to reduce (brain) growth and to influence neurotransmitter concentrations in the 
brain of rats which might put the developing brain at risk (15). Inadequate amino acid 
intake impairs protein synthesis, which is pivotal for growth. The growth rate of the pre-
term infant should mimic at least the growth rate of the intrauterine fetus at the same 
gestational age (16). Achieving appropriate growth and nutrition accretion of preterm 
neonates is often difficult during hospitalization because of metabolic and gastrointes-
tinal immaturity and other complicating medical conditions. Many preterm neonates 
require total parental nutrition for their initial nutritional support but this is associated 
with several complications, including the increased risk of infection, mucosal atrophy 
and cholestatic jaundice. Therefore, transition to full enteral feeding and the cessation of 
TPN are accomplished as soon as feasible and safe, taking in consideration that enteral 
feeding is associated with a detrimental morbidity like necrotising enterocolitis (17). 
Enteral nutrition can be initiated immediately after birth by introducing small amounts 
to enhance the development of the gastro-intestinal tract and for this reason is referred 
to as “trophic”, “priming” or “minimal enteral feeding”.
Protein is an important component of adequate nutrition as it provides essential amino 
acids required for critical protein synthesis and growth. The goal in feeding preterm neo-
nates is to provide the quantity and quality of protein needed to achieve foetal rates of 
tissue growth and nitrogen accretion. This goal should be accomplished in the context of 
physiological and metabolic development of the infant in order to avoid accumulation 
of potentially harmful protein metabolic products (18, 19). Current understanding of the 
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nutritional needs for early growth and development is fragmentary and inadequate to 
provide answers that are needed (20). 
NUTRIENT NEEDS AND DEFENITIONS
Historically, nutrients are categorized in micronutrients and macronutrients. The 
micronutrients are minerals and vitamins. The macronutrients include protein, carbohy-
drates, fat, fiber and water. They supply energy to sustain the body’s various functions, 
including respiration, circulation, physical activity and protein synthesis. Carbohydrates 
provide energy to cells in the body, particularly the brain which uses glucose as the main 
energy source. Fat is a major source of fuel for other parts in the body and contributes 
to the absorption of fat-soluble vitamins and other food components as carotenoids. Via 
dietary fat intake the essential fatty acids linoleic acid and alfa-linoleic acid are absorbed 
which the body cannot synthesize. Proteins form the major structural components of all 
the cells of the body. Along with amino acids, they function as enzymes, transporters 
and hormones. In addition, rotein binds all kinds of toxic metabolites.
Definitions of optimal intakes of all individual macronutrients and their relative con-
centrations in complete formulas are areas of active research. A generic model for the 
protein dietary requirement defines the requirement of the needs of the organism, i.e. 
metabolic demands, and the dietary amount which will satisfy those needs, i.e. efficiency 
of utilization, thus: dietary requirement = metabolic demand/ efficiency of utilization 
(21).
The metabolic demand is determined by the nature and extent of those metabolic path-
ways that consume amino acids and are conventionally identified in most factorial mod-
els of requirement as maintenance and special needs (growth, pregnancy and lactation). 
The dietary requirement is the amount of protein or its constituent amino acids, or both, 
that must be supplied in the diet in order to satisfy the metabolic demand and achieve 
nitrogen equilibrium. The recommended dietary intake is the dietary requirement plus 2 
SD: the intake that will satisfy the metabolic needs of 97.5 % of the population.
An other way of defining the optimal intake is to determine the recommended dietary 
allowance, adequate intake, tolerable upper intake level and estimated mean require-
ment (22). The estimated average requirement (EAR) is the average daily nutrient intake 
level estimated to meet the requirement of half of the healthy individuals in a particular 
life stage and gender group. The recommended dietary allowance (RDA) is the average 
daily dietary nutrient intake level sufficient to meet the nutrient requirement of nearly 
all (97-98 percent) health individuals in a particular life stage and gender group. The RDA 
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is intended to be used as a goal for daily intake by individuals as this value estimates 
an intake level that has a high probability of meeting the requirement of a randomly 
chosen individual (about 97.5%). The adequate intake (AI) is used when a RDA cannot 
be determined. The AI is the recommended average daily intake based on observed or 
experimentally determined approximations or estimates of nutrient intake by a group 
(or groups) of apparently healthy people that are assumed to be adequate. The tolerable 
upper intake level (UL) is the highest average daily nutrient intake level that is likely to 
pose no risk of adverse health effects to almost all individuals in the general popula-
tion. As intake increases above the UL, the potential risk of adverse effects may increase 
(Figure 1).
When assessing nutrient intakes for groups, it is important to consider the variation 
in intake in the same individual, as well as underreporting. The EAR is the appropriate 
reference intake to use in assessing the nutrient intake in groups, whereas the RDA does 
not. Assuming a normal distribution of requirements, the percentage of individuals 
whose intakes is less than the EAR equals the percentage of individuals whose diets are 
considered inadequate based on the criteria of inadequacy chosen to determine the 
requirement (22).
The biological basis of protein or amino acid requirements should be defined on the 
basis of experimental studies. Are a few direct data on the protein requirements for 
children and infants. For term children in the first 6 months the assumption is made that 
human milk from a well-nourished mother can be regarded as providing an optimal 
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Figure 1: This figure shows that the estimated average requirement (EAR) is the intake at which the risk 
of inadequacy is estimated to be 50% to an individual. The recommended dietary allowance (RDA) is the 
intake at which the risk of inadequacy would be very small, only 2-3%. At intakes between the RDA and 
the tolerable upper intake level (UL), the risk of inadequacy and excess are both estimated to be close to 
zero. At intakes above the UL, the potential risk of adverse effects may increase (23).
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intake for the infant (24). The average content of human milk is used to determine an ad-
equate intake (AI). These data can provide some guidance for the composition for infant 
formula, but gross compositional similarity is not an adequate determinant or indicator 
of the safety and nutritional adequacy of infant formula (25). Human milk composition 
shows markedly variation and breastfed infants have a variable milk consumption rate, 
i.e. they largely regulate the intake they require themselves (26-28). For preterm infants, 
infants > 6 months and adults, dietary needs have been estimated by the factorial ap-
proach which we will discuss next.
METHODS TO DETERMINE REQUIREMENTS
Dietary protein requirements can be estimated by 2 different methods. The first method 
calculates the daily requirement theoretically, by a factorial approach which is based on 
estimating the nitrogen (obligatory) losses that occur when a person is fed a diet that 
meets energy needs but is essentially protein free and, when appropriate, also relies on 
estimates of the amount of nitrogen that is accreted during periods of growth or lost to 
mothers during lactation. The second, the empirical approach, measures biochemical or 
physiological responses to graded intakes. It includes anthropometry, chemical indices 
like serum albumin, total protein, immunoglobulin, retinol-binding protein and trans-
thyretin and biochemical markers of protein excess such as blood urea nitrogen (BUN), 
pH, pCO2 and bicarbonate. They also include nitrogen balance and isotopic studies of 
whole-body nitrogen kinetics.
Factorial Approach
The factorial approach is based on the assumption that the basal requirements of a 
component are the same throughout the life cycle and requirements in infants and 
children are higher than those in adults due to growth. The factorial approach considers 
the total requirement for a nutrient as the sum of obligatory losses (e.g. urine, faeces, 
skin), plus the amount incorporated into newly formed tissues (22, 29). This method, 
originally described for use in humans by Hegsted (30), has been useful for estimating 
requirements and designing experiments for obtaining definitive empirical data. In this 
method the obligatory losses (maintenance requirement) are added to the nutrients 
needed for protein synthesis (growth requirement). The factorial model to define the 
protein requirements for preterm infants is based on foetal body composition during 
normal intrauterine development. For the foetus and the preterm infant, protein is the 
predominant component of the requirements for developing new tissue. Compositional 
analysis of foetal issues has been a valuable source of data for our understanding of the 
nutrient needs of the foetus, and by extension, those of the growing preterm infant 
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19
General introduction, outline and aims of the thesis 
(18). Foetal accretion rates of protein have been compiled from compositional analyses 
of aborted foetuses or stillborn infants (31). In these analyses, foetal nitrogen accretion 
has been expressed in terms of gestational age (GA) (24 weeks to term) and birth weight 
(BW) (700-2500 gram). This foetal nitrogen accretion model is limited because of the 
large variations in the rates of foetal weight gain, particular at early time points. 
Nitrogen balance 
Historically, descriptive or gross measures like growth and nitrogen balance have been 
used. In this method an increasing intake of the test amino acid results in an increase 
in growth rate (usually weight gain) or nitrogen balance until the requirement level is 
met for the test amino acid, after which there is no further increase in either growth rate 
or nitrogen balance. Nitrogen balance is the difference between nitrogen intake and 
the amount excreted in urine, feces, skin, and miscellaneous losses such as breath and 
sweat. A limitation of the method is the need for a seven day adaptation time to the diet 
since the body urea pool needs 7 to 10 days to adapt. In addition, intakes of nitrogen 
are often being overestimated and excretion is often underestimated (32). Since it is 
considered unacceptable to maintain children or infants on either deficient of excessive 
intakes for longer periods nowadays, alternative methods were needed. The availability 
of isotopically labelled tracers made it possible to determine the metabolic fate of a 
labelled amino acid at varying dietary intakes as will be discussed next.
Isotopic tracer methods
Isotopic tracer methods measure amino acid oxidation, and are based on the principle that the 
oxidative losses are reversible and need daily replenishment, and that the amino acids provided 
in excess of the needs of protein synthesis, are preferentially oxidized. A 13 C-labelled amino acid is 
administered enterally or parentally and is distributed throughout the body’s free nitrogen pool. 
Stable isotopes are used: atoms with an extra neutron in the nucleus which slightly increases 
the mass which can be detected by mass spectrometry techniques. Different techniques using 
stable isotopes have been developed to determine the requirements of the indispensable amino 
acids like the direct and indirect amino acid oxidation methods. Isotopically labelled tracers are 
used to determine the metabolic rate of a labelled amino acid at varying dietary intakes. Amino 
acids consumed in excess of requirements for protein synthesis are oxidized. Deficient intake 
of an indispensable amino acid will result in only minimal obligatory losses. As intake increases 
above the requirement level, the oxidation of the amino acid will also increase linearly. In the 
direct amino acid oxidation ( DAAO) technique a known dose of labelled indispensable amino 
acid, for example [1-13C] lysine is provided to subjects fed graded dietary intakes of lysine with all 
other dietary factors being constant. The inflection point at which oxidation begins to increase 
rapidly over the obligatory minimum is referred to as the breakpoint and represents the dietary 
requirement for that individual (33) (Figure 2). 
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A refinement of the direct oxidation technique is the 24h tracer balance ( 24-h DAAB) (34, 
35). This method uses a daily balance of the amino acid that is measured and determines 
the requirement level of the test amino acid as the minimum intake at which the esti-
mate of daily balance is zero (36). El- Khoury et al. showed that the short (3-6 h) direct 
oxidation method was within 5% on the 24 h estimate and thus is a valid representation 
of daily amino acid requirements (35). Since a 6 d adaptation to the study diet is needed, 
this method is not applicable to study vulnerable populations like infants.
An alternative approach of estimating indispensable amino acid requirements using 
amino acid oxidation is the indirect amino acid oxidation ( IAAO) technique. The main 
principle of this method is that because there is no storage of free amino acids, defi-
ciency of one essential amino acid will limit protein synthesis. If the tested amino acid 
is deficient in the diet, this will limit protein synthesis and the indicator amino acid will 
be oxidized. If the dietary intake of the test amino acid increases, the oxidation of the 
indicator will decrease until requirement of the test amino acid is met. When intake 
meets the requirement then protein synthesis occurs at an optimum capacity and the 
oxidative degradation of all other essential amino acids plateau. The mean requirement 
or estimated average requirement (EAR) of the test amino acid is identified by this break-
point (Figure 3) (37-39). 
The advantage of the DAAO and IAAO method are the short adaptation time needed to 
the study diet which makes them applicable to study vulnerable groups such as infants.
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Figure 2: Breakpoint estimation using the direct indicator amino acid oxidation (DAAO) method. Adapted 
from (37).
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A limitation of the DAAO method is that it is not applicable to all indispensable amino 
acids whereas with the IAAO method the requirements of any essential amino acid or 
conditionally indispensable amino acid can be studied. Thereby there is no dietary re-
striction on intake of the test amino acid in the IAAO technique as a result of the fact that 
the requirement of one amino acid is determined by the oxidation of another amino 
acid. This makes it possible to study all possible dietary levels of essential amino acids.
PROTEIN AND AMINO ACIDS
Protein is the major functional and structural component of all the cells of the body. The 
defining characteristic of protein is its requisite amino nitrogen group. Proteins are mac-
romolecules consisting of a long chain of amino acid subunits. In the protein molecule, 
the amino acids are joined together by peptide bonds. In biological systems, the chains 
formed might be anything from a few amino acids (di-, tri- or oligopeptide) to thousands 
of units (polypeptide). The sequence of amino acids in the chain is known as the primary 
structure. A critical feature of proteins is the complexity of their physical structures. Poly-
peptide chains do not exist as long chains but they fold in a three-dimensional structure. 
The chains of amino acids tend to coil into helices (secondary structure). Sections of the 
helices may fold on each other due to hydrophobic interactions between non-polar side 
chains and, in some proteins, to disulfide bonds so that the overall molecule might be 
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Figure 3: Breakpoint estimation by using the indicator amino acid oxidation (IAAO) method. Adapted 
from (40).
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globular or rod-like (tertiary structure). Their exact shape depends on their function and 
for some proteins, their interaction with other molecules (quaternary structure) (23).
Amino acids that are incorporated into mammalian protein are α-amino acids, with 
the exception of proline which is an α-imino acid. This means that they have a carboxyl 
group, an amino nitrogen group and a side chain attached to a central α-carbon (Figure 
4). Functional differences among the amino acids lie in the structure of their side chains.
In the body there are 20 amino acids, nine of which are essential. The essential or 
indispensable amino acids are those which cannot be synthesized by the body. Clas-
sically nine amino acids are regarded as dietary essential; if these amino acids are not 
administered in the right proportions the protein synthesis will be reduced (33, 40). 
The classically defined essential amino acids have been supplemented by a group 
deemed conditionally essential in preterm infants because the temporarily metabolic 
and physiologic immaturity of these infants often leads to a delayed onset of adequate 
endogenous synthesis. The infant is unable to make sufficient amounts of that amino 
acid and hence all or a part of the daily needs for that amino acid have to be provided by 
the diet. The non-essential or dispensable amino acids can be synthesized by the body 
from intermediates of the tricarboxylic acid cycle (TCA) and other metabolic pathways. 
An overview of these 3 groups is shown in Table 1. Recently our group determined cys-
teine to be a non-essential amino acid in stead of a conditionally essential amino acid in 
preterm neonates (41).
Protein Turnover
Most proteins in the body are constantly being synthesized from amino acids and de-
graded back to them. There is a continual turnover of protein since there is no storage 
of proteins. There are two main reactions essential to amino acid metabolism: trans-
Figure 4. An amino acid: an amino (NH2) group, a carboxylgroup (COOH) and a side chain attached to a 
central α-carbon (R).
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amination and oxidative deamination. Transamination converts one amino acid into 
another by catalysing the transfer of the α-amino (NH3
+) group from an amino acid to 
an α-keto-acid. All transamination reactions are fully reversible. The second reaction, 
which is irreversible, is the oxidative deamination. It removes the amino group, leaving 
behind the carbon skeleton. The ammonia (NH4
+) formed enters the urea cycle and the 
carbon skeletons are all glycolytic and TCA intermediates. These products can, depend-
ing on the energy status of the cell, either be oxidized in the citric acid cycle to generate 
energy or used to synthesize glycogen or fat. Tyrosine is formed by the hydroxylation of 
phenylalanine, this is an irreversible reaction. Serine, glycine and cysteine are formed 
from glycolytic intermediates. 
In the body is a “pool” of amino acids present in dynamic equilibrium with tissue protein 
as depicted in Figure 5. Amino acids are continually taken from the pool for protein 
synthesis and replaced by the hydrolysis of dietary and tissue protein. 
Table 1: Categorizing dietary amino acids by their degree of indispensability: essential = indispensable. 
Adapted from (42).
Essential Non-Essential Conditionally Essential
Leucine Alanine Tyrosine
Isoleucine Serine Glutamine
Valine Asparagine Arginine
Methionine Aspartate Glycine
Threonine Glutamate Proline
Lysine Cyste(i)ne
Phenylalanine
Histidine
Tryptophane
Dietary
Intake
De novo 
synthesis
AMINO ACID POOL
Excretion
Non-protein pathways 
Oxidation/
Hydroxylation 
TISSUE
PROTEIN
Protein degradation
Protein synthesis
Skin, Feces,Hair  
Protein losses
Figure 5. Exchange between body protein and free amino acid pools. Adapted from (23).
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METABOLISM OF AMINO ACIDS
The branched-chain amino acids (BCAAs)
The branched-chain amino acids, leucine, valine and isoleucine have been extensively 
studied in vivo and in vitro because of the unique role of leucine in protein synthesis. Leu-
cine is unique because it promotes protein synthesis by regulating translation initiation, 
inhibits protein degradation, and stimulates the secretion of insulin (43, 44). The BCAAs 
are the only amino acids that share common metabolic steps and have degradative 
metabolic pathways in the extrahepatic tissues, primarily muscle. They share common 
enzymes for the first 2 degradative steps, which are transamination and decarboxylative 
oxidation. The transamination is catalyzed by the branched-chain aminotransferase 
(BCAT) and yields α-ketoisocaproate (KIC, from leucine), α-keto-β-methylvalerate (KMV, 
from isoleucine) and α-ketoisovalerate (KIV) from valine. Its activity depends on the 
concentrations of the enzymes and substrates. Each of these branched-chain keto-
acids (BCKAs) than undergoes an irreversible oxidative decarboxylation catalyzed by a 
branched-chain keto acid dehydrogenase (BCKAD). This is a multienzyme system located 
in the mitochrondial membranes. Keto-leucine (KIC) or α-ketoisocaproate is metabo-
lized in isovaleryl-CoA, keto-isoleucine (KMV) or α-keto-β-methylvalerate is metabolized 
in 3-methylbutyryl-CoA, and keto-valine (KIV) is metabolized in iso-butytryl-CoA. The 
activity of the BCKAD is controlled by a phosphorylation-dephosphorylation system 
analogous to that of the pyruvate dehydrogenase complex. Thereafter, the pathways 
resemble those for fatty oxidation and leads to end products that can enter the tricar-
boxylic acid cycle. The end products of isoleucine catabolism are propionyl-CoA and 
acetyl-CoA; hence it is both glucogenic and ketogenic. Leucine yields acetoacetate and 
acetyl-CoA; it is therefore ketogenic. Valine yields succinyl-CoA: it is therefore glucogenic 
(45). The different steps are summarized in Figure 6.
BCAAs account for 35-40% of the dietary essential amino acids found in body protein 
and 14% of the total amino acids in skeletal muscle. Their main metabolic fate is incor-
poration into body protein, although utilization by the intestine and splanchnic tissues 
(first pass utilization) is also high (47). The BCAAs compete with other large neutral 
amino acids (LNAA), particularly tryptophan and tyrosine, for membrane transport. 
Although BCAAs do not act as direct precursors for neurotransmitters, they can affect 
the transport of certain LNAAs across the blood-brain barrier and thereby can influence 
central nervous system concentrations of neurotransmitters. Among the BCAAs, leucine 
can act independently as a nutrient signal and stimulates protein synthesis by the 
activation of translation initiation factors. Leucine stimulates insulin secretion (48) and 
when given in larges doses, it causes a transient but significant increase in serum insulin 
concentrations (49).
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Lysine
Lysine is an essential amino acid which is used primarily for protein synthesis: however 
is also acts as a precursor for carnitine synthesis which is used in obligatory fatty acid 
oxidation. In addition, lysine plays a major role in calcium absorption and in the forma-
tion of collagen. In cereals, such as rice and wheat, lysine concentrations are significantly 
lower compared to animal foods. A negative association was found in infants fed cereals 
at 3-6 mo of age on both length and head circumference, probably as a result of a reduc-
tion in breast milk intake (8). The catabolism of lysine is predominantly located in the 
liver. The main catabolic pathway for lysine in mammals is the sacchropine-dependent 
pathway leading to acetyl-CoA. Lysine-α-ketogluratate reductase converts L-Lysine into 
saccharopine which activity is dependent on the dietary intake (50). Because lysine is 
oxidized in the gut, intestinal lysine catabolism is also an important factor in the nutri-
tion of preterms. Using stable isotope tracer techniques, van der Schoor et al. deter-
mined the fractional first pass lysine uptake to be high during enteral feeding in preterm 
infants and parenteral lysine to be not as effective as dietary lysine in promoting protein 
deposition in preterm infants (51). 
Figure 6: Metabolic pathway of the branched-chain amino acids. Adapted from (46).
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Methionine
Sulfur is an essential element for cells and it plays an important role in membrane stabili-
zation. The sulfur-containing amino acids are methionine, cysteine and taurine. Methio-
nine is the single essential sulfur-containing amino acid. The metabolism of methionine 
is characterized by 2 components. The first way is the ubiquitous transmethylation cycle, 
in which methionine is transmethylated to homocysteine and remethylated back to 
methionine. Homocysteine is an intermediate in methionine metabolism and is highly 
correlated with cardiovascular events in neonates (52). The second, catabolic (trans-
sulfuration) pathway of methionine involves the condensation of homocysteine with 
serine to form cystathionine. Cystathionine is converted to cysteine, α –ketobutyrate 
and ammonia and is oxidized in the TCA cycle. Methionine plays a major role as a methyl 
donor in several methylation processes, thereby affecting DNA and RNA translation, pro-
teins, phospholipids, hormones, and neurotransmitters (53). Furthermore, it serves as a 
precursor for cysteine synthesis through the transsulfuration pathway. The splanchnic 
tissues play a major role in the transsulfuration pathway and thus in cysteine produc-
tion (54). In the human fetus an absence of the transsulfation pathway activity has been 
shown, thereby suggesting that cysteine is a conditionally essential amino acid in the 
foetus. This appearance of transsulfation is probably stimulated by the birth-associated 
decrease in plasma insulin, increase in glucagon and thyroid-stimulated hormone (55). 
Recent data on healthy newborns and preterms show that the human neonate develops 
the capacity to metabolize methionine via transsulfuration rapidly after birth (56). 
Threonine
Threonine is an essential amino acid that is does not participate in transamination reac-
tions. It is a major component of the protein backbone of intestinal mucin constituting 
as much as 30% of its amino acid content. In addition, it is a significant (12-14%) com-
ponent of 4E-binding protein-1, an important component of the translation initiation 
pathway. It may also play an important role in the immunological defense system (57). 
The liver and pancreas are the major sites of catabolism of threonine in vivo. Van der 
Schoor et al. showed that in preterm infants the splanchnic tissues extract 70-82% of di-
etary threonine, which indicates a high need for threonine by the gut (57). The absorbed 
threonine is used for synthesis of secretory glycoproteins, for the synthesis of mucosal 
cellular proteins or for oxidative purposes (58-60).
Three independent pathways for threonine degradation in mammals are known which 
primarily take place in the liver. It is either metabolized in the glycine-independent path-
way or the glycine-dependent pathway. The glycine-independent pathway is catalyzed 
by serine/threonine dehydratase (STDH), which converts threonine in different steps 
to Propinoyl-CoA (61). The activity of STDH is regulated by dietary protein, insuline, 
glucagon and cortisol (62). Glycine-dependent oxidation, which converts threonine into 
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glycine and acetyl-CoA, is regulated by threonine dehydrogenase (TDH) and 2-amino-
3-oxobutyrate-CoA ligase enzymatic reaction. Threonine can either be converted to 
2-amino-3-oxobutyrate by the mitochrondial enzyme threonine dehydrogenase, and 
subsequently to glycine by 2-amino-3-oxobutyrate CA ligase, or it can be directly con-
verted by glycine by cytosolic threonine aldolase. Studies show different results regard-
ing the dominant pathway as discussed by Kalhan et al. (63). The different pathways are 
shown in Figure 7.
AMINO ACID REQUIREMENTS FOR NEONATES
The determination of dietary requirements in infants and children has proven to be a 
challenging task. Whatever method is used, graded levels of the amino acid of inter-
est have to be fed to the subjects, ranging from below to above the requirement level 
(37, 64), and changes determined in a biological response. Over fifty-five years ago, 
Snyderman and colleagues have determined individual amino requirements for infants 
by means of the nitrogen balance method and weight gain (65, 66). In 1985, a modi-
fied factorial approach was adopted by the World Health Organization (WHO) which 
calculated a maintenance value derived from protein intakes of breastfed children and 
added a growth requirement. Short term nitrogen balance data were used to select 
a maintenance value (120 mg nitrogen ∙kg-1∙d-1), rounded up from the highest range 
of values (80-118 mg nitrogen∙kg-1∙d-1). The growth requirement, calculated as mean 
nitrogen increment plus 50% to account for day-to-day variation in growth, was added 
to this maintenance value to give the average requirement, assuming a 70% efficiency 
of efficiency of conversion from dietary protein to body protein during growth. It was 
ST
DH
(1)
Threonine Threonine aldolase (3)
2-oxobutyrate (4) CO2
Propionate
                                          
2-amino-3oxobutyrate TDH (2)
Glycine
Acetyl CoA
CoA
(5)
(6) CO2
Figure 7. Hepatic metabolism of threonine. Enzymes 1 and 3 are cytosolic; the remaining enzymes are 
localized in the mitochondria. Adapted from (63).
(1) Serine/threonine dehydratase (STDH)
(2) Threonine dehydrogenase (TDH)
(3) Threonine Aldolase 
(4) Pyruvate dehydrogenase
(5) 2-amino-3-oxybutyrate CoA ligase
(6) Glycine cleavage system
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thought that this 1985 report overestimated the requirement since it used the average 
intake of protein in breastfed children as the mean requirement thereby implying that 
half of breastfed infants have “deficient” intakes. Dewey et al. reviewed the 1985 data 
and re-examined the assumptions and evidence for the derivation of factorial estima-
tions of protein requirement for the breastfed infants from birth to 6 months, and sug-
gested that the requirement for breastfed children should be 10-25 % lower than those 
of the 1985 report (67). For infants aged 0 to 1 month, they calculated that breast milk (at 
intakes of 800 mL) provided on average a 45% excess of indispensable amino acids and 
a 61% excess at 1-3 months. Since intakes of breast milk from a healthy well-nourished 
mother are considered to satisfy protein requirements for the first 6 months of life, cur-
rent recommendations from the WHO are based on the breast milk contents (68). The 
requirements for the essential amino acids determined by these different methods for 
neonates aged 0 to 1 month are summarized in Table 2. 
USE OF THE IAAO METHOD IN THE PEDIATRIC POPULATION
The carbon oxidation methods had previously been developed in animals by Kim and 
Waterlow (69, 70). Vernon Young and co-workers pioneered the application of carbon 
oxidation methods to determine essential amino acids in adults. They used the direct 
oxidation approach, in which the test amino acid was also used as the tracer (71-73). The 
IAAO was introduced by Zello et al. to determine amino acid requirements in adults (33, 
Table 2: Requirement for neonates aged 0 to 1 month determined by the different methods in mg∙kg-1∙day -1.
Amino Acid
(mg∙kg-1∙d-1) 
Nitrogen balance and 
weight gain in infants (65)
DRI: human milk (22)
Average Intake 0-6 
months
 WHO: (68) Human milk 
content
Average requirement
0-1 month
Factorial 
approach by Dewey 
(67)
Minimum requirement
0-1 month
Isoleucine 119 88 95 59
Leucine 150 156 165 109
Valine 105 87 95 72
Lysine 103 107 119 116
Methionine 45a
Sulfur AA 59 57 64
Threonine 87 73 76 63
Phenylalanine 90c
Aromatic AA 135 162 114
Histidine 34 36 36  -
Tryptophan 22 28 29 22
a in presence of cysteine
c in presence of tyrosine
Aromatic amino acids: phenyalanine and tyrosine
Sulfur amino acids: methionine and cysteine
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74). Recently, the IAAO and IAAB were accepted as the most appropriate to determine 
amino acid requirements in humans (21, 22). 
To use the technique in infants and children, the dietary manipulations and study 
protocol most be short and non-invasive. Controversy exists over the necessity for an 
adaptation period to a specific dietary intake of test amino acid. Evidence suggest that 
a previous adaptation did not influence the requirement estimate (33). Thereby, the 
protein intake did not influence requirement of lysine (75) suggesting that amino acid 
requirements are not influenced by habitual protein intake. No studies are performed in 
children or neonates to the time needed to adapt to a study diet. 
To avoid unnecessary invasive handling, non-invasive methods have been incorporated 
into the stochastic model for the study of protein and amino acid metabolism. An oral 
or intra-gastric infusion of isotope was used in infants (76) and an urine analysis of 
isotope enrichment was used in infants to measure amino acid kinetics (77). A minimally 
invasive protocol was developed which used oral tracers and isotopic enrichment in 
urine and breath as a viable alternative for the measurement of amino acid kinetics in 
vulnerable populations. This minimally invasive IAAO was used to determine amino acid 
requirements in school-aged children and recently in parenterally fed neonates (78-80). 
No studies have been performed in enterally fed term or preterm neonates to determine 
essential amino acid requirements. 
AIMS OF THIS THESIS
The overall purpose of the work presented in this thesis is to determine the requirement 
of the individual essential amino acids in the term infant aged 0 to 1 month of age. In 
adults it was demonstrated using the factorial approach and studies with isotopic la-
belled amino acids that the nitrogen balance method underestimated the requirements 
of adults by two- to threefold (81). No studies have been performed using stable isotope 
techniques to determine essential amino acid requirements for enterally fed neonates. 
Because of the great importance of nutrition in preterm and term neonates with regard 
to long term effects as described in the introduction, determination of the amino acid 
requirements in these children is of high priority. Thereby, it is of great importance to 
use a minimal invasive protocol in this vulnerable group. 
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The overall aims of the work presented in this thesis are:
1. To determine whether adaptation to the study diet in the IAAO method influences 
the indicator oxidation rate.
2. To determine the tracer washout time and baseline adaptation to the study diet in 
the IAAO method.
3. To determine whether the use of only expired air is sufficient to determine amino 
acid requirements by comparing the breakpoint determined in air, urine and plasma 
using the IAAO method.
4. To determine the requirement for the branched-chain amino acids isoleucine, leu-
cine and valine in the term infant 0 to 1 month of age using the IAAO method.
5. To determine the optimal BCAA ratio in term infants aged 0 to 1 mo of age using the 
IAAO method.
6. To compare current recommendations based on the different methods with the 
mean requirements determined by the IAAO method. We will compare these mean 
requirements with the amount of amino acids in current formulas and discuss the 
possible new recommendations based on our studies.
Part II: Validation of the minimally invasive protocol in preterm/term neonates 
In chapter 2 we determine whether an adaptation to the study diet for 1, 2, 4 or 6 days 
has an effect on the indicator amino acid oxidation rate. Preterm infants are adapted for 
6 days to one of the leucine intakes and we determine the fractional oxidation of the [1-
13C] phenylalanine at days 1, 2, 4 and 6. We also determine the tracer washout time; the 
minimal time needed to perform the next tracer study. Chapter 3 describes the study 
design of the study we recently started in the High Care Centers of the Erasmus Medical 
Center in Rotterdam to the requirement for threonine in the preterm infant. In chapter 
4 we compare the mean requirement for lysine determined in urine, plasma and air to 
show whether the sampling of 13CO2 in expired air is sufficient to determine the mean 
requirement in term neonates.
Part III: The branched-chain amino acid requirement in term neonates 
These three amino acids share a common membrane system for their transamination 
and decarboxylative oxidation. In chapter 5 we determine the mean requirement of the 
essential amino acid isoleucine using the IAAO method in term neonates. In chapter 6 
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the mean requirement of valine is determined in term males in the first month of life, 
and the time needed to allow background adaptation to the study diet. In chapter 7 the 
mean requirement of leucine in term neonates is determined using the IAAO method. 
In chapter 8 we describe the optimal BCAA ratio and compare our estimated mean re-
quirements with the current recommendations and current contents of infant formulas 
for term infants.
Part IV: West meets East/East meets West 
This chapter describes the western versus the eastern view considering starting up a re-
search project in China. In chapter 9 the practical and ethical issues are explained by the 
western group , in chapter 10 the eastern view is described by our Chinese colleagues.
Part V: Other essential amino acid requirement in term neonates 
Chapter 11 describes the methionine requirement for term infants neonates in the first 
month of life.
Part VI: General discussion, overview of the studies, future perspectives and 
summary
In the general discussion, Chapter 12, we compare the requirements determined by 
the different methods with the requirements determined by our studies using the IAAO 
method. We compare these mean requirements with the amount of amino acids and 
protein in current formulas. Finally we will discuss the possible new recommendations 
for infant formulas for infants aged 0 to 1 month based on our studies and will give 
directions for future research. The results of the studies are summarized in chapter 13 
(English version) and Chapter 14 (Dutch version).
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ABSTRACT
Background: Infants and children are known to have higher turnover rates than adults, 
possibly reducing the required adaptation period. We aimed to determine the effect 
of adaptation to the study diet on the oxidation of the indicator amino acid and the 
required tracer washout time.
Methods: Subjects received a study diet for 6d that entailed a 50% reduction in leucine. 
Tracer studies using enterally infused [13C]bicarbonate and [1-13C]phenylalanine were 
performed on days 1, 2, 4 and 6. Breath samples containing 13CO2 were collected during 
isotopic plateau, measured by infrared isotope analysis and F13CO2 was calculated.
Results: Preterm infants (n=11, birth weight 1.9 ± 0.1 kg, gestational age 32.6 ± 1.5 
wks) received 166 mg∙kg-1∙d-1 of leucine. Baseline enrichment changed significantly at 
day 1 of the study diet. F13CO2 did not change significantly between days 2 and 4 but 
was significantly lower at day 6. The tracer washout time was determined 7.5 h using a 
biphasic regression analysis.
Conclusion: One day of adaptation to a new diet is necessary before starting infant 
requirement studies. Adaptation for a period of 5 d results in a protein sparing response. 
The minimal time between two studies within the same subject is 7.5 h.
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INTRODUCTION
Adequate nutrition is essential for optimal growth and development in preterm and 
term neonates. Protein is an important component, as it provides essential amino acids 
required for protein synthesis and growth. Nitrogen balance has long been used as 
the method to determine the requirement of the essential amino acids. An adaptation 
time of 7 d was needed to achieve equilibrium in the urea body pool and in urinary 
urea excretion (1). Because it is considered unethical to administer a deficient diet to 
an infant for 7-10 d, alternative methods were needed. The oxidation (or hydroxylation) 
of essential amino acids by the liver and peripheral tissues is dependent on the activity 
of the degrading enzymes, which in turn are dependent on the intake of the essential 
amino acids. Consequently, it is necessary to have sufficient time to adapt to a changing 
dietary intake (2, 3).
Studies have been performed using tracer oxidation methods in adults and pigs to 
examine whether protein intake or the adaptation time to the study diet influenced the 
amino acid kinetics (Table 1). Following a 2 d strictly controlled normal protein intake, 
an adaptation time of 8 h appears to be sufficient for adult subjects (4, 5). In premature 
or term infants, no studies have been performed to determine the necessary adaptation 
time. Amino acid and protein turnover studies in infants are 2 to 3 times higher than in 
adults on average, potentially reflecting a higher adaptive system to changes in the diet 
(6, 7). The adaptation to the study diet should be as short as possible to avoid restric-
tions in growth and development in this vulnerable population. This is especially true 
when considering preterm infants because protein intake in the first 4 weeks of life has a 
major influence on later cognitive function (8, 9) and blood pressure (10).
Therefore, we performed a study to determine the period of adaptation in infants who 
receive a study diet with decreased leucine content. We measured the oxidation rate 
of the indicator amino acid [1-13C]phenylalanine to F13CO2. In addition, we determined 
the minimal time needed to perform the next tracer study by determining the tracer 
washout time.
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SUBJECTS AND METHODS
Subjects
Subjects eligible for the study were preterm infants admitted to the Neonatology Depart-
ment of the Fudan Children’s Hospital in Shanghai, China. Their gestational ages ranged 
between 28 to 37 wks, and their birth weights were less than 2.2 kg. The children had 
Table 1: Overview of studies performed to define the time needed to adapt to a study diet using stable 
isotopes
IAAO/DAAO
Studies
Intake Objects Days of 
adaptation
Indicator
Oxidation /Flux
Changes?
Conclusion
Thorpe (35), IAAO 0.8 -1.4- 2.0 g∙kg-1∙d-1 
protein
Adult humans 2 d Flux↓a Oxidation↓a 
in 1.4 g/kg/d
2d adaptation to 
protein intake
Moehn (25), IAAO Deficient and excess 
lysine
Growing pigs 2-6 d Oxidation↑b
No differences
2-6 d
Adaptation < 2 d
Moehn (25), IAAO 100/50 % protein Adult pigs <1-10 Oxidation↑c
No differences  
1-10 d
Adaptation < 24 h
Motil (36), IAAO 1.5- 1.0 -0.4 g∙kg-1∙d-1  
protein
Adult women #6 d Oxidation↓↑d ,89% 
of changes within 
24 h
Adaptation < 2 d
Duncan (27), IAAO 0.8 or 1.0 g∙kg-1∙d-1  
protein
Adult men 3-9 d No No effect on 
requirements
Elango (5), IAAO 5,20,35,70 mg
Lysine
Adult humans #8 h, 3 d, 7 d No 8h adaptation is 
sufficient
Young (22), DAAO 7, 14, 30 mg
Leucine
Adult humans 7 d, 21 d Flux↓ e
Oxidation↓ e
Downregulation in 
lower intakes after 1 
and 3 wks
Castillo (28), DAAO Arginine-rich/ free 
diet
Adult humans 6 d Flux↓
Oxidation↓
Downregulation of 
arginine catabolism
Tharakan (23), DAAO Arginine-free/control 
diet
Adult humans 28 d Flux↓
Oxidation↓
Similar downregulation 
of arginine catabolism
Zello (29), DAAO 4.2 or 14 mg∙kg-1∙d-1
phenylalanine
Adult humans 3,6,9 d No differences Adaptation < 3 d
Requirement
independent of prior 
intake
Kurpad (37), DAAO 4 intakes lysine Adult men 7-21 d No differences Adaptation
< 7 d
# after a controlled protein intake of 2 days prior to the study day
a 1.4 g∙kg-1∙d-1  was significantly lower than 0.8 and 1.6 g∙kg-1∙d-1 in flux and oxidation, respectively
b  Oxidation was significantly increased in the low intake compared to the adequate level
c  Oxidation was significantly increased in the 50% and 100% intakes compared to 200%
d   Oxidation was significantly increased in the 0.4 compared to 1.0 and significantly decreased 
in the 1.5 compared to 1.0 g∙kg-1∙d-1 
e   Oxidation and flux were significantly decreased in the fed state in the 7-mg, 14-mg and 30-mg diets compared 
to an intake of 80 mg. Flux was significantly decreased in the 7- and 14-mg diets at 3 wks compared to 1 wk, 
and oxidation was decreased in the 7- and 30-mg diets at 3 wks compared to 1 wk 
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to be clinically stable and in a growth state, defined as gaining weight at a rate greater 
than 10 g∙kg-1∙d-1 over the previous 5 d. All subjects tolerated full enteral feeding well 
and had no congenital or gastrointestinal diseases. The study protocol was approved by 
the Medical Ethical Committee of the Fudan Children’s Hospital, and a statement of no 
objection was obtained from the Medical Ethical Committee of the Erasmus MC-Sophia 
Children’s Hospital. Similar studies, including those determining cysteine requirements, 
have been performed previously in the Erasmus MC-Sophia Children’s Hospital (11,12). 
Written informed consent was obtained from one or both parents for all participants 
after a Mandarin-speaking researcher provided a precise explanation of the study.
Experimental design
Tracer washout time
The tracer washout time was determined once in all 11 subjects on day 2. Breath 
samples were collected directly after the [1-13C]phenylalanine was stopped (T0) and 
subsequently every hour during the first 9 h. Over the following 6 h, the breath samples 
were collected every 2 h. Subsequently, samples were collected every 3 h for 9 h until 
a 24-hour period had passed since the beginning of the tracer washout study. These 
samples were compared with the baseline samples of the study day to determine the 
time needed between 2 tracer study days. Subjects were weighed daily, and a head 
circumference was measured at the days that the IAAO study was performed. The study 
protocol is shown in Figure 1.
Figure 1: Study Design
[13C]Bicarbonate [1-13C]phenylalanine
Feeding
Time
0 180 480
Breath
samples
F F F F  F
Tracer
1 2
Adaptation
time in days
Study
formula
IAAO
studyday
Tracer
washout
643 5
X  X X X
 X 
X=IAAO studyday
Figure 1: Study Design
F time of oral feeding (given every hour) 
 time that breath samples were taken
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Adaptation study
Tracer studies were performed on days 1, 2, 4 and 6. On the study days, baseline samples 
were obtained 15 and 5 min before starting the tracer infusion. Directly after the first 
study formula was administered, subjects received a primed (10 µmol∙kg-1) continuous 
(10 µmol∙kg-1·h-1) enteral infusion of [13C]bicarbonate (sterile pyrogen free, 99% 13C APE; 
Cambridge Isotopes, Woburn, MA) for 2.5 h to quantify individual CO2 production. The 
labelled sodium bicarbonate infusion was directly followed by a primed (30 µmol∙kg-1) 
continuous (30 µmol∙kg-1·h-1) enteral infusion of [1-13C]phenylalanine (99% 13C APE; 
Cambridge Isotopes, Woburn, MA) for 5 h by an infusion pump via the nasogastric tube. 
Breath samples were collected on all study days and were obtained using the direct 
sampling method described by van der Schoor et al. (13). During the experiment du-
plicate, 13C-enriched breath samples were collected every 15 min during the isotopic 
steady state, beginning 1.75 h after start of [13C]bicarbonate administration and 3 h after 
the start of [1-13C]phenylalanine administration, as depicted in Figure 1.
Study Formula
The study formula contained 166 mg∙kg-1∙d-1 leucine, which is 50% below the current 
recommended intake for preterm neonates (14). Subjects received the leucine-low 
study formula for 6 d. All of the other essential amino acids were present at levels above 
the current recommendations and are presented in Table 2.
These amino acid concentrations were obtained by mixing a leucine-free formula, 
which also contained decreased amounts of valine and isoleucine (Analog, Danone/SHS 
International, Liverpool, United Kingdom) with regular Neocate, an amino acid based 
formula designed to fulfill the amino acid requirements of infants (Danone/SHS Inter-
national, Liverpool, United Kingdom). Before the start of the study formula, subjects 
received Chinese formula from different brands. All subjects received the study formula 
in 8-12 boluses for 6 d. On these days, subjects received a fluid intake of 170 ml ∙kg-1∙d-1, 
which provided 135 kcal ∙kg-1∙d-1 and a protein intake of 3.7 g ∙kg-1∙d-1, according to the 
current recommendations for preterm infants (14). 
Analysis and Calculations
Samples were sent from Shanghai to Rotterdam every three weeks by air transport.
The 13CO2 isotopic enrichment in expired air was measured using infrared isotope 
analysis (Helifan, Analytic Fischer Instruments, Leipzig, Germany) and expressed as atom 
percent excess (APE) above baseline. APE was plotted relative to time. Steady state was 
defined as three or more consecutive points with a slope not significantly different from 
zero (p ≥ 0.05).
Femke Maingay-de Groof 15-8.indd   46 20-08-12   15:43
47
New insights in the methodological issues of the IAAO method in preterm neonates 
Estimated body CO2 production (mmol ∙kg
-1·h-1) was calculated for each infant as de-
scribed previously (11). The fraction of 13CO2 recovery from [1-
13C]phenylalanine oxida-
tion as a percentage (F13CO2) was calculated using the following equation: 
F13CO2 (%) = [IEPHE x iB ]/[ iPHE x IEB] x 100 (15)
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]phenylalanine infu-
sion (APE), iB is the infusion rate of [
13C]bicarbonate (µmol ∙kg-1·h-1), iPHE is the infusion rate 
of [1-13C]phenylalanine (µmol ∙kg-1·h-1) and IEB is the 
13C isotopic enrichment in expired 
air during [13C]bicarbonate infusion.
Statistical analysis
Descriptive data were expressed as mean ± SD. Steady state of 13CO2 in expired breath 
during the [1-13C]phenylalanine was achieved when the linear factor of the slope was 
found to be not significantly different from zero (p ≥ 0.05). Biphasic linear regression 
analysis was performed to analyze oxidation rates as described below. Statistical analy-
ses were performed using SPSS (SPSS, Chicago, IL, USA). A p-value ≤ 0.05 was considered 
significant. For the washout time, a biphasic regression analysis was determined on the 
breath enrichment values. In this model, a breakpoint is estimated using non-linear re-
gression. With the biphasic linear regression analysis, the regression equation was split 
into 2 parts. For the first part, an intercept and slope were estimated. For the second 
part, the slope was restricted to zero. Therefore, the estimated intercept of the second 
line was equal to the breakpoint. The model with the best fit on the basis of the highest 
r2 was selected. A correction was made to account for the fact that the measurements 
were performed within the same patients. A paired t-test was used to determine the 
differences before and during the study day and to compare measurements from day 1 
Table 2: Intakes of essential amino acids compared to current recommendations
Minimum amino acid recommendations 
for preterm infants (mg∙ 135 kcal-1) (14)
Study formula containing leucine 166 
mg∙kg-1∙d-1 
(mg∙135 kcal -1)
Leucine 340 166
Histidine 72 191
Isoleucine 174 174
Lysine 246 307
Phenylalanine & tyrosine 265 Phe: 224
Tyr: 220
Sulfur amino acid (methionine & cysteine) 115 Met: 83
Cys:121
Threonine 153 214
Tryptophan 51 82
Valine 178 194
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to those from days 2, 4 and 6. The effect of growth during the study and the F13CO2 were 
tested with Pearson’s correlation coefficient analysis.
RESULTS
Eleven patients were enrolled in the study, and the patient characteristics are shown in 
Table 3. Weight gain rates tended to decrease during the study when compared to rates 
before the study, but this trend did not reach significance. In addition, the study was 
not designed or powered to detect differences in weight gain rates. No correlation was 
observed between growth during the study and F13CO2. 
Tracer washout time
The tracer washout time studies were performed on day 2. In 1 patient, two tracer wash-
out studies were performed at day 2 and day 4; therefore, a total of 12 tracer washout 
studies were performed. After the end of the study protocol, the 13C enrichment de-
creased, and stable background enrichment was determined using a biphasic regression 
analysis. From the two-phase regression analysis with time as the independent variable 
and 13C enrichment in APE as the dependent variable, the breakpoint was determined 
to be 7.5 h (r2 = 0.43, p < 0.000) (upper CI: 8.1 h; lower CI: 6.8 h). The return to baseline 
enrichments was determined to be 7.5 h. These results are depicted in Figure 2.
Table 3: Characteristics of subjects (n=11)
Mean ± SD
Birth weight (g) 1860 ± 143 
Gestational age (wks) 32.6 ± 1.5 
Postnatal age (d) 17.4 ± 8.2 
Postconceptional age (wks) 35.0 ± 1.1
Study weight (g) 1948 ± 150
Growth before study (g∙kg-1∙d-1) 15.0 ± 3.8
Growth during the 6 d study diet  (g∙kg-1∙d-1) 12.5 ± 5.5 
Kcal before study 109.6 ± 15.4
Kcal during study 134.4 ± 2.9 *
Protein intake 1 day before study (g∙kg-1∙d-1) 3.03 ± 0.36
Protein intake during study (g∙kg-1∙d-1) 3.67± 0.08 *
*p < 0.05 between before study and during study using paired t-test (2-tailed)
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Baseline enrichments
Baseline enrichments were significantly decreased on the first day when compared 
to all other study days (Table 4). The enrichment increased on the second day on the 
study formula. A small, statistically significant but not relevant difference of 1 PDB was 
observed between the baseline enrichments measured on day 4 and that measured on 
day 6. The large change in the baseline enrichment on the first day on the study formula 
made it impossible to calculate the whole body CO2 for that day. The body CO2 produc-
tion estimated by the infusion of [13C]bicarbonate did not differ between days 2, 4 and 6, 
indicating that energy expenditure did not change over the study period. 
Oxidation rate of the indicator
No difference was observed in F13CO2 levels in infants receiving the study formula 
between days 2 and 4 (Figure 3). However, interestingly, day 6 F13CO2 was significantly 
lower than that measured on the preceding days (days 2 and 6, p= 0.033; days 4 and 6, 
p= 0.043).
Tracer washout time
0 1 2 3 4 5 6 7 8 9 111315182124baseline-0.015
-0.010
-0.005
0.000
0.005
0.010
0.015
0.020
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Figure 2: Tracer washout-time: From the two-phase regression analysis with time as the independent 
variable and 13C enrichment in atom percent excess (APE) as the dependent variable, the breakpoint was 
determined to be 7.5 h (upper CI: 8.1 h; lower CI: 6.8 h)
Table 4: Comparison between days 1, 2, 4 and 6 using paired t-tests 
Day 1 Day 2 Day 4 Day 6
Baseline PDB -23.4 ± 1.1 -17.2 ± 1.3* -16.1 ± 1.2*,   ** -16.3 ± 1.1 *, ***
Fractional oxidation (%) 14.6 ± 6.6 13.0 ± 5.9 11.1 ± 5.6  ***,****
Body CO2 production
(mmol∙kg-1∙h-1)
26.7 ± 1.8 28.0 ± 2.4 28.9 ± 1.8
* p < 0.05 between day 1 and 2/4/6 (2-tailed)
** p < 0.05 between day 2 and 4 (2-tailed)
*** p < 0.05 between day 2 and 6 (2-tailed)
**** p < 0.05 between day 4 and 6 (2-tailed)
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DISCUSSION
Several interesting issues emerge from the present studies. First, energy expenditure is 
remarkably stable over a period of slightly less than a week. Secondly, the washout time 
of tracer is not a rate-limiting step in performing subsequent studies in infants because 
F13CO2 in the expired air returns to baseline levels within 8 h.
However, the present data do not allow us to draw firm conclusions about the time to 
adapt to a study diet. On the one hand, we did not observe differences in fractional 
oxidation rates between days 2 and 4. On the other hand, we did observe a significantly 
lower oxidation rate after 5 d of adaptation. This coincided with a lower weight gain rate 
observed after a period of 6 d. These results can be interpreted in two ways. First, a pe-
riod of at least 5 d of adaptation to a study diet is necessary in IAAO studies determining 
the amino acid requirements in preterm infants. Secondly, the body adapts to a reduced 
essential amino acid intake by decreasing the growth rate, which again is reflected by a 
new equilibrium. In the new equilibrium, there is a decreased requirement for essential 
amino acids because growth is reduced. Therefore, a requirement determined under 
those circumstances would not reflect the optimal intake. If this theory were true, this 
would reflect the remarkable flexibility of the human body to adapt to changing cir-
cumstances. However, one would expect a higher oxidation rate of the indicator amino 
acid, whereas we observed the opposite. For example, Moehn et al. observed higher 
oxidation rates of the indicator in pigs fed a low protein diet after a 1-2 d adaptation 
to the study diet using phenylalanine flux and enriched expired CO2 (24). The only pos-
sible explanation for our results is that the plasma phenylalanine concentration (the 
indicator amino acid) increased, resulting in a lower intestinal absorption of the dietary 
phenylalanine, including the enterally administered 13C phenylalanine. Subsequently, 
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Figure 3: Fractional oxidation rate (F13CO2)  after adaptation to the study diet for 2, 4 and 6 d. A significant 
decrease was observed in F13CO2 between days 2 and 6 (p= 0.033) and between days 4 and 6 ( p= 0.043). * 
p < 0.05 determined by paired t-test (2-tailed).
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plasma enrichment would have been lower, resulting in a lower 13CO2 production rate. 
Unfortunately, we did not collect either blood or urine samples to enable us to test this 
hypothesis. 
Adaptation to a specific diet is widely studied. A decrease in the intake of protein or a 
specific indispensable amino acid intake results in a reduced rate of amino acid oxida-
tion (16-19) and subsequently decreases the rate of nitrogen loss (18). When intakes of 
energy and other nutrients are adequate but the protein level is very low, this decline 
in N-excretion reaches, within a few days to 1 wk, a new, lower and relatively steady 
state (1). Harper described the enzymatic changes that occurred after ingestion of 
low- and high-protein diets (2). Enzymes involved in the metabolism of dispensable 
amino acids responded to the amount of protein consumed, whereas enzymes involved 
in the catabolism of indispensable amino acids adapted to changes in protein intake 
(and indispensable amino acid intake) in relation to the amino acid needs of the body. 
Thus, the capacity to degrade amino acids depends to a considerable extent on the 
diet. A change in the intake of an amino acid is promptly (within a few h) followed by a 
parallel change in its oxidation rate (20, 21). Young and co-workers observed a decrease 
in leucine oxidation in adult humans fed a leucine-restricted diet for 1 and 3 wks (22) 
and a decrease in arginine oxidation in adults receiving an arginine-free diet for 1 and 
4 wks (23), indicating a decrease in catabolism to maintain the body’s equilibrium. In 
an elegant study in which adults received a proline-free diet for 4 wks, a marked differ-
ence was observed in proline kinetics, but only small differences were noted in leucine 
kinetics. Therefore, long-term adaptation to a specific amino acid-deficient diet does 
not result in changes of other amino acids in adults (24). Because these studies used the 
DAAO, which is proposed to produce low oxidation rates in response to lower intakes 
of the test amino acid, these results are not comparable to our results using the IAAO 
method, in which deficient intakes are proposed to give high oxidation rates. Therefore, 
these direct oxidation studies involved a change in the pool size of the amino acid being 
oxidized due to the change in the dietary intake of the same amino acid. In contrast, 
because the IAAO technique employs an unchanging intake and pool size for the oxi-
dized amino acid, it should be expected that the adaptation period for the IAAO method 
would be at least as short as that for the DAAO method and possibly shorter (25). The 
IAAO method is based on the partitioning of the indicator amino acid in either protein 
synthesis or oxidation, which occurs primarily at the acyl-t-RNA level. The adaptation 
needed does not relate to the urea pool, which needs 7 d to achieve an equilibrium, 
but does relate to the turnover of acylated t-RNAs, which adapt in less than 4 h (26). 
Because the Michaelis-Menten constant (Km) for various amino acid degrading enzymes 
are relatively high and are not saturated under the physiological range of plasma or 
tissue amino acid concentrations, the oxidation will respond quite rapidly to a change in 
intracellular amino acid concentrations (2). Whether amino acid requirements for growth 
Femke Maingay-de Groof 15-8.indd   51 20-08-12   15:43
Chapter 2
52
and maintenance have already changed in these few hours is not known, but it does not 
seem likely. A recent IAAO study demonstrated no differences in lysine requirements 
in adults adapted to lower protein intakes with the remark that the test formulas were 
given only on the study day (27). To clear this controversy, a study should be performed 
that compares the requirement of an essential amino acid after 1 and 5 or more days of 
adaptation and meanwhile takes the reduced growth into account. Because we consider 
it unethical to maintain neonates for long periods on a deficient diet, we did not test 
adaptation longer than 6 d and consequently did not resolve the question of whether 
more than 6 d has an additional effect on the tracer oxidation. Further, in adult humans 
fed a 4-wks arginine-free diet, the decrease in oxidation was similar to a 1-wk restriction 
alone (23, 28). 
Previous studies demonstrated that the carry-over effect of the isotope did not affect 
the background enrichment after 2 d (29). Most studies used a latency of 2 d (30, 31) or 7 
d (32, 33) between 2 measurements. We determined a tracer washout time of 7.5 h. This 
makes it possible to measure the same patient on two consecutive study days, as we did 
in the present study. 
A significant increase was observed between the baseline 13C enrichment at day 1 com-
pared to days 2, 4 and 6, implying that time is needed to adapt to the 13C enrichment 
of the study diet. Because every diet differs in naturally enriched 13C depending on the 
carbohydrate source used (34), a period of time is necessary to allow background adapta-
tion to the experimental diet. This is probably a result of the fact that we used European 
formulas, which might be based on different sources of carbohydrates and proteins than 
the Chinese formula that the infants received before the adaptation day. A limitation 
of the present study is that because of the large increase in baseline enrichments after 
the start of the study formula on day 1, the F13CO2 on day 1 was not comparable to that 
measured on the other days. 
In conclusion, our study indicates that a period of time is necessary to adapt to the 13C 
level of the study formula, this adapts within 24h. Furthermore, if adaptation to a specific 
deficient diet has occurred, a tracer study as described here can be performed at daily 
intervals. No conclusive evidence has been generated as to how long an adaptation 
period on a deficient diet should last. No differences in metabolism were shown at day 2 
or day 4, whereas at day 6, significant changes in metabolism were observed, most likely 
as a result of a protein-sparing adaptive response.
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ABSTRACT
Background: The exact requirement of essential amino acids for term and preterm neo-
nates is not known. So far, requirements have been estimated either from the composi-
tion of human milk or are derived using nitrogen balance studies which are known to be 
imprecise. By using a new method, the indicator amino acid oxidation (IAAO) method, 
we are able to determine the exact individual requirement for all essential amino acids in 
both term and preterm infants. This will improve our knowledge on how to feed infants 
and might improve functional outcome in these vulnerable patient groups.
Design: The objective of the study is to quantify the mean requirement of threonine in 
preterm infants. We hypothesize that the current formulas provide too much threonine.
Study design: This will be a randomized, unblinded, non-therapeutic intervention 
study. We will perform the study in fully enterally fed preterm infants. Inclusion criteria 
are: preterm infants with a gestational age of 30-35 weeks, a postnatal age of 28 days 
and a birth weight between -2 SD and + 2 SD for the gestational age.
Intervention: Fully enterally fed preterm infants will randomly receive graded intakes 
of threonine (5-206 mg∙kg-1∙d-1) as part of an elemental formula. After 1 day adaptation 
to the study formula, [13C]bicarbonate and [1-13C]lysine tracers will be given enterally. 
Breath samples containing 13CO2 will be collected during [1-
13C]lysine infusion, measured 
by infrared isotope analysis, and analyzed using a biphasic regression model. We will test 
the mean requirement for threonine by breakpoint estimation. This study will be the first 
to be conducted in a research program that will define the requirement of all 9 essential 
amino acids in preterm infants. These can be compared to the current recommenda-
tions based on the factorial approach and compared to what current preterm formulas 
provide. New recommendations can be made for preterm infant formulas. 
Femke Maingay-de Groof 15-8.indd   58 20-08-12   15:43
59
Threonine requirement in the enterally fed preterm infant
BACKGROUND
Appropriate nutrition is essential for optimal growth and development in the preterm 
and term neonate. Protein is an important component of adequate nutrition as it pro-
vides essential amino acids required for critical protein synthesis and growth. Nutrition 
is especially important during the early phase of life since protein intake in the first 4 
weeks of life has a major influence on later cognitive function (1) and blood pressure (2). 
Classically nine amino acids are regarded as dietary essential; if these amino acids are 
not administered in the right proportions, protein synthesis will be reduced (3, 4). The 
requirement of the indispensable amino acids have been determined by a number of
different methods. Historically, descriptive or gross measures like growth and nitrogen 
balance have been used. New techniques using stable isotopes have shown that adult 
requirements have been underestimated using the balance techniques, and that the 
requirements for adults are 2-3 times higher than the current international recommen-
dations which were based on balance data (5-9). No studies have been performed using 
stable isotope techniques to measure amino acid requirements for enterally fed infants 
properly until recently. Riedijk et al determined the minimal cysteine requirement for 
infants born at gestational age 32-34 wks to be < 18 mg∙kg-1∙d-1. They found that cysteine 
is not a conditionally essential amino acid and that the cysteine requirement does not 
depend on the gestational age or postmenstrual age in enterally fed preterm infants 
born < 29 wks (10, 11). More recently, we determined the requirement of methionine 
and lysine in enterally fed term infants (12, 13), i.e. determined that some of the cur-
rently used formulas provide 2 times too much essential amino acids. This study is the 
first to conduct in a research program that will define the requirement of all 9 essential 
amino acids in preterm infants to optimize infant nutrition. These requirements can be 
compared to the current recommendations based on the factorial approach and com-
pared to what current preterm formulas provide. New recommendations can be made 
for preterm infants based on our mean requirements. The objective of the study is to 
quantify the mean threonine requirement for preterm infants. We hypothesize that the 
current preterm formulas provide too much threonine.
STUDY DESIGN
This will be a multi-centre, non-therapeutic, randomized, unblinded, investigator-initi-
ated intervention study. The study will be performed in the Erasmus MC-Sophia and in 
the High Care Centers of the Sint Franciscus Gasthuis Hospital, Maasstad Hospital (both 
Rotterdam), Albert Schweitzer Hospital in Dordrecht, Amphia Hospital in Breda and the 
HAGA Hospital in the Hague, the Netherlands. Oral and written information about the 
study will be provided to the parents or legal guardians by one of the investigators. Writ-
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ten and signed informed consent will be obtained of both parents or legal guardians 
prior to study initiation. The study started March 2012 and will last for 1-2 yrs. 
Subjects
We will perform the study in fully enterally fed preterm infants. Eligible for the study 
are preterm infants with a gestational age of 30-35 wks and a birth weight between the 
-2 SD and +2 SD for the gestational age.
Inclusion criteria are: 
- fully enterally fed preterm infants as described above
- weight gain rate > 10 g ∙kg-1∙d-1 in preceding 5 d 
-  postnatal age < 28 d
Exclusion criteria are: 
- congenital anomalies
- sepsis
- gastrointestinal pathology
Study formula
The study formula will be identical to regular Neocate, an amino acid based formula de-
signed to fulfil the amino acid requirements for infants (SHS, Liverpool, UK), but without 
threonine and with less lysine. The amount of threonine will be adjusted separately as 
L-threonine. L-lysine will be supplied during the adaptation time and during the infusion 
of [13C]bicarbonate to obtain a stable total intake of 166 mg∙kg-1∙d-1 during the entire 
study. L-alanine will be added separately to make the formula isonitrogenous.
The present minimum recommendations for threonine in preterm infants range from 
113 - 128 mg∙100 kcal-1 (14, 15), this is 138-192 mg∙kg-1∙d-1. In regular Neocate the con-
centration is 180 mg∙100 kcal-1. This supplies 206 mg∙kg-1∙d-1 threonine when an intake 
of 170 mL∙kg-1∙d-1 is given. We will use study formulas containing the following graded 
threonine intakes in mg∙kg-1∙d-1:
5,10,15,20,25,30,35,40,45,50,55,60,65,70,75,80,85,90,100,110,120,130,140,150,160,170,
180,190,200,206.
Tracer protocol
30 min before start of the oxidation study the feeding regimen will be changed into 
continuous drip-feeding via a nasogastric tube. An elemental diet (Neocate®, Danone) 
will be used to provide the infants with different amino acid intakes. After the adaptation 
period of 1 d, subjects will receive a primed (15 µmol∙kg-1) continuous (10 µmol∙ kg-1∙h-1) 
enteral infusion of [13C]bicarbonate (sterile pyrogen free, 99% 13C; Cambridge Isotopes, 
Woburn, MA) by the nasogastric tube for 150 min to quantify individual CO2 production. 
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The IAAO technique uses as indicator a labelled essential amino acid that is different 
from the test amino acid. The indicator is an amino acid labelled with 13C, a stable isotope 
which is safe and non-radioactive. The indicator is independent of the different intake 
levels of the test amino acid and has an oxidative pathway distinct from and unrelated 
to the test amino acid. We have chosen [1-13C]lysine as the indicator which is a safe and 
good indicator as previously shown in (preterm) infants (16, 17). Taking into account 
the first-pass uptake of 18% for lysine [13], and the need to have a substantial tracer 
infusion rate to detect the label in expired air, we chose an amount of 40 µmol ∙kg-1∙h-1 
infusion rate. We will infuse the tracer enterally (by the nasogastric tube) to minimize the 
invasiveness of the experiment in preterm infants. 
The labelled sodium bicarbonate infusion will be directly followed by a primed (50.0 
µmol µmol ∙kg-1) continuous (40 µmol ∙kg-1∙h-1) enteral infusion of [1-13C]lysine (99% 13C; 
Cambridge Isotopes, Woburn, MA) for 4 h. Enterally infused tracer will be mixed with 
the study formula and infused continuously by an infusion pump via the nasogastric 
tube. All infants will be breathing spontaneously but are allowed to need supplemental 
oxygen by a nasal prong. 
Sample collection
Breath samples will be obtained using the direct sampling method described by van der 
Schoor et al. (18) Briefly, a 6 Fr gastric tube (6 Ch Argyle; Cherwood Medical, Tullamore, 
Ireland) will be placed 1 to 1.5 cm into the nasopharynx and end-tidal breath will be 
taken slowly with a syringe connected at the end. Collected air will be transferred into 10 
ml sterile, non-silicon-coated evacuated glass tubes (Van Loenen Instruments, Zaandam, 
the Netherlands) and stored at room temperature until analysis. Baseline samples will be 
obtained 15 and 5 min before starting tracer infusion. During the experiment duplicate 
13C-enriched breath samples will be collected every 10 min during the last 45 min of the 
[13C]bicarbonate infusion and the last hour of the [1-13C]lysine infusion.
Randomisation and blinding 
Individuals will randomly receive one of the 30 intakes of threonine, randomization will 
be obtained by using sealed envelopes. It will be non-blinded study since the investiga-
tor will be the person that calculates and prepares the formulas based on the actual 
weight the day before the study day. It is not necessary to blind this process since it 
cannot influence the results.
Analysis and calculations
We will test the mean requirement of threonine by breakpoint estimation. This will be 
determined by applying a two-phase linear regression crossover model as discussed 
below.
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Analysis of 13CO2 isotopic enrichment in expired air will be performed in the Academic 
Medical Center Amsterdam, where we have ample experience (18-21). Baseline samples 
will be obtained 15 and 5 min before starting tracer infusion. During the experiment 
duplicate 13C-enriched breath samples will be collected every 10 min during the last 45 
min of the [13C]bicarbonate infusion and the last hour of the [1-13C]lysine infusion. The 
13CO2 isotopic enrichment in expired air will be measured using infrared isotope analysis 
(Helifan, Analytic Fischer Instruments, Leipzig, Germany) and expressed as atom percent 
excess (APE) above baseline. APE will be plotted relative to time. Steady state will be 
defined as three or more consecutive points with a slope not significantly different from 
zero (p ≥ 0.05).
Estimated body CO2 production (mmol ∙kg
-1∙h-1) is calculated for each infant as described 
previously (19). The rate of fractional [1-13C]lysine oxidation is calculated as follows:
 fractional lysine oxidation (%) = [IElys x iB ]/[ ilys x IEB] x 100%
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]lysine infusion 
(APE), iB is the infusion rate of [
13C]bicarbonate (µmol ∙kg-1∙h-1), ilys is the infusion rate of 
[1-13C]lysine (µmol ∙kg-1∙h-1) and IEB is the 
13C isotopic enrichment in expired air during 
[13C]bicarbonate infusion.(16)
Univariate analysis
Descriptive data will be expressed as mean ± SD. Steady state of 13CO2 in expired breath 
during the [1-13C]lysine is achieved when the linear factor of the slope is found to be 
not significantly different from zero (P > 0.05). The test amino acid requirement is deter-
mined by using the IAAO method. The rate of oxidation of the indicator amino acid is 
plotted against varying dietary intakes of a test amino acid. The inflection or breakpoint 
in the rate of indicator oxidation represents the physiological requirement of the test 
amino acid (3). Biphasic regression analysis will be performed to analyze oxidation rates. 
All statistical analyses will be performed using SPSS (SPSS, Chicago, IL, USA). 
The power analysis cannot be performed. We aim to study 20 to 35 infants, more than 
studies in parenterally fed infants using the same approach with intravenous adminis-
tration of the tracer (22-24).
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ABSTRACT
Background: Infant nutrition has a major impact on child growth and functional devel-
opment. Low and high intakes of protein or amino acids could have a detrimental effect.
Objective: The objective of the study was to determine the lysine requirement of en-
terally fed term neonates by using the indicator amino acid oxidation (IAAO) method. 
L-[1-13C]phenylalanine was used as an indicator amino acid.
Design: Twenty-one neonates were randomly assigned to lysine intakes that ranged 
from 15 to 240 mg·kg-1·d-1. Breath, urine and blood samples were collected at baseline 
and during the plateau. The mean lysine requirement was determined by using bipha-
sic linear regression crossover analysis on the fraction of 13CO2 recovery from L-[1-
13C]
phenylalanine oxidation (F13CO2) and phenylalanine oxidation rates calculated from the 
L-[1-13C]phenylalanine enrichment of urine and plasma.
Results: The mean (± SD) phenylalanine flux calculated from urine and plasma L-[1-13C]
phenylalanine enrichment data were 88.3 ± 6.9 and 84.5 ± 7.4 µmol·kg-1·h-1, respec-
tively. Graded intakes of lysine had no effect on phenylalanine fluxes. The mean lysine 
requirement determined by F13CO2 was 130 mg·kg
-1·d-1 (upper and lower CIs: 183.7 and 
76.3 mg·kg-1·d-1, respectively). The mean requirement was identical to the requirement 
determined by using phenylalanine oxidation rates in urine and plasma.
Conclusions: The mean lysine requirement of enterally fed term neonates was de-
termined by using F13CO2 and phenylalanine oxidation rates calculated from L-[1-
13C]
phenylalanine enrichment of urine and plasma. These methods yield a similar results of 
130 mg·kg-1·d-1. This study demonstrates that sampling of 13CO2 in expired air is sufficient 
to estimate the lysine requirement by using the IAAO method in infants.
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INTRODUCTION
Lysine is an essential amino acid that is primarily used for protein synthesis (1). In ad-
dition, lysine, together with methionine, is required for the biosynthesis of carnitine, 
which is essential for fatty acid metabolism (2). Lysine is the first limiting amino acid 
in the all cereal-based diet consumed by a large proportion of the world’s population 
(3). A deficiency in the intake of lysine limits protein synthesis and causes weight loss 
in infants (4). In contrast, excess lysine intake also reduces the growth rate of animals 
caused by an imbalanced diet (5, 6). Thus, the dietary intake of amino acids is important 
for the rate of protein synthesis and growth.
Only a few studies have been performed in infants to determined enteral lysine require-
ments (4, 7). The criteria for adequacy of a diet were nitrogen balance and growth rates, 
which may not be the most sensitive methods. Thereby, the number of infants (n = 
6-13) studied was relatively small. Because breast milk is considered to be the optimal 
nutrition for infants ≤ 6 months of age, the joint WHO/FAO/United Nations University 
expert consultation (8) recommended a lysine intake of 119 mg·kg-1·d-1 on the basis of 
the average intake of exclusively breastfed infants rather than on the available experi-
mental evidence. Recently, the indicator amino acid oxidation (IAAO) method has been 
developed to estimate essential amino acid requirements (9).
Our aim was to determine the lysine requirement of enterally fed neonates by using 
the IAAO method. Furthermore, we aimed to test whether requirement estimates on 
the basis of the fraction of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) 
yielded similar results compared twith the phenylalanine oxidation rates measured in 
urine and plasma. In addition, to shorten our study protocol, we compared the lysine re-
quirement derived from F13CO2 data from a short-term (420 min) tracer infusion protocol 
with the results derived from a 900-min infusion protocol.
SUBJECTS AND METHODS
Subjects
Twenty-one neonates admitted to the Neonatal Ward in the Children’s Hospital of Fudan 
University in Shanghai participated in the study. Each subject was selected for study by 
the following criteria: fully enterally fed infants with a gestational age of ≥ 37 weeks, 
birth weight ≥ 2500 grams, and clinically stable with a weightgain rate ≥ 5 g·kg-1·d-1 in 
the preceding 3 days. Subjects were excluded if they had congenital anomalies, gastro-
intestinal pathology, or sepsis. 
The study was approved by the Institutional Review Boards of the Children’s Hospital 
of Fudan University, and a statement of no objection was obtained from the Sophia 
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Children’s Hospital, Erasmus Medical Center Rotterdam. Written consent was obtained 
from at least one of the parents by a Chinese-speaking researcher.
Study formula
The study formula used was an elemental formula that was based on free amino acids. 
The composition was the same as Neocate® (SHS International) except for the lysine 
and phenylalanine content. Lysine, which was completely withdrawn from the study 
formula, was separately added in the form of L-lysine to obtain different amounts of 
intake. The phenylalanine intake was kept constant during the study by separately add-
ing L-phenylalanine during the 24 h adaptation period to obtain the same amount as in 
the Neocate (SHS International), and this amount of phenylalanine was given as stable 
isotope L-[1-13C]phenylalanine on the tracer infusion day. The phenylalanine intake dur-
ing the study was 166 mg·kg-1·d-1, which was above the recommended amount of 72 
mg·kg-1·d-1 (8). A generous amount of tyrosine (166 mg·kg-1·d-1) was provided to ensure 
that the newly formed [1-13C]tyrosine hydroxylated from [1-13C]phenylalanine would be 
directly channeled to oxidation into 13CO2, which can be measured in expired air (10). 
This amount of tyrosine was almost twice the amount ingested by exclusively breastfed 
infants (8). The nitrogen intake was kept constant for all of the subjects by the substitu-
tion of L-alanine for the lysine that was withdrawn. The caloric intake was kept constant 
during the study period in all infants.
Experimental design
The study was designed to determine the lysine requirement of term neonates by us-
ing the minimally invasive IAAO method (9). The IAAO method is based on the concept 
that, when the test amino acid intake is insufficient to meet the requirement, protein 
synthesis will be limited and all of the amino acid will be oxidized, including the indica-
tor amino acid, which is labeled with a stable isotope. As the dietary intake of the test 
amino acid increases, the oxidation rate of the indicator amino acid will decrease until 
the requirement of the test amino acid is met. Once the requirement of the test amino 
acid is met, a additional increase in its intake will have no further influence on the oxida-
tion rate of the indicator amino acid. The oxidation of the indicator amino acid can be 
measured in expired air as 13CO2. To use the IAAO method in infants and children, the 
study protocol must be non-invasive. Initially, the IAAO method was used in adults to 
determine amino acid requirements by measuring the amino acid kinetics in plasma and 
the rate of release of 13CO2 from the oxidation of the indicator amino acid in expired air 
(11-13). Because a good correlation between [1-13C]phenylalanine enrichment in urine 
and plasma has been shown in adults (14, 15) and in neonates (16), the IAAO method 
has been used in vulnerable populations, such as parenterally fed neonates (17-19). The 
method has been additionally adapted to make it minimally invasive by using enteral 
Femke Maingay-de Groof 15-8.indd   70 20-08-12   15:43
71
Lysine requirement of the enterally fed term infant in the first month of life
instead of intravenous isotope administration (20, 21) and additionally simplified by 
using the direct nasopharyngeal sampling method of the expired air (22).
During the study, all infants received a fluid intake of ~150 mL·kg-1·d-1, a caloric intake 
of 108 kcal·kg-1·d-1, and an amino acid intake equal to the protein intake of ~2.96 g·kg-
1·d-1. Infants were randomly assigned to one of the graded test intakes of lysine, which 
ranged from 15 to 240 mg·kg-1·d-1. Each study took place over a 39-h period whereby 
the study formula was fed to the neonates. After 24h of study formula consumption, 
tracers were administered on day 2 for 15 h. Infants were bottle fed every 3h during the 
adaptation period. Subsequently, the feeding regimen changed to hourly bottle feeding 
during the tracer infusion until the end of the study. On the tracer day, a nasogastric 
tube was placed for tracer infusion. Infants received a primed (14 µmol·kg-1) continuous 
(9 µmol·kg-1·h-1) enteral infusion of [13C]bicarbonate (sterile, pyrogen free, 99% 13C APE; 
Cambridge Isotopes) for 3h to quantify individual CO2 production rates. Phenylalanine 
was used as the indicator amino acid. After the [13C]bicarbonate infusion was stopped, a 
primed (34 µmol·kg-1) continuous (27 µmol·kg-1 ·h-1) enteral infusion of L-[1-13C]phenyl-
alanine (99% 13C APE; Cambridge Isotopes) was started and lasted for 12 h. The duration 
of [1-13C]phenylalanine infusion was 12 h, to ensure achievement of the steady state in 
urine and to ensure adequate urine sample collection during the steady state. Syringes 
were weighted before and after the study to determine the exact amount of the tracers 
that were given to the infants. The tracer infusion day is depicted in Figure 1.
Breath samples were obtained by using the direct nasopharyngeal sampling method 
described by van der Schoor et al. (22). Briefly, a 6F gastric tube (6 CH Argyle; Sherwood 
Medical) was placed 1-1.5 cm into the nasopharynx and the end-tidal breath was taken 
slowly with a syringe. Collected air was transferred into 12 mL sterile, non-silicon-coated 
evacuated glass tubes (Van Loenen Instruments) and was stored at room temperature 
until analysis. Baseline breath samples were collected before the start of tracer infu-
Figure 1.
[13C]bicarbonate [1-13C]phenylalanine Tracer 
Feeding 
Time 
(min)
Breath 
samples 
   0                        180                                420                                                                        900             
Urine
samples 
Blood
samples 
Figure 1. Schematic overview of tracer infusion day. Triangles indicate time that bolusfeeding was given.
The arrows indicate the times the breath, urine and plasma samples were taken. 
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sion. Duplicated breath samples were obtained at 15 min intervals during the period 
of 105-180 min after the tracer infusion, and duplicated samples were obtained at 10 
min intervals during the period of 360-420 min (the first plateau period). Another set of 
duplicated samples were obtained at 10 min intervals during the last hour of L-[1-13C]
phenylalanine infusion (the second plateau period). To validate the short term study 
protocol, the requirement estimated during the first 13CO2 enrichment plateau was com-
pared to the requirement estimated during the second plateau. The period of 360-420 
min was chosen because the isotopic steady state of L-[1-13C]phenylalanine in expired 
air was obtained after 360 min of tracer infusion in our pilot study, which was 180 min 
after L-[1-13C]phenylalanine infusion.
Urine samples were collected by using urine bags. One urine sample (1 mL per sample) 
was collected at the baseline, and 4 to 10 samples were collected depending on the 
voiding frequencies of the infants from 360 min onward until the end of the study. Urine 
samples were kept at -80˚C until analysis.
Blood samples (0.5 mL per sample) were collected by venipuncture. One blood sample 
was taken at the baseline and one blood sample at the end of the study. Blood samples 
were collected in anticoagulant tubes and were immediately centrifuged; the plasma 
was stored at -80˚C until analysis.
Analytical procedures
13CO2 isotopic enrichment in breath samples was analyzed by an infrared isotope analysis 
technique (Helifan, Analytic Fischer Instruments). The 13C enrichment was expressed as 
the atom percentage excess above baseline (APE).
Urine and plasma enrichment of L-[1-13C]phenylalanine were measured by gas chroma-
tography-mass spectrometry ( MSD 5975C Agilent GCMS; Agilent Technologies) as their 
ethyl chloroformate ester derivatives. Briefly, amino acid fractions in 50 µL of urine and 
30 µL plasma were isolated by a Dowex cation-exchange resin column (AG 50W-X8, hy-
drogen form, Bio-Rad Laboratories) and were eluted with 0.7 mL 6 M NH4OH. The eluate 
was evaporated under vacuum at room temperature in a speedvac (GeneVac miVac, Ge-
neVac Ltd). Ethyl chloroformate derivatization of the samples was performed according 
to a modified procedure of Hušek (23). A CP-Chirasil L-Val GC column (25 m x 0.25 mm 
id, 0.12 µm film thickness; Varian) was used for the separation of D-[1-13C]phenylalanine 
and L-[1-13C]phenylalanine. An enrichment calibration curve was made for the measure-
ment of L-[1-13C]phenylalanine in urine and plasma. Samples were measured by using 
a selected ion monitoring mode method by using the mass fragments with an m/z of 
176 for the unenriched (M) and a m/z 177 for the enriched (M + 1) L-phenylalanine. Each 
sample was analyzed in triplicate by using gas chromatography-mass spectrometry. 
Enrichments were calculated from the mean of the 3 analyses. Isotopic enrichment was 
calculated at the isotopic steady state and was expressed as mole percent excess (MPE).
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Calculations
The isotopic steady state was represented by plateaus in 13CO2 and L-[1-
13C]phenylala-
nine enrichments in urine. The last plasma sample was considered to be at isotopic pla-
teau. Plateaus were determined by visual inspection and were confirmed by regression 
analysis as a slope not significantly different from zero.
Phenylalanine flux (Q) was measured from the dilution of the administered L-[1-13C]
phenylalanine into the amino acid pool by using enrichments of L-[1-13C]phenylalanine 
in urine or plasma once the isotopic steady state was reached by using the following 
equation:
Qurine or plasma = iPHE × [(IEi ÷ IEurine or plasma) - 1]
where iPHE is the infusion rate of [1-
13C]phenylalanine in µmol·kg-1·h-1, and IEi is the 
isotopic enrichment of L-[1-13C]phenylalanine in the infusate in MPE. IEurine or plasma is the 
isotopic enrichment of L-[1-13C]phenylalanine of urine or plasma, respectively.
The estimated body CO2 production rate (mmol·kg
-1·h-1) was calculated as follows (20):
 
Body CO2 production = [(IEi ÷IEB – 1) × iB] ÷1000
where IEi is the 
13C enrichment of [13C]bicarbonate in the infusate (APE), IEB is the 
13C 
isotopic enrichment in expired air during [13C]bicarbonate infusion (APE), iB is the infu-
sion rate of [13C]bicarbonate (µmol·kg-1·h-1). This equation does not correct for retention 
of labelled carbon within the body bicarbonate pool and will overestimate the CO2 
production rate. However, the same correction factor has to be applied to quantify the 
phenylalanine oxidation rate with the assumption of a constant CO2 production rate dur-
ing the [13C]bicarbonate infusion and during the L-[1-13C]phenylalanine infusion (24). 
Consequently, this correction factor can be diminished in the following equation, and 
there is no need to measure the exact CO2 production rate.
The fraction of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation in percentage 
(F13CO2) was calculated by using the following equation (24):
F13CO2 = (IEPHE × iB) ÷ (iPHE × IEB) × 100
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]phenylalanine infu-
sion (APE), iB is the infusion rate of [
13C]bicarbonate (µmol·kg-1·h-1), iPHE is the infusion rate 
of L-[1-13C]phenylalanine (µmol·kg-1·h-1) and IEB is the 
13C isotopic enrichment in expired 
air during [13C]bicarbonate infusion.
Whole body phenylalanine oxidation by using urinary L-[1-13C]phenylalanine enrich-
ment or plasma L-[1-13C]phenylalanine enrichment was calculated as follows:
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Whole body phenylalanine oxidation = (F13CO2 ÷ 100) × Qurine or plasma
Statistical analysis
Descriptive data are expressed as means ± SDs. The effect of lysine intake on phenylala-
nine was tested with Pearson’s correlation coefficient analysis. The difference in L-[1-13C]
phenylalanine enrichment of urine during isotopic plateau and plasma at 900 min was 
evaluated by a paired t-test. Bland and Altman analysis (25) was used to assess the agree-
ment of L-[1-13C]phenylalanine enrichment of urine during isotopic plateau and plasma 
at 900 min. The determination of the mean lysine requirement (ie, the breakpoint) was 
performed by using a biphasic linear regression crossover model (26). With the biphasic 
linear regression analysis, the regression equation was split into two parts. For the first 
part an intercept and slope were estimated, whereas for the second part, the slope was 
restricted to zero. Therefore, the estimated intercept of the second line was equal to the 
breakpoint. The model with the best fit on the basis of the highest r2 was selected. The 
95% CIs were calculated. The analyses were performed in STATA (version 11; StataCorp 
LP). p < 0.05 was considered significant. 
RESULTS
Subject characteristics
Twenty-one term neonates participated in the study. The neonates were studied at a 
lysine intake that ranged between 15 and 240 mg·kg-1·d-1. Subject characteristics are 
summarized in Table 1. All subjects were growing well before entering the study. The 
mean (± SD) weightgain rate 3 days before the study was 9 ± 4 g∙kg-1∙d-1. The mean (± SD) 
energy intake was 109.1 ± 0.8 kcal·kg-1·d-1. The nitrogen intake was equivalent to a pro-
tein intake of 2.99 ± 0.02 g·kg-1·d-1. The infants were clinically stable and were considered 
healthy because they were discharged on the study day or the day after. The primary 
Table 1: Subject characteristics of infants participating the study (n = 21)
Mean ± SD
Birthweight (kg) 3.3 ± 0.3
Gestational age (wk) 39 ± 1
Age on study day (d) 12 ± 6
Weight on study day (kg) 3.5 ± 0.4
Weight gain before study (g·kg-1·d-1) 9 ± 4
Sex (F:M) 9:12
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reasons for admissions were unconjugated hyperbilirubinemia (n = 15), pneumonia (n = 
3), infection suspicion (n = 2) and skin infection (n = 1). Intravenous antibiotics (penicil-
lins and/or cephalosporins) were given to 15 of the 21 neonates.
Phenylalanine kinetics
Complete data sets of breath and urine samples were obtained from all but one subject. 
We could not obtain the last blood sample from the one infant.
The mean (± SD) phenylalanine flux calculated from urinary enrichment and plasma 
enrichment was 88.3 ± 6.9 µmol·kg-1·h-1 and 84.5 ± 7.4 µmol·kg-1·h-1, respectively. There 
were no significant correlations between urinary phenylalanine flux and lysine intake (p 
= 0.73) or plasma phenylalanine flux and lysine intake (p = 0.53).
The 13C enrichments in expired air of the first and second plateaus during L-[1-13C]phe-
nylalanine infusion are shown in Figure 2. The breakpoints in F13CO2 data as analyzed by 
biphasic linear regression crossover analysis from 13CO2 isotopic enrichment of the first 
plateau (the period 360-420 min) and the second plateau (the period 840-900 min), are 
shown in Figures 3, A and B, respectively. For the first and second F13CO2 plateau data, 
a negative correlation was shown between lysine intake (if the intake increased to 130 
mg·kg-1·d-1) and F13CO2; additional increases in lysine intake did not affect F
13CO2. The 
breakpoint represented the mean lysine requirement, which was 130 mg·kg-1·d-1, with 
95% upper and lower CIs of 188.4 and 71.6 mg·kg-1·d-1, respectively, for the first plateau 
(p < 0.0001, r2 = 0.46). The breakpoint of the second plateau was also 130 mg·kg-1·d-1, 
with 95% upper and lower CIs of 183.7 and 76.3 mg·kg-1·d-1, respectively (p < 0.0001, r2 
= 0.51).
As illustrated in Figure 4, the urinary L-[1-13C]phenylalanine enrichment was significantly 
different from the plasma L-[1-13C]phenylalanine enrichment (p = 0.04, 2-tailed). From 
Figure 2 
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%
Figure 2. 13C enrichments in APE (Mean ± SEM) in expired air during the first (period 360-420 min) and the 
second (period 840-900 min) isotopic plateaus of the [1-13C]phenylalanine infusion (n = 21).
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the Bland and Altman analysis, the mean (upper and lower 95% CIs) difference between 
urine and plasma enrichments was -0.72 (2.06, -3.51) MPE. There was a 5% probability 
that the measured enrichment using urine and plasma differed more than this amount 
(Figure 5). Phenylalanine oxidation calculated from the urine and plasma enrichment 
data also decreased with increasing lysine intake to 130 mg·kg-1·d-1, an additional in-
crease of lysine intake more than 130 mg·kg-1·d-1 did not result in an additional decrease 
Figure 3a.
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Figure 3b.
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Figure 3B. The rates of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) during the second 
isotopic plateau (period 840-900 min), at different lysine intakes (n = 21). Using a biphasic linear 
regression crossover model, the breakpoint was estimated to be 130 mg·kg-1·d-1 (p < 0.0001, r2 = 0.51). The 
upper and lower 95% confidence intervals of the breakpoint estimate were 183.7 and 76.3 mg·kg-1·d-1, 
respectively.
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Figure 3A. The rates of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) during the 
first isotopic plateau (period 360-420 min), at different lysine intakes (n = 21). Using a biphasic linear 
regression crossover model, th  breakpoint was estimated to be 130 mg·kg-1·d-1 (p < 0.0001, r2 = 0.46). The 
upper and lower 95% confidence intervals of the breakpoint estimate were 188.4 and 71.6 mg·kg-1·d-1, 
respectively.
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of phenylalanine oxidation. The breakpoints in the urinary and plasma phenylalanine 
oxidation data are shown in Figures 6A and 6B, respectively. Identical to the breakpoint 
determined by using F13CO2, the breakpoint determined by using phenylalanine oxida-
tion rates in urine and plasma was 130 mg·kg-1·d-1 (p < 0.0001, r2 = 0.51 and p < 0.0001, r2 
= 0.49, respectively). The 95% upper and lower CIs for urine was 183.2 and 76.8 mg·kg-
1·d-1, respectively. The upper CI for plasma was 185.6 mg·kg-1·d-1 and the lower CI was 74.4 
mg·kg-1·d-1.
Figure 4 
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Figure 4. L-[1-13C]phenylalanine enrichments in MPE (Mean ± SEM) in urine during isotopic plateau and 
the L-[1-13C]phenylalanine enrichments in plasma at 900 min.
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Figure 5. Bland-Altman analysis showing the difference between the mean L-[1-13C]phenylalanine 
enrichments in urine during the isotopic plateau and the L-[1-13C]phenylalanine enrichments in plasma 
at 900 min in 20 infants. The mean (upper and lower 95% confidence intervals) difference between urine 
and plasma enrichments was -0.72 (2.06, -3.51) MPE. There was a 5% probability that the measured 
enrichment in urine differs from the measured enrichment in plasma.
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Figure 6a.
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Figure 6A. Phenylalanine (Phe) oxidation calculated from urinary enrichment data at different lysine 
intakes (n = 21). Using a biphasic linear regression crossover model, the breakpoint was estimated to be 
130 mg·kg-1·d-1 (p < 0.0001, r2 = 0.51). The upper and lower 95% confidence intervals of the breakpoint 
estimate were 183.2 and 76.8 mg·kg-1·d-1, respectively.
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Figure 6B. Phenylalanine (Phe) oxidation calculated from the plasma enrichment data at different lysine 
intakes (n = 20). Using a biphasic linear regression crossover model, the breakpoint was estimated to be 
130 mg·kg-1·d-1 (p < 0.0001, r2 = 0.49). The upper and lower 95% confidence intervals of the breakpoint 
estimate were 185.6 and 74.4 mg·kg-1·d-1, respectively.
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DISCUSSION
To our knowledge, this was the first study of the lysine requirement of fully enterally fed 
term neonates that used the IAAO method. The mean lysine requirement of enterally fed 
term neonates was estimated to be 130 mg·kg-1·d-1. 
The experimental evidence for the lysine requirements of infants is very scarce. With 
the use of nitrogen balance and weight gain, Holt and Snyderman (27) estimated lysine 
requirements of 6 infants of postnatal ages between 1 and 5 months to be 90-105 mg·kg-
1·d-1. The difference in estimated requirements with our study might have been due to 
the ages of the infants studied, the small number of infants studied, and the use of the 
nitrogen balance method, which may have underestimated the requirement. Fomon et 
al. (7) observed adequate growth in 13 normal full term female infants during ages of 8 
to 41 days with an average lysine intake of 114 mg·kg-1·d-1, which was in the same range 
as our estimates. The infants in the study of Fomon et al. (7) were fed ad libitum, which 
meant that the infants can regulate their own intake, which resulted in a wide range of 
observed intakes.
Recently, Chapman et al. (17) estimated the lysine requirement of parenterally fed post-
surgical neonates by using the IAAO method to be 104.9 mg·kg-1·d-1. Because the use of 
dietary essential amino acids by the intestine results in a lower systemic availability of 
these essential amino acids (28, 29), a higher amino acid requirement can be expected 
in fully enterally fed neonates. The first-pass lysine uptake in preterm infants with full 
enteral feeding was 18% (29). In our results, a requirement of 130 mg·kg-1·d-1 fit perfectly 
in the parenteral requirement determined by Chapman et al. (17) at a first pass use of 
20%.
The current recommended lysine intake is based on human milk composition (8). Hu-
man milk has huge variations in protein concentrations; the protein content declines 
from 23 g/L on post partum day 3 to 14 g/L on day 28 (30, 31). This decline in protein 
content is accompanied by changes in the whey-casein ratio (32); consequently, the 
amino acid composition changes during the lactation period. However, the average 
lysine intake estimated in exclusively breastfed infants in the first month of life is 119 
mg·kg-1·d-1 (8), which is comparable with our estimated requirement. The gross amino 
acid composition of human milk may not necessarily reflect the requirement profile of 
infants who consume infant formula because protein andamino acid digestibility and 
bioavailability are different in human milk from that in formula. Our study provided 
scientific knowledge of amino acid needs of infants fed an infant formula.
Raffii et al. (33) showed that change in phenylalanine hydroxylation, which is the first 
step in phenylalanine oxidation was better represented by apoB-100 instead of plasma 
phenylalanine. However, the requirement derived from F13CO2 data in our study was 
identical to the requirement estimated from the urine and plasma L-[1-13C]phenylala-
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nine enrichment data. The reason for the same estimates might have been due to the 
relative small range of distribution of phenylalanine flux in our study caused by the strict 
control of amino acid intake and the continuous tracer infusion. Because phenylalanine 
oxidation was calculated by multiplying F13CO2 with the flux, and the flux was constant, 
the phenylalanine oxidation rate consequently depended on the F13CO2. Moreover, by 
using the [13C]bicarbonate method, which thereby determined the changes in 13CO2 
of each individual infant during both the [13C]bicarbonate and L-[1-13C]phenylalanine 
infusions (which corrected the bicarbonate retention individually), the F13CO2 can be 
measured more accurately. 
Our second aim was to compare the lysine requirement from a short period tracer 
infusion protocol with a 900 min infusion protocol. Both protocols yielded identical 
requirement estimates. Therefore, we concluded that a short (and, thus, less invasive) 
IAAO protocol is valid for enterally fed infants.
We showed a small but significant difference of L-[1-13C]phenylalanine enrichment in 
urine compared with plasma. Amino acid enrichment in urine is assumed to reflect 
the enrichment in arterialized blood. The difference might be because urine samples 
represent average enrichment values during the collection period, whereas plasma rep-
resents enrichment at a specific time and site of sampling. In our study, urine samples 
were collected in the period before the collection of the venous blood sample from the 
hand or foot. Another explanation might be that isotopic steady state had not yet been 
reached in urine of neonates who had relative long voiding intervals, which resulted 
in few urine samples at steady state. The lower urinary L-[1-13C]phenylalanine enrich-
ment compared with in plasma was also shown in the studies by Zello et al. (15) and 
Bross et al. (14) in adults. A possible explanation is the short tracer infusion time (4 h), 
which resulted in non steady-states. The lack of significance in the study by Bross et al. 
(14) was possibly the consequence of a small number of subjects (n = 4). Wykes et al. 
(16) observed a higher enrichment in urine compared with plasma. This observation 
might have been due to the contamination of D-[1-13C]phenylalanine in the tracer. A 
recent study showed a significant confounding effect of D-phenylalanine in urine even 
when [1-13C]phenylalanine was used with optical purity of 0.1% in neonates (34). We 
used a chiral column for the separation of the D- and L-phenylalanine to overcome this 
problem.
There were some limitations in our study design. The study was performed by using an 
amino acid formula. Metges et al. (35) have shown that leucine oxidation is higher and 
non-oxidative leucine disposal is lower when an amino acid diet is used compared with 
when a casein diet is used. These results suggest that leucine derived from an amino 
acid diet has a lower utilization rate. Their findings were supported by the study of Dan-
gin et al. (36), which demonstrated that the protein digestion rate is an independent 
factor of protein retention. The effect of the decreased utilization rate of amino acids by 
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consuming an amino acid diet could result in higher requirement estimates compared 
with consumption of a protein diet. Therefore, our determined lysine requirement could 
have been an overestimation. Future studies with an intrinsically labelled protein that 
is the closest simulation to a normal dietary amino acid intake are required to evaluate 
this issue.
Another limitation of our study was the antibiotic used in our study population. 
Antibiotics are extensively prescribed to children who are admitted to the children’s 
hospitals in China (37). As a result of this practice, 15 of 21 infants in our study received 
intravenous antibiotics. Antibiotic treatment has a major impact on the bacterial flora in 
the gastrointestinal tract (38), and it has been shown that microbial lysine can be made 
available to a human host (39, 40). Previous studies did not clarify the issue whether 
microbial lysine contributes to the dietary amino acid requirement estimates (41). To our 
knowledge, there are no data in the literature on antibiotic use and its effect on essential 
amino acid requirements.
In conclusion, this study was the first in a series of studies designed to determine the 
essential amino acid requirements of enterally fed neonates by using the adapted mini-
mal invasive IAAO method. Under the conditions of this study, the lysine requirement 
of enterally fed term neonates was 130 mg·kg-1·d-1. Current term formulas provide an 
excess of lysine (172-256 mg·kg-1·d-1) according to our estimated mean requirement (42, 
43). The lack of knowledge with regard to the optimal amino acid pattern in formula 
feeding is a reason to perform additional studies on the amino acid requirements of 
enterally fed infants to optimize nutrition for (preterm) infants.
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ABSTRACT
Background: Knowledge of the essential amino acid requirements for infants is im-
portant because excessive intake can lead to increased long-term morbidity, such as 
obesity. A deficient intake can lead to suboptimal growth and impaired neurodevelop-
ment. Current recommended isoleucine requirement for infants aged 0 to 1 month (95 
mg∙kg-1∙d-1) is based on the amino acid content of human milk. 
Objective: To quantify the isoleucine requirement for term neonates using the indicator 
amino acid oxidation (IAAO) method with [1-13C]phenylalanine as the indicator.
Design: Fully enterally fed term infants received randomly graded amounts of isoleu-
cine (5-216 mg∙kg-1∙d-1) as part of an elemental formula. After 1 day adaptation to the 
test diet [13C]bicarbonate and [1-13C]phenylalanine tracers were given enterally. Breath 
samples containing 13CO2 were collected during [1-
13C]phenylalanine infusion, measured 
by infrared isotope analysis, and analyzed using a biphasic regression model. Data are 
expressed as mean ± SD. 
Results: Twenty-two Asian term neonates (birth weight 3.22 ± 0.41 kg, gestational age 
39.5 ± 1.2 wks) were studied at a postnatal age of 12 ± 5 d. The mean isoleucine require-
ment (at breakpoint) was 105 mg∙kg-1∙d-1 (r2 = 0.61, p < 0.001). The upper and lower CIs 
were determined to be 150 and 60 mg∙kg-1∙d-1, respectively.
Conclusion: Our study shows that the current human milk-based recommendation for 
isoleucine in term infants aged 0 to 1 month are correct. The IAAO method should be 
used to determine the requirements for valine and leucine as well to validate current 
recommendations.
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INTRODUCTION
The increased prevalence and severity of obesity in children has renewed an interest in 
feeding patterns during infancy. High early weight gain in the first 1-2 years of life is as-
sociated with adverse health outcomes later in life, including increased blood pressure 
(1), increased weight gain and body fat deposition (2-5) and an increased risk of diabetes 
(6). The higher protein intake in infants who are fed formula may play a role with these 
health outcomes because formula-fed infants reach a higher body weight and weight for 
length at one year of age compared with infants who are fed breast milk (7, 8). However, 
early nutrition (especially protein intake) correlates with improved neurodevelopment 
in preterm infants (9, 10). Thus, protein intake should be strictly regulated early in life to 
result in the best possible neurodevelopment while reducing the risk of obesity.
The current recommended isoleucine requirement for infants aged 0 to 1 month (95 
mg∙kg-1∙d-1) is based upon the amino acid content of human milk, which is considered 
to be the optimal nutrition for infants up to 6 months of age (11). Breastfed infants, 
however, have a variable milk consumption rate, which makes it difficult to provide an 
accurate estimation of the amino acid intake, and they largely regulate the intake they 
require themselves (12-14). Our group recently showed that the indicator amino acid 
oxidation (IAAO) method is a minimally invasive method that can be used to determine 
the amino acid requirement in neonates (15). To validate current recommendations 
based on human milk we will determine the requirement for all the nine essential amino 
acids in term neonates. 
The branched-chain amino acids (BCAAs) valine (Val), isoleucine (Ile) and leucine (Leu) 
are similar in structure and share common enzymes for transamination and oxidative 
decarboxylation (16, 17). Considerable interaction has been reported in humans and 
animals in response to disproportional intake of BCAAs. In rats, the antagonism of BCAAs 
results in impaired growth, and BCAA supplementation has negative effects on fetal 
brain growth (17). BCAA-enriched total parental nutrition results in decreased apnea 
and an improvement of the respiratory pattern and function in premature neonates (18). 
A high BCAA concentration in plasma, which has been observed for infants who are 
fed formula with a high protein content, may affect insulin metabolism, carbohydrate 
metabolism, weight gain and the future incidence of diabetes (19, 20). Identifying the 
optimal isoleucine intake and the optimal BCAA ratio can benefit neonates. Therefore, 
the aim of the present study is to determine the mean isoleucine requirement for term 
neonates.
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SUBJECTS AND METHODS
Subjects
Term infants (n= 22) admitted to the Neonatology Department of the Fudan Children’s 
Hospital in Shanghai, China, between September 2008 and July 2009 were enrolled in 
this study. The infants’ gestational age was 37 to 43 wks, their birth weight exceeded 2.5 
kg and their postnatal age was ≤ 28 d. Each infant was clinically stable and in an anabolic 
growth state as shown by a weight gain ≥ 5 g∙kg-1 ∙d-1 over the previous 3 days. All toler-
ated full enteral feeding well and had no congenital or gastrointestinal diseases. The 
study protocol was approved by the Medical Ethics Committee of the Fudan Children’s 
Hospital and a statement of no objection was obtained from the Medical Ethics Com-
mittee of the Erasmus MC- Sophia’s Children’s Hospital. Similar studies, such as those 
determining cysteine requirements, have been performed previously at the Erasmus 
MC-Sophia Children’s Hospital (21, 22). Written informed consent was obtained from 
one or both parents for all participants after a Mandarin-speaking researcher provided a 
precise explanation of the study. 
Experimental design
The study is based on the minimally invasive IAAO method that our group recently 
modified for use in enterally fed infants by using a short period of adaptation to the test 
diet (1 d), enterally infused isotopes and the sampling of expired air without the sam-
pling of amino acid enrichments in urine of plasma (15). The IAAO technique (23) uses 
an indicator that is oxidized when one essential amino acid is limiting; typically, there is 
no storage of amino acids because they are incorporated into protein or metabolized by 
oxidation (24). If the tested amino acid is deficient in the diet, protein synthesis will be 
limited, causing the indicator amino acid to be oxidized. Upon the increase of the dietary 
intake of the test amino acid, indicator oxidation will decrease until the test amino acids’ 
requirement is met. Once the intake meets a critical threshold (or requirement), protein 
synthesis can occur at an optimum capacity, and the oxidative degradation of all other 
essential amino acids reaches a plateau. The mean requirement for the test amino acid 
is identified by this breakpoint.
The subjects were randomly assigned to receive graded amounts of isoleucine ranging 
from 5 to 216 mg∙kg-1∙d-1. Each infant received a different intake and was studied one 
time with one intake. After adaptation to the study diet for 24 h, baseline breath samples 
were obtained, and a tracer protocol was initiated, as depicted in Figure 1. Subjects were 
weighed daily, before and at the end of the tracer protocol. 
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Study Formula
The study formula was based on an amino acid-based formula designed to fulfill infants’ 
amino acid requirements of infants (SHS, Liverpool, United Kingdom), but without 
isoleucine and with reduced phenylalanine to compensate for the tracer. The amount of 
isoleucine was adjusted separately as L-isoleucine. L-phenylalanine was supplied during 
the adaptation period and during the infusion of [13C]bicarbonate to obtain a stable to-
tal intake of 166 mg∙kg-1∙d-1 throughout the entire study. L-alanine was added separately 
to make the formula isonitrogenous. The formula’s amino acids, fat, carbohydrates and 
energy content are shown in Table 1. The osmolality of the study formula is 330 Osm/L. 
The minerals, trace elements and vitamins of the formula were described previously (25). 
Because phenylalanine, which is hydroxylated to tyrosine before oxidation can occur, 
served as indicator, we made sure that tyrosine intake exceeded present requirements. 
A tyrosine intake of 166 mg∙kg-1∙d-1 was provided ,which is almost twice the human milk-
based recommendated intake of 90 mg∙kg-1∙d-1,to ensure that the newly formed [1-13 C] 
tyrosine hydroxylated from [1-13C]phenylalanine would be directly channeled into 13CO2 
which could be measured in expired air (26).
We used [1-13C]phenylalanine as a tracer, but because the tracer behaves identical to 
the tracee, phenylalanine intake was appropriate and constant for the complete dura-
tion of the study. On the adaptation day the subjects were fed every 3 h. On the study 
day the subjects were fed by a continuous dripfeeding during the [13C]bicarbonate 
infusion to minimize the variance in CO2 production which is dependent on the feeding 
regimen (27). We changed it into hourly feedings during [1-13C]phenylalanine infusion 
to minimize the discomfort because the infants were used to drink their own bottles. 
This hourly feeding regimen has shown a steady state during 4h of [1-13C]phenylalanine 
infusion in our previous study (15).
[13C]Bicarbonate [1-13C]phenylalanineTracers
Feeding
Time
minutes  0 150 420
Breath
sample
Figure 1: Study design after one day of adaptation to the study diet 
 time of oral feeding (given every hour) 
—— continuous feeding (dripfeeding) 
  time that breath samples were taken
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Tracer protocol
On the study day, the subjects received a primed (14 µmol∙kg-1) continuous (9 µmol∙kg-
1·h-1) enteral infusion of [13C]bicarbonate (sterile pyrogen free, 99% 13C atom percent 
excess (APE); Cambridge Isotopes, Woburn, MA) for 2.5 h to quantify individual CO2 pro-
duction. The labelled sodium bicarbonate infusion was directly followed by a primed (34 
µmol∙kg-1), continuous (27 µmol∙kg-1·h-1) enteral infusion of [1-13C]phenylalanine (99% 
13C APE; Cambridge Isotopes, Woburn, MA) for 4.5 h by an infusion pump via the naso-
gastric tube. Our previous study showed that this short-term protocol of 420 min was 
sufficient to determine the lysine requirement when compared to a 900 min infusion 
protocol; they showed a similar requirement in breath, urine and plasma (15). Syringes 
with tracers were weighed before and after infusion to determine the exact amount of 
tracer administered during the study.
Table 1: Energy, carbohydrates, fat and amino acid content of the study formula1. 
Component Per 100g formula
Energy (kcal) 475
Carbohydrates (g) 54
Fat (g) 23
Total amino acid (g) 13 
L-Alanine (g) 2 ≥ 0.61
L-Arginine (g) 1.08
L-Asparagine (g) 1.01
L-Cyst(e)ine (g) 0.4
Glycine (g) 0.95
L-Histidine (g) 0.62
L-Isoleucine (g) 3 0
L-Leucine (g) 1.63
L-Lysine (g) 1.11
L-Methionine (g) 0.26
L-Phenylalanine (g) 4 0.20 
L-Proline (g) 1.16
L-Serine (g) 0.71
L-Threonine (g) 0.8
L-Tryptophan (g) 0.32
L-Tyrosine (g) 0.73
L-Valine (g) 1.04
L-Carnitine (g) 0.01
Taurine (g) 0.03
L-Glutamine (g) 1.34
1 The study formula was based on Neocate (Danone, United Kingdom), an amino acid based formula.
2  Variable levels of L-alanine were added to the diet depending on the test isoleucine
level of each infant to maintain an isonitrogenous diet. The study formula contained at 
least 0.61 g L-alanine per 100 g formula.
3 L-isoleucine was added separately, depending on the test isoleucine level.
4  0.53 g L-phenylalanine per 100 g formula was added to the study diet on day 1.
Equivalent amount of L-phenylalanine (0.52 g per 100 g formula) was given as isotope on day 2.
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Sample collection 
On the study day, baseline samples were obtained 5 and 15 min before starting the 
tracer infusion using the direct sampling method, as described by van der Schoor et al. 
(28). Duplicate 13C-enriched breath samples were collected every 10 min starting after 
1.75 h during the isotopic steady state of the [13C]bicarbonate infusion and then every 
15 min during the isotopic steady state of the [1-13C]phenylalanine infusion starting 
after 3 h, as depicted in Figure 1. 
Analysis and Calculations
Samples were sent from Shanghai to Rotterdam every 3 wks by air transport. The 13CO2 
isotopic enrichment in expired air was measured using infrared isotope analysis (Helifan, 
Analytic Fischer Instruments, Leipzig, Germany) and expressed as the APE above baseline. 
Steady state was defined as 3 or more consecutive points with a slope not significantly 
different from zero (p ≥ 0.05). The estimated body CO2 production (mmol∙kg
-1∙h-1) was 
calculated for each infant as previously described (15, 29). The fraction of 13CO2 recovery 
from [1-13C]phenylalanine oxidation in percentage (F13CO2) was calculated by using this 
equation (30):
F13CO2 (%) = [IEPHE x iB ]÷[ iPHE x IEB] x 100
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]phenylalanine infu-
sion (APE), iB is the infusion rate of [
13C]bicarbonate (μmol∙kg-1∙h-1), iPHE is the infusion rate 
of [1-13C]phenylalanine (μmol∙kg-1∙h-1) and IEB is the 
13C isotopic enrichment in expired air 
during [13C]bicarbonate infusion. 
Phenylalanine flux was not obtained. As shown in our previous study, the test amino 
acid intake has no effect on the phenylalanine flux (15). Regarding the potential interac-
tion of the BCAAs; in enterally fed adults, valine kinetics were determined at different 
leucine intakes and leucine kinetics were determined at different valine and isoleucine 
intakes. Valine turnover did not change among the various intakes of valine and leucine. 
Leucine flux was also not affected by the valine or the isoleucine intakes. Valine and 
leucine requirements were not affected by the ratio of BCAA used when given within a 
physiological range (31, 32).
Statistical analysis
Descriptive data are expressed as the mean ± SD. The effect of weight gain on F13CO2 was 
tested with Pearson’s correlation coefficient analysis. A paired t-test was used to test the 
difference between the weight for age z-score at birth and the weight for age z-score at 
the study day. The effects of isoleucine intake on mean 13CO2 enrichment at the isotopic 
plateau during [13C]bicarbonate infusion, and on CO2 production rate were tested with 
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Pearson’s correlation coefficient analysis. Mean isoleucine requirement was determined 
by applying a two-phase regression model (24, 33) on the F13CO2 values. In this model a 
breakpoint is estimated using non-linear regression. With the biphasic lineair regression 
analysis, the regression equation was split into 2 parts. For the first part, an intercept and 
slope were estimated. For the second part, the slope was restricted to zero. Therefore, 
the estimated intercept of the second line was equal to the breakpoint. The model with 
the best fit (based on the highest r2) was selected. The 95% confidence intervals (CIs) 
were calculated. All statistical analyses were performed with STATA (version 11; Stata-
Corp LP). A p-value < 0.05 was considered significant. The power analysis could not be 
performed. We aimed to study 20-25 infants which is a higher number of subjects than 
was studied in the IAAO studies that used intravenous administration of the tracer in 
parenterally fed infants (34-36).
RESULTS
Clinical characteristics
The clinical characteristics of the 22 subjects studied are presented in Table 2. A total 
of 22 oxidation studies were performed. The reasons for admission were unconjugated 
hyperbilirubinemia (n=8), pneumonia with a negative blood culture (n= 7), infection 
suspicion with a negative blood culture (n= 3), cardiac arrhythmia (n=2), asphyxia (n=1) 
and pneumothorax (n=1). The infants were in a clinically stable condition and consid-
ered healthy as demonstrated by their weight gain rates and the fact that they were 
discharged on the study day or the day after. The mean weight gain rate in the five 
days before the study was 12.6 ± 6 g∙kg-1 ∙d-1. The weight for age z-scores at birth and 
the weight for age z-scores at the study day were determined as shown in Table 2. The 
Table 2: Subject characteristics, protein and caloric intake before and during the study (n = 22).
Mean ± SD
Gestational age at birth (wks) 39.5 ± 1.2
Age at study (d) 12 ± 5
Birth weight (g)
Weight for age z-score at birth 
3.22 ± 0.41
- 0.25 ± 1.04
Weight at study day (g)
Weight for age z-score at study day
3.36 ± 0.41
- 0.55 ± 1.00
Male:Female ratio 9:13
Intake during study (mL∙kg-1·d-1)
Intake during study day (g formula∙kg-1·d-1)
150.2 ± 0.7
22.8 ± 0.1
Caloric intake before study (kcal∙kg-1·d-1)
Caloric intake during study (kcal∙kg-1·d-1)
112 ± 8.3
108.2 ± 0.5
Protein intake before study (g∙kg-1·d-1)
Protein intake during study (g∙kg-1·d-1)
2.53 ± 0.25
2.96 ± 0.15
Femke Maingay-de Groof 15-8.indd   96 20-08-12   15:43
97
Isoleucine requirement for enterally fed term neonates in the first month of life
weight for age z-score at the study day was significantly lower than the weight for age 
z-score at birth (p < 0.000, 2-tailed). 
Expired CO2 enrichment 
All subjects achieved an isotopic steady state (plateau) at both the [13C]bicarbonate and 
the [1-13C]phenylalanine infusion as shown in Figure 2. The baseline 13CO2 enrichment 
was -18.45 ± 1.11 pee dee belemnite (PDB) (0.0000 APE). The mean 13CO2 enrichment 
at isotopic plateau during [13C]bicarbonate infusion was 0.0370 ± 0.0043 APE. The cor-
responding mean CO2 production rate was 24.45 ± 3.01 mmol∙kg
-1∙h-1. No correlation was 
found between isoleucine intake and the mean 13CO2 enrichment at isotopic plateau (p= 
0.21) or between the isoleucine intake and the CO2 production rate (p=0.13).
The mean 13CO2 enrichment at isotopic plateau during [1-
13C]phenylalanine infusion was 
0.0203 ± 0.0040 APE. The mean 13CO2 enrichments during [1-
13C]phenylalanine infusion 
were plotted against isoleucine intakes and are shown in Figure 3A.
No correlation was found between weight gain before the study and F13CO2 (p = 0.35).
Figure 2
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Figure 2: Mean ± SD 13C enrichments in APE in expired air at isotopic plateaus: the first plateau is during 
[13C]bicarbonate infusion (T105-T150)  and second plateau is during [1-13C]phenylalanine infusion (T330-
420). APE: atom percent excess.
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Figure 3A: Mean 13CO2 enrichment of each infant at isotopic plateau during [1-
13C]phenylalanine infusion 
plotted against isoleucine intake (n=22). 
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Overall there was a significant decrease in fractional oxidation when isoleucine intake 
increased (r2 = 0.61, p < 0.001). From the two-phase regression analysis with isoleucine 
intake as the independent variable and fractional oxidation of the [1-13C]phenylalanine 
tracer as the dependent variable, the breakpoint was determined to be 105 mg∙kg-1·d-1 
(Figure 3B). The upper and lower 95% CIs of the breakpoint estimate were determined 
to be 150 and 60 mg∙kg-1∙d-1, respectively.
DISCUSSION
The mean isoleucine requirement in term neonates fed an elemental diet using the IAAO 
method is 105 mg∙kg-1∙d-1. The current recommended isoleucine requirement based on 
human milk is 95 mg∙kg-1∙d-1 in infants aged 0 to 1 month. The present data suggest that 
the current human milk-based recommendations for isoleucine are correct. 
There are no isotopic data for individual isoleucine requirements in humans or animals. 
In 1964, Snyderman et al. (37) determined the isoleucine requirement in 6 healthy male 
infants to be between 79 and 126 mg∙kg-1∙d-1 based on the nitrogen balance method and 
weight gain. The nitrogen balance method underestimated the amino acid requirements 
in adults (38) which was likely due to the failure to account for miscellaneous nitrogen 
losses. Because a limited amount of available data regarding amino acid requirements 
in infants and children, the use of a factorial approach was proposed to define dietary 
indispensable amino acid requirements (11, 39). This method uses the obligatory losses 
as maintenance requirement and adds the nutrients needed for growth. Using the facto-
rial approach, Dewey et al. (40) determined the isoleucine requirement in infants aged 0 
to 1 month to be 59 mg∙kg-1∙d-1 and implied that breast milk provided on average a 45% 
excess of indispensable amino acids at 0  month of age. Because the fact that the intake 
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Figure 3B: F13CO2 during the isotopic plateau at different isoleucine intakes (n=22).  Each infant received 
a different intake and was studied one time with one intake. With the use of a biphasic linear regression 
model the breakpoint (mean isoleucine requirement) was estimated to be 105 mg∙kg-1∙d-1 (r2 = 0.61, p < 
0.001). The upper CI was 150 mg∙kg-1∙d-1 and the lower was 60 mg∙kg-1∙d-1. APE: atom percentage excess; 
F13CO2 : fraction of recovery from [1-
13C]phenylalanine oxidation.
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of breast milk from a healthy, well-nourished mother is considered to satisfy protein 
requirements in the first 6 months of life, the amino acid content of breast milk was 
considered to be the best estimate of amino acid requirement for this group. Recently, 
we determined the mean lysine requirement using the IAAO method in term neonates 
to be comparable to the recommendation based on human milk (130 mg∙kg-1∙d-1 vs. 119 
mg∙kg-1∙d-1 ), and the mean isoleucine requirement determined in the present study was 
also similar to the recommendation based on human milk (105 mg∙kg-1∙d-1 vs. 95 mg∙kg-
1∙d-1) (15). The mean methionine requirement determined by our group, however, was 
substantially higher than the estimations based on human milk (38 mg∙kg-1∙d-1 vs. 28 
mg∙kg-1∙d-1) (25) but the requirement based on human milk was within the 95% confi-
dence interval determined by the IAAO method. Our estimations might overestimate 
requirements because a higher amount of amino acids derived from intact casein are 
utilized for protein synthesis than the proportion derived from an equivalent intake of 
free amino acids (41). Because human milk contains approximately 25% of non- protein 
nitrogen and calculations on human milk are based on the 75% of total nitrogen in 
breastfed infants, the actual amino acid intake in breastfed children might be slightly 
higher than the current recommendations (i.e., because the non-protein content of milk 
includes some free amino acids) (11). Indeed, the actual mean isoleucine requirement 
for infants aged 0 to 1 month might be between 95 and 105 mg∙kg-1·d-1. 
Isoleucine requirements should be considered and compared with the requirements for 
the other BCAAs valine and leucine, which are similar in structure and share common 
enzymes for transamination and oxidative decarboxylation (16, 17). Recent studies have 
shown that certain characteristics (e.g., the ratio between individual BCAAs) influence 
protein synthesis (42, 43). A high intake of leucine by humans or animals enhances 
the activity of branched chain keto-acid dehydrogenase (BCKAD) in various tissues 
(which catalyzes the decarboxylation of the BCAAs) (17, 44), and decreases valine and 
isoleucine concentrations in the blood. As described earlier, in adults it was shown that 
individual BCAA requirements do not change when the BCAA ratio was changed within 
the physiological range (32). Because these studies were performed using the direct 
oxidation model, one could argue whether this is also true for the indirect method in 
which the test amino acid differs from the indicator amino acid and the potential for 
antagonism might be increased. Highly elevated leucine concentrations (four to six fold 
above normal concentrations) decreased the concentrations of other amino acids such 
as valine, isoleucine, phenylalanine, tyrosine and methionine, probably as a result of al-
tering amino acid transport (45). Interestingly, the reduction in the amino acids concen-
trations was determined to be a leucine-specific effect, e.g. valine and isoleucine intake 
had limited effect on the concentrations of phenylalanine, tyrosine and methionine (46). 
Because phenylalanine is the indicator amino acid in our study, the phenylalanine flux 
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is not allowed to change. We did not study the phenylalanine flux in the present study 
but the upper amount of isoleucine was within normal ranges (max 216 mg∙kg-1·d-1), 
as we used a commercial formula. So besides the fact that isoleucine is not known to 
influence phenylalanine kinetics, the amount of isoleucine in the highest ranges of our 
study is not likely to result in a significant effect on the phenylalanine plasma concentra-
tions. However, no studies have been performed in human neonates who have higher 
turnover rates and might react differently. Pencharz et al. studied a wide range of BCAA 
intakes in neonatal piglets, without an effect on phenylalanine flux (43), while also no 
change in phenylalanine flux was noted at different BCAA intakes in five 20 year old male 
syrup disease patients (47).
Regular protein and amino acid based formulas provide a maximum isoleucine of ap-
proximately 100-230 mg∙kg-1∙d-1 at an intake of 150-180 ml∙kg-1∙d-1 (48-51). A previous 
study showed no correlation between urinary phenylalanine flux and lysine intake or 
plasma phenylalanine flux and lysine intake (15).
By determining the BCAA requirements individually we can determine the optimal 
BCAA ratio in enterally fed infants. The current recommendated Ile:Leu:Val ratio in 
enteral feeding is 1:1.8:1 (39). Different formulas use BCAAs in different Ile:Leu:Val ratios 
depending on their casein-whey ratio (i.e.,1 : 1.4 : 0.9 – 1 : 2.3 : 1.2) (48-51). Identifying 
the optimal BCAA ratio can optimize infant nutrition. It would also be interesting to 
determine the BCAA ratio in parenteral nutrition because a BCAA ratio of 1 : 1 : 1 in 
parentally fed piglets is considered optimal, and isoleucine is considered to be the most 
limiting BCAA (52).
Previous studies in enterally fed subjects have shown that intrasubject variation is the 
major source of variability in amino acid requirements and is a potential source of error 
in the estimation of amino acid requirements in humans (53, 54). Present study shows a 
wide variability, reflected in the 95% confidence interval range of the breakpoint estima-
tion. We postulate that the variability is largely the result of interindividual differences, 
with a possible cause being the enterally infused tracer because its oxidation depends 
on the rate of gastric emptying (55). A wide variability is also shown in the mean weight 
gain in the 5 days before the study. This might be the result of catch-up weight gain 
after recovery since all infants were admitted at the neonatal ward for several reasons (as 
described in the results section), and might have had suboptimal intakes before admis-
sion to the hospital. At the study day they were considered healthy since they were 
discharged on the study day or the day after. For children during rapid recovery, a high 
value of 70% for the efficiency of protein utilization is assumed whereas a value of 58% 
is assumed for normal children (11). Because the mean weight for age z-score was above 
the -2 at the study day (i.e., there was no wasting) we postulate that it did not influence 
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the requirements. If there was a minimal effect, the mean requirement would be lower 
because of the more efficient protein utilization of the diet. 
The present study shows that current recommendations based on the content of amino 
acids in breast milk are correct. The factorial approach in infants aged 0  month that was 
calculated by Dewey et al. seems to underestimate the requirements in these infants. 
The IAAO method should be used to determine the requirements for valine and leucine 
and the optimal BCAA ratio in term infants to validate current recommendations based 
on human milk. 
Femke Maingay-de Groof 15-8.indd   101 20-08-12   15:43
Chapter 5
102
REFERENCES
 1. Bansal N, Ayoola OO, Gemmell I, Vyas A, Koudsi A, Oldroyd J, Clayton PE, Cruickshank 
JK. Effects of early growth on blood pressure of infants of British European and South 
Asian origin at one year of age: the Manchester children’s growth and vascular health 
study. J Hypertens 2008;26:412-8.
 2. Toschke AM, Grote V, Koletzko B, von Kries R. Identifying children at high risk for over-
weight at school entry by weight gain during the first 2 years. Arch Pediatr Adolesc 
Med 2004;158:449-52.
 3. Wells JC. The programming effects of early growth. Early Hum Dev 2007;83:743-8.
 4. Stettler N. Nature and strength of epidemiological evidence for origins of childhood 
and adulthood obesity in the first year of life. Int J Obes (Lond) 2007;31:1035-43.
 5. Singhal A, Lanigan J. Breastfeeding, early growth and later obesity. Obes Rev 2007;8 
Suppl 1:51-4.
 6. Dunger DB, Salgin B, Ong KK. Session 7: Early nutrition and later health early develop-
mental pathways of obesity and diabetes risk. Proc Nutr Soc 2007;66:451-7.
 7. Koletzko B, von Kries R, Monasterolo RC, Subias JE, Scaglioni S, Giovannini M, Beyer J, 
Demmelmair H, Anton B, Gruszfeld D, et al. Can infant feeding choices modulate later 
obesity risk? Am J Clin Nutr 2009;89:1502S-1508S.
 8. Koletzko B, von Kries R, Closa R, Escribano J, Scaglioni S, Giovannini M, Beyer J, 
Demmelmair H, Gruszfeld D, Dobrzanska A, et al. Lower protein in infant formula is 
associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr 
2009;89:1836-45.
 9. Lucas A, Morley R, Cole TJ, Gore SM, Davis JA, Bamford MF, Dossetor JF. Early diet in 
preterm babies and developmental status in infancy. Arch Dis Child 1989;64:1570-8.
 10. Stephens BE, Walden RV, Gargus RA, Tucker R, McKinley L, Mance M, Nye J, Vohr BR. 
First-week protein and energy intakes are associated with 18-month developmental 
outcomes in extremely low birth weight infants. Pediatrics 2009;123:1337-43.
 11. WHO/FAO/UNU. Protein and Amino Acid Requirements in Human Nutrition. Public 
Health Nutrition 2005;Vol. 8: No. 7(A). 7. 92-4-120935-6_CH01_7.
 12. Allen JC, Keller RP, Archer P, Neville MC. Studies in human lactation: milk composition 
and daily secretion rates of macronutrients in the first year of lactation. Am J Clin Nutr 
1991;54:69-80.
 13. Hofvander Y, Hagman U, Hillervik C, Sjolin S. The amount of milk consumed by 1-3 
months old breast- or bottle-fed infants. Acta Paediatr Scand 1982;71:953-8.
 14. Neville MC, Keller R, Seacat J, Lutes V, Neifert M, Casey C, Allen J, Archer P. Studies in 
human lactation: milk volumes in lactating women during the onset of lactation and 
full lactation. Am J Clin Nutr 1988;48:1375-86.
 15. Huang L, Hogewind-Schoonenboom JE, de Groof F, Twisk JW, Voortman GJ, Dorst K, 
Schierbeek H, Boehm G, Huang Y, Chen C, et al. Lysine requirement of the enterally fed 
term infant in the first month of life. Am J Clin Nutr 2011;94:1496-503.
 16. Champe PCH, R.A. Amino acids: metabolism of carbon atoms. In: Biochemistry 
(Champe, P.C. & Harvey, R.A. eds.) 1987;pp 242-252:pp. 242-252.
 17. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr 
1984;4:409-54.
Femke Maingay-de Groof 15-8.indd   102 20-08-12   15:43
103
Isoleucine requirement for enterally fed term neonates in the first month of life
 18. Blazer S, Reinersman GT, Askanazi J, Furst P, Katz DP, Fleischman AR. Branched-
chain amino acids and respiratory pattern and function in the neonate. J Perinatol 
1994;14:290-5.
 19. Jarvenpaa AL, Rassin DK, Raiha NC, Gaull GE. Milk protein quantity and quality in the 
term infant. II. Effects on acidic and neutral amino acids. Pediatrics 1982;70:221-30.
 20. Lonnerdal B, Chen CL. Effects of formula protein level and ratio on infant growth, 
plasma amino acids and serum trace elements. II. Follow-up formula. Acta Paediatr 
Scand 1990;79:266-73.
 21. Riedijk MA, van Beek RH, Voortman G, de Bie HM, Dassel AC, van Goudoever JB. Cyste-
ine: a conditionally essential amino acid in low-birth-weight preterm infants? Am J Clin 
Nutr 2007;86:1120-5.
 22. Riedijk MA, Voortman G, van Beek RH, Baartmans MG, Wafelman LS, van Goudoever 
JB. Cyst(e)ine requirements in enterally fed very low birth weight preterm infants. 
Pediatrics 2008;121:e561-7.
 23. Zello GA, Pencharz PB, Ball RO. Dietary lysine requirement of young adult males deter-
mined by oxidation of L-[1-13C]phenylalanine. Am J Physiol 1993;264:E677-85.
 24. Ball RO, Bayley HS. Tryptophan requirement of the 2.5-kg piglet determined by the 
oxidation of an indicator amino acid. J Nutr 1984;114:1741-6.
 25. Huang LH-SJ, Dongen MJA, de Groof F, Voortman GJ, Schierbeek H, Twisk JWR, Vermes 
A, Chen C, Huang Y, van Goudoever JB. Methionine requirement of the enterally fed 
term infant in the first month of life in presence of cysteine. American Journal of Clini-
cal Nutrition 2012;Accepted March 1, 2012.
 26. Shiman R, Gray DW. Formation and fate of tyrosine. Intracellular partitioning of newly 
synthesized tyrosine in mammalian liver. J Biol Chem 1998;273:34760-9.
 27. Hoerr RA, Yu YM, Wagner DA, Burke JF, Young VR. Recovery of 13C in breath from 
NaH13CO3 infused by gut and vein: effect of feeding. Am J Physiol 1989;257:E426-38.
 28. van der Schoor SR, de Koning BA, Wattimena DL, Tibboel D, van Goudoever JB. Valida-
tion of the direct nasopharyngeal sampling method for collection of expired air in 
preterm neonates. Pediatr Res 2004;55:50-4.
 29. Riedijk MA, Voortman G, van Goudoever JB. Use of [13C]bicarbonate for metabolic 
studies in preterm infants: intragastric versus intravenous administration. Pediatr Res 
2005;58:861-4.
 30. van der Schoor SR, Reeds PJ, Stellaard F, Wattimena JD, Sauer PJ, Buller HA, van Gou-
doever JB. Lysine kinetics in preterm infants: the importance of enteral feeding. Gut 
2004;53:38-43.
 31. Pelletier V, Marks L, Wagner DA, Hoerr RA, Young VR. Branched-chain amino acid inter-
actions with reference to amino acid requirements in adult men: valine metabolism at 
different leucine intakes. Am J Clin Nutr 1991;54:395-401.
 32. Pelletier V, Marks L, Wagner DA, Hoerr RA, Young VR. Branched-chain amino acid inter-
actions with reference to amino acid requirements in adult men: leucine metabolism 
at different valine and isoleucine intakes. Am J Clin Nutr 1991;54:402-7.
 33. Seber GA. Linear regression analysis. John Wiley and sons, New York, NY. 1977.
 34. Chapman KP, Courtney-Martin G, Moore AM, Ball RO, Pencharz PB. Threonine require-
ment of parenterally fed postsurgical human neonates. Am J Clin Nutr 2009;89:134-41.
Femke Maingay-de Groof 15-8.indd   103 20-08-12   15:43
Chapter 5
104
 35. Courtney-Martin G, Chapman KP, Moore AM, Kim JH, Ball RO, Pencharz PB. Total sulfur 
amino acid requirement and metabolism in parenterally fed postsurgical human 
neonates. Am J Clin Nutr 2008;88:115-24.
 36. Chapman KP, Courtney-Martin G, Moore AM, Langer JC, Tomlinson C, Ball RO, Pencharz 
PB. Lysine requirement in parenterally fed postsurgical human neonates. Am J Clin 
Nutr 2010;91:958-65.
 37. Snyderman SE, Boyer A, Norton PM, Roitman E, Holt LE, Jr. The Essential Amino Acid 
Requirements of Infants. Ix. Isoleucine. Am J Clin Nutr 1964;15:313-21.
 38. Young VR, Bier DM, Pellett PL. A theoretical basis for increasing current estimates of 
the amino acid requirements in adult man, with experimental support. Am J Clin Nutr 
1989;50:80-92.
 39. Institute of Medicine FaNB. Dietary Reference Intakes for Macronutrients. In: Acad-
emies UN, ed. Washington: National Academy Press, 2005.
 40. Dewey KG, Beaton G, Fjeld C, Lonnerdal B, Reeds P. Protein requirements of infants and 
children. Eur J Clin Nutr 1996;50 Suppl 1:S119-47; discussion S147-50.
 41. Metges CC, El-Khoury AE, Selvaraj AB, Tsay RH, Atkinson A, Regan MM, Bequette BJ, 
Young VR. Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unla-
belled or intrinsically labelled casein. Am J Physiol Endocrinol Metab 2000;278:E1000-
9.
 42. Riazi R, Rafii M, Wykes LJ, Ball RO, Pencharz PB. Valine may be the first limiting branched-
chain amino acid in egg protein in men. J Nutr 2003;133:3533-9.
 43. Elango R, Pencharz PB, Ball RO. The branched-chain amino acid requirement of paren-
terally fed neonatal piglets is less than the enteral requirement. J Nutr 2002;132:3123-
9.
 44. Block KP, Harper AE. Valine metabolism in vivo: effects of high dietary levels of leucine 
and isoleucine. Metabolism 1984;33:559-66.
 45. Hagenfeldt L, Eriksson S, Wahren J. Influence of leucine on arterial concentrations and 
regional exchange of amino acids in healthy subjects. Clin Sci (Lond) 1980;59:173-81.
 46. Eriksson S, Hagenfeldt L, Wahren J. A comparison of the effects of intravenous infusion 
of individual branched-chain amino acids on blood amino acid levels in man. Clin Sci 
(Lond) 1981;60:95-100.
 47. Riazi R, Rafii M, Clarke JT, Wykes LJ, Ball RO, Pencharz PB. Total branched-chain amino 
acids requirement in patients with maple syrup urine disease by use of indicator 
amino acid oxidation with L-[1-13C]phenylalanine. Am J Physiol Endocrinol Metab 
2004;287:E142-9.
 48. Viadel B, Alegria A, Farre R, Abellan P, Romero F. Amino acid profile of milk-based infant 
formulas. Int J Food Sci Nutr 2000;51:367-72.
 49. Decsi T, Veitl V, Burus I. Plasma amino acid concentrations, indexes of protein metabo-
lism and growth in healthy, full-term infants fed partially hydrolyzed infant formula. J 
Pediatr Gastroenterol Nutr 1998;27:12-6.
 50. Hernell O, Lonnerdal B. Nutritional evaluation of protein hydrolysate formulas in 
healthy term infants: plasma amino acids, hematology, and trace elements. Am J Clin 
Nutr 2003;78:296-301.
 51. Nutritionals MJ. Product Information Magazine Nutramigen.
Femke Maingay-de Groof 15-8.indd   104 20-08-12   15:43
105
Isoleucine requirement for enterally fed term neonates in the first month of life
 52. Elango R, Goonewardene LA, Pencharz PB, Ball RO. Parenteral and enteral routes of 
feeding in neonatal piglets require different ratios of branched-chain amino acids. J 
Nutr 2004;134:72-8.
 53. Van Aerde JE, Sauer PJ, Pencharz PB, Canagarayar U, Beesley J, Smith JM, Swyer PR. 
The effect of energy intake and expenditure on the recovery of 13CO2 in the parenter-
ally fed neonate during a 4-hour primed constant infusion of NAH13CO3. Pediatr Res 
1985;19:806-10.
 54. Bross R, Ball RO, Pencharz PB. Development of a minimally invasive protocol for the 
determination of phenylalanine and lysine kinetics in humans during the fed state. J 
Nutr 1998;128:1913-9.
 55. Sanaka M, Yamamoto T, Kuyama Y. Retention, fixation, and loss of the [13C] label: a re-
view for the understanding of gastric emptying breath tests. Dig Dis Sci 2008;53:1747-
56.
Femke Maingay-de Groof 15-8.indd   105 20-08-12   15:43
Femke Maingay-de Groof 15-8.indd   106 20-08-12   15:43
Chapter
6Valine requirement for enterally fed term 
neonates in the first month of life
Femke de Groof
Lisha Huang
Gardi J. Voortman
Andras Vermes
Jos W.R. Twisk 
Chao Chen
Ying Huang
Johannes B. van Goudoever
Provisionally accepted Am J Clin Nutr 
Femke Maingay-de Groof 15-8.indd   107 20-08-12   15:43
Chapter 6
108
ABSTRACT
Background: Knowledge of newborns’ essential amino acid requirement is important 
to prevent long term morbidity. Excess amino acid intake can lead to obesity; deficient 
intake to reduced growth and cognitive development. The currently recommended va-
line requirement for infants aged 0 to 1 month (95 mg∙kg-1∙d-1) is based upon the amino 
acid content of human milk. Since human milk composition shows remarkable variation, 
studies are needed to validate these data.
Objectives: To quantify the valine requirements for term neonates using the indicator 
amino acid oxidation (IAAO) method with [1-13C]phenylalanine as the indicator.
Design: Fully enterally fed term infants received randomly graded intakes of valine (5-
236 mg∙kg-1∙d-1) as part of an elemental formula. After 1 day adaptation to the study 
formula, [13C]bicarbonate and [1-13C]phenylalanine tracers were given enterally. Breath 
samples containing 13CO2 were collected during [1-
13C]phenylalanine infusion, measured 
by infrared isotope analysis, and analyzed using a biphasic regression model.
Results: Twenty-eight Asian term male neonates (birth weight 3.39 ± 0.44 kg, gesta-
tional age 39.5 ± 1.2 wks) were studied at a mean postnatal age of 15 ± 7 d. The mean 
requirement (at breakpoint) was 110 mg∙kg-1∙d-1 ( r2 = 0.35, p = 0.001) (upper and lower 
CIs: 164 and 56 mg∙kg-1∙d-1).
Conclusion: Our study shows that the present recommendations for valine in term in-
fants aged 0 to 1 month based on the amino acid content of human milk are close to our 
mean requirement determined with the IAAO method and are within our confidence 
interval.
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INTRODUCTION
Knowledge of the essential amino acid requirements for (preterm) infants is important 
since excessive or deficient intake might lead to long term morbidity such as obesity (1, 
2) or suboptimal growth and impaired neurodevelopment (3, 4). Protein intake should 
be strictly regulated early in life to result in the best possible neurodevelopment while 
reducing the risk of obesity. According to the World Health Organization, exclusive 
breastfeeding by a healthy mother is the feeding standard from birth to 6 months in 
healthy, term infants. The current recommended valine requirement for term infants 
aged 0 to 1 month (95 mg∙kg-1∙d-1) is based upon the amino acid content of human milk 
(5). Since breastfed children have quite variable milk intakes it is difficult to provide an 
accurate estimation based on human milk (6-8). Furthermore, the human milk composi-
tion varies over the different stages on lactation; the protein intake of breastfed infants 
decreases from 1.7- 2.09 g∙kg-1∙d-1 at 0-1 month to 0.9- 1.2 g∙kg-1∙d-1 at 3-4 months (9, 
10). Other methods are needed to validate current recommendations. The IAAO method 
is a minimally invasive method to determine amino acid requirement in neonates (11, 
12) and children (13). Our group estimated the mean requirement for methionine and 
lysine in infants in the first month of life with the IAAO method. The mean requirement 
of methionine showed to be higher than current recommendations based on human 
milk, the lysine requirement we found was comparable to the recommendations based 
on human milk (11, 12). To validate current recommendations based on human milk, 
our objective was to determine the valine requirements for enterally fed neonates using 
the IAAO technique. Our second objective was to determine the time needed to allow 
background adaptation to the experimental diet.
SUBJECTS AND METHODS
Subjects
Term male infants (n=28) admitted between September 2008 and March 2009 to the 
Neonatology Department of the Fudan Children’s Hospital in Shanghai, China, were 
enrolled in this study. Their gestational age was 37-43 wks, birth weight exceeded 2.5 
kg and their postnatal age was ≤ 28 days. They were clinically stable and in a positive 
growth state as shown by a weight gain > 5 g∙kg-1∙d-1 over the last 5 days. All tolerated full 
enteral feeding well and had no congenital or gastrointestinal disease. The study pro-
tocol was approved by the Medical Ethical Committee of the Fudan Children’s Hospital 
and a statement of no objection was obtained from the Medical Ethical Committee of 
the Erasmus MC- Sophia’s Children’s Hospital. Similar studies, such as those determin-
ing cysteine requirements, have been previously performed in the Erasmus MC-Sophia 
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Children’s Hospital (14, 15). Written informed consent was obtained from one or both 
parents for all participants after precise explanation of the study by a Mandarin speak-
ing researcher.
Experimental design
The study is based on the minimally invasive IAAO method which our group recently 
modified to apply in enterally fed infants by using a short adaptation period to the test 
diet (1 d), enterally infused isotopes and sampling of expired air without sampling of 
amino acid enrichments in urine of plasma (11). The IAAO technique (16) uses an indica-
tor that is oxidized when one essential amino acid is limiting. Because there is no storage 
of amino acids and amino acids must be partitioned between incorporation into protein 
or oxidation (17). If the tested amino acid is deficient in the diet, this will limit protein 
synthesis and the indicator amino acid, which is in excess at low protein synthesis rates, 
will be oxidized. Upon the increase of the dietary intake of the test amino acid, oxidation 
of the indicator will decrease until the requirement of the test amino acid is met. Once 
intake meets a critical threshold (or requirement), protein synthesis can occur at an opti-
mum capacity, and the oxidative degradation of all other essential amino acids reaches 
plateau. The mean requirement of the test amino acid is identified by this breakpoint. 
Subjects were randomly assigned to receive graded amounts of valine ranging from 5 
to 236 mg∙kg-1∙d-1. Each infant received a different intake and was studied one time with 
one intake except for one infant that was measured twice. After adaptation to the study 
diet for 24 h, baseline breath samples were obtained, and a tracer protocol was initiated 
as depicted in Figure 1. Subjects were weighed daily, before and at the end of the tracer 
protocol.
In our protocol the infants adapt to the study formula for 24 h. The natural enrichment of 
stable isotopes is normally accounted for by taking baseline samples prior to the start of 
Breath
samples
   0 180         330    390                   480
[13C]Bicarbonate [1-13C]phenylalanine
▲ ▲ ▲
Tracer
Feeding
Time
minutes
Figure 1: Study design after one day of adaptation to the study diet 
▲: time of oral feeding (every 3 h) 
: time that breath samples were taken
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the isotope infusion, and then subtracting the enrichment of the baseline sample from 
all the samples obtained during and/or after the isotope infusion. Since every diet differs 
in naturally enriched 13C (18) a period is necessary to allow background adaptation to 
the experimental diet. Because we used European formulas which might be based on 
different sources of carbohydrate and protein than the Chinese formulas the infants 
received before the adaptation day, we also determined the time needed to reach a 
stable background enrichment in the first 8 patients.
Study Formula
The study formula was based on an amino acid based formula designed to fulfil the 
amino acid requirements of infants (SHS, Liverpool, United Kingdom), but without valine 
and with reduced phenylalanine to compensate for the tracer. The amount of valine was 
adjusted separately as L-valine. L-phenylalanine was supplied during the adaptation 
time and during the infusion of [13C]bicarbonate to obtain a stable total intake of 166 
mg∙kg-1∙d-1 during the entire study. L-alanine was added separately to make the formula 
isonitrogenous. The amino acids, fat, carbohydrates and energy content of the study 
formula are shown in Table 1. The minerals, trace elements and vitamins of the formula 
were described previously (12). Since phenylalanine, which is hydroxylated to tyrosine 
before oxidation can occur, served as indicator, we made sure that tyrosine intake ex-
ceeded present requirements. Limited tyrosine intake reduces recovery of 13C label in 
expiratory air. A tyrosine intake of 166 mg∙kg-1∙d-1 was provided which is almost twice 
the human milk-based recommendated intake of 90 mg∙kg-1∙d-1 to ensure that the newly 
formed [1-13 C] tyrosine hydroxylated from [1-13C]phenylalanine would be directly chan-
neled into 13CO2 which could be measured in expired air (19).
We used [1-13C]phenylalanine as a tracer, but because the tracer behaves identical to the 
tracee, phenylalanine intake was appropriate and constant for the complete duration of 
the study. Both on the adaptation day and study day subjects were fed every 3 h.
Tracer protocol
On the study day subjects received a primed (14 µmol∙kg-1) continuous (9 µmol∙kg-1·h-1) 
enteral infusion of [13C]bicarbonate (sterile pyrogen free, 99% 13C atom percent excess 
(APE); Cambridge Isotopes, Woburn, MA) for 3 h to quantify individual CO2 produc-
tion. The labelled sodium bicarbonate infusion was directly followed by a primed (27 
µmol∙kg), continuous (27 µmol∙kg-1·h-1) enteral infusion of [1-13C]phenylalanine (99% 13C 
APE; Cambridge Isotopes, Woburn, MA) for 5 h by an infusion pump via the nasogastric 
tube. The syringes with tracers were weighed before and after infusion to determine the 
exact amount of tracer given during the study.
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Sample collection
Breath samples of the first 8 patients were collected before start of the study formula at 
the adaptation day and every 30 min for 8.5 h to determine the time needed to obtain a 
stable background enrichment, using the direct sampling method described by van der 
Schoor et al. (20). These samples were compared to the baseline samples at the study 
day (t= 1440) when 24 h of adaptation was achieved. At the study day, baseline samples 
were obtained 15 and 5 min before starting tracer infusion. Duplicate 13C-enriched 
breath samples were then collected every 10 min during the isotopic steady state of the 
[13C]bicarbonate infusion starting after 1.75 h, and next every 15 min during the isotopic 
steady state of the [1-13C]phenylalanine infusion starting after 3 h as depicted in Figure 
1.
Table 1: Energy, carbohydrates, fat and amino acid content of the study formula1
Component Per 100g formula
Energy (kcal) 475
Carbohydrates (g) 54
Fat (g) 23
Total amino acid (g) 13 
L-Alanine (g) 2 ≥ 0.61
L-Arginine (g) 1.08
L-Asparagine (g) 1.01
L-Cyst(e)ine (g) 0.4
Glycine (g) 0.95
L-Histidine (g) 0.62
L-Isoleucine (g) 0.95
L-Leucine (g) 1.63
L-Lysine (g) 1.11
L-Methionine (g) 0.26
L-Phenylalanine (g) 3 0.20 
L-Proline (g) 1.16
L-Serine (g) 0.71
L-Threonine (g) 0.8
L-Tryptophan (g) 0.32
L-Tyrosine (g) 0.73
L-Valine (g)4 0
L-Carnitine (g) 0.01
Taurine (g) 0.03
L-Glutamine (g) 1.34
1 The study formula was based on Neocate (Danone, United Kingdom), an amino acid based formula
2  Variable levels of L-alanine were added to the diet depending on the test valine level of each infant to maintain 
an isonitrogenous diet. The study formula contained at least 0.61 g L-alanine per 100 g formula.
3  0.53 g L-phenylalanine per 100 g formula was added to the study diet on day 1.
Equivalent amount of L-phenylalanine (0.52 g per 100 g formula) was given as isotope on day 2.
4 L-valine was added separately, depending on the test valine level.
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Analysis and Calculations
Samples were sent from Shanghai to Rotterdam every three weeks by air transport.
13CO2 isotopic enrichment in expired air was measured by isotope ratio mass spectrome-
try (Helifan, Analytic Fischer Instruments, Leipzig, Germany) and expressed as APE above 
baseline. Steady state was defined as three or more consecutive points with a slope not 
significantly different from zero (p ≥ 0.05). Estimated body CO2 production (mmol∙kg
-
1∙h-1) was calculated for each infant as described previously (11, 21). The fraction of 13CO2 
recovery from [1-13C]phenylalanine oxidation in percentage (F13CO2) was calculated as 
described previously (12, 22). Phenylalanine flux was not obtained. As shown in our 
previous study, the test amino acid intake has no effect on the phenylalanine flux (11). 
Regarding the potential interaction of the BCAAs; in enterally fed adults, valine kinetics 
were determined at different leucine intakes and leucine kinetics were determined at 
different valine and isoleucine intakes. Valine turnover did not change among the vari-
ous intakes of valine and leucine. Leucine flux was also not affected by the valine or the 
isoleucine intakes. Valine and leucine requirements were not affected by the ratio of 
BCAA used when given within a physiological range (23, 24).
Statistical analysis
Descriptive data were expressed as mean ± SD. For the background enrichment a bipha-
sic regression analysis was determined on the breath enrichment values as described 
below. An adjustment was made for the fact that repeated measurements within the 
same patients were used for analysis. The effect of valine intake on mean 13CO2 enrich-
ment at isotopic plateau during [13C]bicarbonate infusion, and on CO2 production rate 
were tested with Pearson’s correlation coefficient analysis. Mean valine requirement was 
determined by applying a two-phase regression model (17, 25) on the fractional oxida-
tion rates. In this model a breakpoint is estimated using non-linear regression. With the 
biphasic lineair regression analysis, the regression equation was split into 2 parts. For 
the first part, an intercept and slope were estimated. For the second part, the slope was 
restricted to zero. Therefore, the estimated intercept of the second line was equal to 
the breakpoint. The model with the best fit on the basis of the highest r2 was selected. 
The 95% confidence intervals were calculated. All statistical analyses were performed 
with STATA (version 11; StataCorp LP). A p-value < 0.05 was considered significant. The 
power analysis cannot be performed. We aimed to study 30 infants equal to our previous 
studies (11, 12) which is a higher amount of subjects than the IAAO studies performed 
in parenterally fed infants which used intravenous administration of the tracer (26, 27).
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RESULTS
Clinical characteristics
Clinical characteristics of the 28 subjects studied are presented in Table 2. A total of 
29 oxidation studies were performed, as one subject was measured twice with two 
different valine intakes. All subjects were male term Asian neonates. The reasons for 
admission were pneumonia with negative bloodculture (n=13), unconjugated hyper-
bilirubinemia (n=5), asphyxia (n=4), pneumothorax (n=2), infection suspicion with a 
negative blood culture (n=2), RS-bronchiolitis (n=1) and humerus fracture (n=1). Infants 
were studied just before discharge, when they were in a clinically stable condition and 
considered healthy as demonstrated by their weight gain rates and the fact that they 
were discharged on the study day or the day after. The mean weight gain in the 5 days 
before the study was 10.7 ± 4.3 g∙kg-1∙d-1.
Expired CO2 enrichment 
All subjects achieved isotopic steady state (plateau) at both the [13C]bicarbonate and 
[1-13C]phenylalanine infusion. In the first 8 subjects, the mean background enrichment 
at the adaptation day before the start of the study formula was – 27.45 ± 1.15 pee dee 
belemnite (PDB). On the adaptation day, a stable background enrichment was achieved 
after 282 ± 9.6 min or the ingestion of two bottles of formula in the first 8 subjects as 
shown in Figure 2. The mean baseline 13CO2 enrichment of the 22 subjects at the study 
day was -19.83 ± 1.42 PDB (0.0000 APE). The mean 13CO2 enrichment at isotopic plateau 
during [13C]bicarbonate infusion was 0.0389 ± 0.0059 APE. The corresponding mean CO2 
production rate was 23.26 ± 3.57 mmol∙kg-1∙h-1. The mean 13CO2 enrichment at isotopic 
plateau and the corresponding CO2 production rate were plotted against the valine 
intake (Figure 3A and 3B respectively). No correlation was found between valine intake 
and the mean 13CO2 enrichment at isotopic plateau (p= 0.46) and between the valine 
intake and the CO2 production rate ( p=0.37).
Table 2. Subject characteristics, protein and caloric intake before and during the study (n = 28).
Mean ± SD
Gestational age at birth (wks) 39.5 ± 1.2
Age at study (d) 15 ± 7
Birth weight (kg) 3.39 ± 0.44
Weight at study day (kg) 3.67 ± 0.53
Male:Female ratio 28:0
Intake during study (mL∙kg-1·d-1) 150.2 ± 0.8
Intake during study day (g formula∙kg-1·d-1)
Caloric intake before study (kcal∙kg-1·d-1)
Caloric intake during study (kcal∙kg-1·d-1)
Protein intake before study (g∙kg-1·d-1)
22.8 ± 0.1
112.8 ± 13.8
108.1 ± 0.6
2.43 ± 0.27
Protein intake during study (g∙kg-1·d-1) 2.96 ± 0.15
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The mean 13CO2 enrichment at isotopic plateau during [1-
13C]phenylalanine infusion was 
0.0216 ± 0.0065 APE. The mean 13CO2 enrichments during [1-
13C]phenylalanine infusion 
are plotted against valine intakes which is shown in Figure 4A.
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Figure 2: Background enrichment adaptation versus time (in PDB) to the study formula (n=8), expressed 
as box plots. PDB: pee dee belemnite.
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Figure 3A: mean 13CO2 enrichment of each infant at isotopic plateau during [
13C]bicarbonate infusion 
plotted against valine intake (n=28).
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Figure 3B: The CO2 production rate of each infant plotted against the valine intake (n=28).
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Overall there was a significant decrease in fractional oxidation when valine intake in-
creased (r2 = 0.35, p =0.001). From the two-phase regression analysis with valine intake 
as the independent variable and F13CO2 as the dependent variable, the breakpoint was 
determined to be 110 mg∙kg-1·d-1 (Figure 4B). The upper CI was 164 mg∙kg-1∙d-1 and the 
lower CI was 56 mg∙kg-1∙d-1.
DISCUSSION
The mean valine requirement for term male neonates fed an elemental diet using the 
IAAO method is 110 mg∙kg-1∙d-1. Current recommended valine requirement for infants 
aged 0 to 1 month, based on human milk, is 95 mg∙kg-1∙d-1(5). Our data suggest that the 
current recommendations for valine, based on human milk, are correct.
In 1959, Snyderman et al. determined the valine requirement in five neonates to be 
between 85-105 mg∙kg-1∙d-1 using the nitrogen balance and weight gain (28). Although 
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Figure 4A: Mean 13CO2 enrichment of each infant at isotopic plateau during [1-
13C]phenylalanine infusion 
plotted against valine intake (n=28).
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Figure 4B: F13CO2 plotted against increasing valine intakes (n=28). A biphasic linear regression model 
estimated the breakpoint (mean valine requirement) to be 110 mg∙kg-1∙d-1 (r2 = 0.35, p = 0.001). The upper 
CI was 164 mg∙kg-1∙d-1 and the lower was 56 mg∙kg-1∙d-1. APE: atom percentage excess; F13CO2 : fraction of 
recovery from [1-13C]phenylalanine oxidation.
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the nitrogen balance method underestimated the essential amino acid requirements in 
adults, our mean requirement is at the upper range of the requirement that Snyderman 
et al. determined and above the current recommendations based on human milk. Since 
we and Snyderman both used free L-amino acids in the study diet – rather than total 
proteins – our requirements might be overestimated since amino acids derived from 
intact casein are utilized in a higher proportion for protein synthesis than that from an 
equivalent intake of free amino acids (29). Most currently available infant formulas pro-
vide intakes of protein that markedly exceed the requirement and exceed the protein 
intakes from human milk in breast-fed infants. For example, the measured daily protein 
intake in infants aged 0 to 1 month is 1.7 – 2.09 g∙kg-1∙d-1 which declines to 0.9-1.0 g∙kg-
1∙d-1 at 5-6 months (9, 10). Term neonates fed a formula with a protein content of 1.6 g 
∙dL-1 received a protein intake of 2.5 g∙kg-1∙d-1 at 12 weeks (30) which is much higher than 
the intake of a breastfed infant at 3 months of age (0.9-1.2 g∙kg-1∙d-1 ) (9, 10) . The amino 
acid composition of the nutritionally available proteins from human milk differs from 
that found of bovine proteins (9). This results in different plasma amino acid profiles in 
formula fed infants compared to breastfed infants. For example, the concentrations of 
threonine, valine and total branched-chain amino acids are significantly higher in for-
mula fed children fed a whey-dominant formula than in breastfed infants at 3 months of 
age (31) . At 6 months of age, children fed a casein-dominant formula which contained 
2.7 g ∙dL-1 of protein, the concentrations of phenylalanine, methionine, leucine, valine 
and proline and isoleucine were more than 2 fold the values found in breastfed infants 
(32). Since high levels of branched-chain amino acids (BCAA) interfere with the transport 
of tryptophan (a serotonine precursor) and other large neutral amino acids (tyrosine) 
across the blood-brain-barrier, they influence central nervous system concentrations of 
neurotransmitters (33, 34). We speculate that current formulas provide too much protein 
and do not contain the optimal amino acid composition. The amino acid requirement of 
all essential amino acids should be determined to optimize infant nutrition. We postu-
late that formulas may contain lower amounts of protein if the quality of the milk protein 
can be modified. 
One difficulty in determining the requirement of the individual BCAA is the interaction 
between the three amino acids due to their common catabolic enzymes (35). In animals 
elevated rates of valine oxidation were seen when high intakes of leucine were given, 
and these high intakes also depressed the concentrations of free isoleucine and valine 
in plasma and tissue amino acids pools (36, 37). In elderly males receiving prolonged 
leucine supplementation the concentrations of valine and isoleucine decreased in 
blood, probably as a result of the BCAA antagonism (38). In adults fed BCAA intakes 
within the physiological range, however, no effect was seen on valine oxidation with dif-
ferent leucine intakes (23) and individual BCAA requirements did not change when the 
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BCAA ratio was changed (24). Because the upper intake level of the BCAAs in the present 
study is based on the amount supplied by a regular infant formula, we do not supply 
supraphysiological BCAA intakes. Thus, we postulate that the oxidation and requirement 
of the individual BCAAs will not be influenced by the BCAA ratio and that we can study 
the BCAAs individually.
Since breastfed boys consume 10% more human milk than girls in the first months after 
birth (10) and have a greater protein deposition in this period (39), the essential amino 
acids requirement in infants might be gender-specific. Gender-specific impaired neuro-
developmental outcomes have reported for preterm boys who consumed less protein in 
the first week of life (3) and were fed standard versus preterm formula in the first month 
of life (4). In China more boys than girls are born and admitted at the Neonatology De-
partment (40). Following the inclusion of the first 15 children we noticed that only boys 
were included. Therefore we decided that we would proceed by including boys only for 
the present study. We speculate that the valine requirement for girls is slightly lower 
than our mean requirement in boys of 110 mg∙kg-1∙d-1. 
One of the limitations of our study is the wide range of the 95% confidence interval. 
Intra-subject variation is the major source of variability in amino acid requirements and 
a potential source of error in the estimation of amino acid requirement in humans (13, 
41). Thereby there might be large inter-individual differences between requirements in 
individuals as is shown in breastfed infants who have a variable milk consumption rate 
and largely regulate the intake they require themselves (6-8). Since we use enterally 
tracers whose oxidation depends on the rate of gastric emptying (42), this might be 
partially responsible for the variability in the fractional oxidation rates. 
Every diet differs in naturally enriched 13C. The natural abundance of 13C in nature is 
approximately 1.1% 13C. Atmospheric abundance differs: European breath CO2 has a 
different percentage of natural abundance 13C than North American breath CO2 (18).
 13C 
abundances of formula differ dependent on the constituents: for example the source of 
protein, the source of lipids and carbohydrates all vary in 13C abundance (18). Therefore, 
a period is necessary to allow background adaptation to the experimental diet. Since 
we used European formulas which might be based on different sources of carbohydrate 
and protein than the Chinese formulas the infants received before the adaptation day, 
we determined the time needed to reach a stable background enrichment in the first 8 
patients. We found the time to obtain a stable background enrichment was two bottles 
of formula given every 3 h, or 4.7 h at the present feeding regimen used at the NICU 
of the Fudan Children’s Hospital. These results are comparable to the study of Bross et 
al, who showed a stable background enrichment in breath between 225 and 255 min 
in adult humans fed hourly meals, and suggested that 5 hourly mails are required to 
achieve a constant 13CO2 enrichment (13). This means that our protocol in which we 
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adapt 24 h to the study formula is sufficient to allow background enrichment to adapt 
to the new formula.
Concluding, our study shows that current human-milk based recommendations for the 
valine requirement in term male infants aged 0 to 1 month are correct. The IAAO method 
should be used to determine the requirements of isoleucine and leucine as well as the 
optimal BCAA ratio in term infants to optimize infant nutrition.
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ABSTRACT
Background: Leucine is a nutritionally essential amino acid for protein synthesis. Addi-
tionally, it regulates the protein turnover and serves as an important nitrogen donor for 
the brain glutamate synthesis. The present recommended leucine intake of 166 mg·kg-
1·d-1 for term infants is based on average human milk composition and the estimated 
volume intake. Marketed milk-based formulas provide 195 ± 15 mg leucine per kg per 
day at an intake of 150 mL·kg-1·d-1. 
Objective: The objective is to determine the leucine requirement for fully enterally fed 
term infants using the indicator amino acid oxidation (IAAO) method. L-[1-13C]phenyl-
alanine was used as the indicator amino acid.
Design: Infants were randomly assigned to leucine intakes ranging from 5 to 370 mg·kg-
1·d-1, as part of an elemental formula. After 24 h of study formula consumption, [13C]
bicarbonate and L-[1-13C]phenylalanine tracers were given enterally. Breath samples 
were collected at baseline and during isotopic plateaus. Mean leucine requirement 
was determined by using biphasic linear regression crossover analysis on the fraction 
of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2). Data are presented as 
mean ± SD. 
Results: Thirty-three term neonates (gestational age at birth of 39 ± 1 weeks) were stud-
ied at 11 ± 4 days. The mean requirement was determined at 140 mg·kg-1·d-1 (p <0.01, r2 = 
0.26), with the upper CI of 241 mg·kg-1·d-1 and the lower CI of 40 mg·kg-1·d-1.
Conclusion: For term infants we propose a mean leucine requirement of 140 mg·kg-1·d-1, 
which is in the same range as the amount found in human milk. These data provide more 
evidence for leucine requirement in formula-fed infants. 
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INTRODUCTION
Leucine is one of the branched-chain amino acids (BCAA), along with isoleucine and 
valine, and is considered an essential amino acid in humans. The main metabolic fate 
of dietary BCAA is incorporation into body protein (1). Additionally, leucine has numer-
ous metabolic effects. First, it plays an important role in regulation of protein turnover. 
Leucine inhibits protein degradation and acts independently as a nutrient signal stimu-
lating protein synthesis via the activation of translation initiation factors (2-4). It is the 
most potent physiological insulin secretagogue among the amino acids (5). Anabolic 
effect of leucine has been shown in rats (6-7), neonatal pigs (8-9) and in men (10). Sec-
ondly, leucine is one of the main nitrogen donors for brain glutamate synthesis (11). 
Brain glutamate metabolism is crucial for the glutamatergic neurotransmission. Thirdly, 
dietary BCAA intakes influence the brain amino acid concentrations and consequently 
the neurotransmitter synthesis by competing with other large neutral amino acids for 
uptake into brain (1). Therefore, it is important to determine the leucine requirement. 
Experimental evidence of essential amino acid requirements in infants is scarce. A series 
of essential amino acid requirement studies was performed in the 1960s using weight 
gain rate and nitrogen retention (12). For leucine, this amount has been found to be 
between 76 and 229 mg·kg-1·d-1 in 6 infants up to 5 months of age (13). However, the 
recommendations for essential amino acid requirements of infants are based on the 
average intakes of breastfed infants rather on experimentally derived requirement 
values (14). The estimated average leucine intake in exclusively breastfed infants is 166 
mg·kg-1·d-1 (14).
The indicator amino acid oxidation (IAAO) method has been successfully used to deter-
mine BCAA requirements in adults (15) and children (16). The recently modified IAAO 
method has been used successfully to determine amino acid requirements in enterally 
fed infants (17-18). The aim of this study is to determine the leucine requirement in 
enterally fed term infants using the IAAO method.
METHODS
Subjects
Thirty-three neonates admitted to the neonatal ward in the Children’s Hospital of Fudan 
University, participated in the study. Each subject was selected for study by the follow-
ing criteria: fully enterally fed infants with a gestational age of ≥ 37 weeks, birth weight 
≥ 2500 gram, and clinically stable with a weight gain rate ≥ 5 g·kg-1·d-1 in the preceding 3 
days. Subjects were excluded if they had congenital anomalies, gastrointestinal pathol-
ogy, or sepsis. 
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The study was approved by the Institutional Review Boards of the Children’s Hospital 
of Fudan University, and a statement of no objection was obtained from the Erasmus 
MC-Sophia Children’s Hospital. Written consent was obtained from at least one of the 
parents of each subject by a Chinese-speaking researcher. 
Study formula
The study formula used was an elemental formula that was based on free amino acids. 
The amino acids, fat, carbohydrates, and energy content of the study formula are shown 
in Table 1. The composition was the same as Neocate (SHS International) except for the 
leucine, phenylalanine and alanine content. Leucine, which was completely withdrawn 
from the study formula, was separately added in the form of L-leucine to obtain differ-
ent amounts of intake. The phenylalanine intake was kept constant during the study 
by separately adding L-phenylalanine during the 24 h adaptation period to obtain the 
Table 1. Energy, carbohydrates, fat, and amino acids content of the study formula.
Component Per 100 g formula
Energy (kcal) 475
Carbohydrates (g) 54
Fat (g) 23
Total amino acid (g) 13
L-Alanine (g) 1 ≥ 0.61
L-Arginine (g) 1.08
L-Asparagine (g) 1.01
L-Cyst(e)ine (g) 0.4
Glycine (g) 0.95
L-Histidine (g) 0.62
L-Isoleucine (g) 0.95
L-Leucine (g) 2 0
L-Lysine (g) 1.11
L-Methionine (g) 0.26
L-Phenylalanine (g) 3 0.20 
L-Proline (g) 1.16
L-Serine (g) 0.71
L-Threonine (g) 0.8
L-Tryptophan (g) 0.32
L-Tyrosine (g) 0.73
L-Valine (g) 1.04
L-Carnitine (g) 0.01
Taurine (g) 0.03
L-Glutamine (g) 1.34
1  Variable levels of L-alanine were added to the diet depending on the test leucine level of each infant to maintain 
an isonitrogenous diet. The study formula contained at least 0.61 g L-alanine per 100 g formula.
2 L-leucine was added separately, depending on the test leucine level.
3  0.53 g L-phenylalanine per 100 g formula was added to the study diet on day 1. Equivalent amount of
L-phenylalanine (0.52 g per 100 g formula) was given as isotope on day 2. 
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same amount as in the Neocate (SHS International) and this amount of phenylalanine 
was given as stable isotope L-[1-13C]phenylalanine on the tracer infusion day. The 
phenylalanine intake during the study was 166 mg·kg-1·d-1, which was above the recom-
mended amount of 72 mg·kg-1·d-1 (14). A generous amount of tyrosine (166 mg·kg-1·d-1) 
was provided to ensure that the newly formed [1-13C]tyrosine hydroxylated from [1-13C]
phenylalanine would be directly channeled to oxidation into 13CO2, which can be mea-
sured in expired air (19). This amount of tyrosine was almost twice the recommended 
intake (14). The nitrogen intake was kept constant for all subjects by the substitution 
of L-alanine for the leucine that was withdrawn. The caloric intake was kept constant 
during the study period in all infants.
The minerals and trace elements supplied in 100 g formula were as follows: iron 7.0 mg, 
calcium 325 mg, phosphorus 230 mg, magnesium 34 mg, sodium 120 mg, chloride 290 
mg, potassium 420 mg, manganese 0.38 mg, iodine 47 µg, selenium 11 µg, copper 380 
µg, and zinc 5.0 mg.
The vitamin content of 100 g formula was as follows: vitamin A 528 µg retinol equivalent, 
vitamin D 8.5 µg, vitamin E 3.3 mg α-tocopherol equivalent, vitamin K 21 µg, thiamin 390 
µg, riboflavin 600 µg, niacin 4.5 mg, vitamin B6 520 µg, vitamin B12 1.3 µg, pantothenic 
acid 2.3 mg, folic acid 38 µg, vitamin C 40 mg, and biotin 26 µg. 
Experimental design
The study was designed to determine the leucine requirement in term infants using 
the minimally invasive IAAO (20-22), that has recently been modified to determine the 
essential amino acid requirements in enterally fed infants (17). The IAAO method is 
based on the concept that when the test amino acid intake is insufficient to meet the 
requirement, protein synthesis will be limited and all of the amino acids will be oxidized, 
including the indicator amino acid, which is labelled with a stable isotope. As the dietary 
intake of the test amino acid increases, the oxidation rate of the indicator will decrease 
until the requirement of the test amino acid is met. Once the requirement of the test 
amino acid is met, an additional increase in its intake will have no further influence on 
the oxidation rate of the indicator amino acid. The oxidation of the indicator amino acid 
can be measured in expired air as 13CO2. 
During the study, all infants received fluid intake of ~150 mL·kg-1·d-1, a caloric intake of 
~108 Kcal·kg-1·d-1, and an amino acid intake of ~2.95 g·kg-1·d-1. Infants were randomly 
assigned to one of the graded test intake of leucine, ranging from 5 to 370 mg·kg-1·d-1. 
Each study took place over a 31 h period whereby the study formula was fed to the 
infants. After 24 h of study formula consumption, a nasogastric tube was placed. Infants 
received a primed (14 µmol·kg-1) continuous (9 µmol·kg-1·h-1) enteral infusion of [13C]
bicarbonate (sterile pyrogen free, 99% 13C APE; Cambridge Isotopes, Woburn, MA) for 3 
h to quantify individual CO2 production rates (23). Phenylalanine was used as the indica-
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tor. After the [13C]bicarbonate infusion was stopped, a primed (34 µmol·kg-1) continuous 
(27 µmol·kg-1·h-1) enteral infusion of L-[1-13C]phenylalanine (99% 13C APE; Cambridge 
Isotopes) was started and lasted for 4 h. Syringes were weighted before and after the 
study to determine the exact amount of the tracers that were given to the infants. The 
tracer infusion day is depicted in Figure 1. Infants were bottle fed every 3 h during the 
adaptation period (the first 24 h). Subsequently, the feeding regimen changed to con-
tinuous feeding during [13C]bicarbonate infusion and hourly bottle feeding during the 
L-[1-13C]phenylalanine infusion until the end of the study.
Sample collection and analysis
Breath samples were obtained by using the direct nasopharyngeal sampling method 
described by van der Schoor et al. (24). Briefly, a 6F gastric tube (6 CH Argyle; Sherwood 
Medical, Tullamore, Ireland) was placed 1 to 1.5 cm into the nasopharynx and the end-
tidal breath was taken slowly with a syringe. Collected air was transferred into 12 mL 
sterile, non-silicon-coated evacuated glass tubes (Van Loenen Instruments, Zaandam, 
the Netherlands) and was stored at room temperature until analysis. Two duplicated 
baseline samples were obtained before the start of tracer infusion. Six duplicated breath 
samples were obtained every 15 min during isotopic plateau of [13C]bicarbonate be-
tween 105 and 180 min. Seven duplicated samples were obtained every 10 min during 
isotopic plateau of L-[1-13C]phenylalanine between 360 and 420 min (Figure 1). 
13C isotopic enrichment in the breath samples was analyzed by an infrared isotope 
analysis technique (Helifan, Analytic Fischer Instruments, Leipzig, Germany). The 13C 
enrichment was expressed as the atom percent excess above baseline (APE). 
Calculations
The isotopic steady state was represented by plateaus in 13CO2. Plateaus were deter-
mined by visual inspection and were confirmed by regression analysis as a slope not 
significantly different from zero. The estimated body CO2 production rate (mmol·kg
-1·h-1) 
was calculated as described previously (17, 23). The fraction of 13CO2 recovery from L-[1-
Figure 1.  
 
 
 
[13C]Bicarbonate Tracers 
Feeding 
Time 
(min) 
Breath 
samples 
[1-13C]phenylalanine 
   0                             180                                                    420     
Figure 1. Schematic overview of tracer infusion day. The dashed line indicates the period of continuous 
intragastric feeding. Triangles indicate times that bolus feeding were given via a bottle. Arrows indicate 
times that breath samples were taken.
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13C]phenylalanine oxidation (F13CO2) in % was calculated with the following equation 
(25):
F13CO2 = (IEPHE × iB ) ÷ (iPHE × IEB) × 100%
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]phenylalanine infu-
sion (APE), iB is the infusion rate of [
13C]bicarbonate (µmol·kg-1·h-1), iPHE is the infusion rate 
of L-[1-13C]phenylalanine (µmol·kg-1·h-1) and IEB is the 
13C isotopic enrichment in expired 
air during [13C]bicarbonate infusion. 
Phenylalanine flux was not obtained. As shown in our previous study, test amino acid 
intake has no effect on the phenylalanine flux (17).
Statistical analysis
Descriptive data are expressed as means ± SDs. Determination of the leucine require-
ment, the breakpoint, was performed using a biphasic linear regression crossover model 
(26). With the biphasic linear regression analysis, the regression equation was split into 
two parts. For the first part an intersept and slope were estimated, while for the second 
part, the slope was restricted to zero. Therefore, the estimated intercept of the second 
line is equal to the breakpoint. The model with the best fit, based on the highest r2 was 
selected. The 95% confidence interval was calculated. A value of p < 0.05 was taken as 
significant. The analyses were performed in STATA software (version 11; StataCorp LP).
RESULTS
Subject characteristics
Thirty-three term neonates participated in the study. The neonates were studied at a 
leucine intake that ranged between 5 and 370 mg·kg-1·d-1. Subject characteristics are 
Table 2. Subject characteristics and protein and energy intake before the study of infants who 
participated in the study (n = 33).
Values
Birth weight (kg) 3.3 ± 0.3
Gestational age (wk) 39 ± 1
Age at study (d) 11 ± 4
Weight on study day (kg) 3.4 ± 0.4
Weight gain before study (g∙kg-1·d-1) 13 ± 6
Sex (F:M) 16:17
Protein intake before the study (g·kg-1·d-1) 2.8 ± 0.4 
Energy intake before  the study (kcal·kg-1·d-1) 117 ± 15
All values are means ± SDs. 
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summarized in Table 2. All subjects were growing well before entering the study. The 
mean (± SD) weight gain rate three days before the study was 13 (± 6) g∙kg-1∙d-1. The 
mean (± SD) energy intake was 109 ± 1 kcal·kg-1·d-1. The nitrogen intake was equivalent 
to a protein intake of 3.0 ± 0.02 g·kg-1·d-1. The infants were clinically stable and consid-
ered healthy supported by the discharge on the study day or the day after. The primary 
reason of admissions were unconjugated hyperbilirubinemia (n = 21), pneumonia with 
a negative blood culture (n = 6), asphyxia (n = 2), bloody stool (n = 1), wet lung (n = 1), 
constipation (n = 1) and urine tract infection (n = 1). Intravenous antibiotics (penicillins 
and/or cephalosporins) were given to 19 of the 33 infants.
13CO2 enrichments during [
13C]bicarbonate infusion
The baseline 13CO2 enrichment was -17.18 ± 1.17 pee dee belemnite (PDB). The mean 
13CO2 enrichment at isotopic plateau during [
13C]bicarbonate infusion was 0.0396 ± 
0.0045 APE. The corresponding mean CO2 production rate was 22.45 ± 2.50 mmol·kg
-
1·h-1. The mean 13CO2 enrichment at isotopic plateau and their corresponding CO2 
Figure 2A: Mean 13CO2 enrichment at isotopic plateau during enteral [
13C]bicarbonate infusion of each 
infant plotted against the leucine intake (n=33). APE, atom percent excess. 
Figure 2B: CO2 production rate of each infant plotted against the leucine intake (n=33). 
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production rate of each infant were plotted against the leucine intake (Figure 2A and 
2B respectively). 
L-[1-13C]phenylalanine oxidation
The mean 13CO2 enrichment at isotopic plateau during L-[1-
13C]phenylalanine infusion 
was 0.0173 ± 0.0039 APE. These 13CO2 enrichment values and the F
13CO2 are plotted 
against leucine intakes in Figure 3A and 3B. As the leucine intake increased, F13CO2 
decreased. This negative correlation was shown between F13CO2 and leucine intakes up 
to 140 mg·kg-1·d-1; additional increase in leucine intake did not affect the F13CO2. Using 
a biphasic linear regression crossover model, the breakpoint representing the mean 
Figure 3A: Mean 13CO2 enrichment at isotopic plateau during enteral L-[1-
13C]phenylalanine infusion of 
each infant plotted against the leucine intake (n=33). APE, atom percent excess.
Figure 3B: The fraction of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) during the 
isotopic plateau at different leucine intakes (n = 33). Each infant received a different leucine intake. With 
the use of a biphasic linear regression crossover model, the breakpoint was estimated to be 140 mg·kg-
1·d-1 (p < 0.01, r2 = 0.26). The upper CI was 241 mg·kg-1·d-1 and the lower CI was 40 mg·kg-1·d-1
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requirement was determined at 140 mg·kg-1·d-1 (p <0.01, r2 = 0.26). The upper CI was 241 
mg·kg-1·d-1 and the lower CI was 40 mg·kg-1·d-1.
DISCUSSION
Using the IAAO method, the mean leucine requirement for term infants less than one 
month of age is estimated to be 140 mg·kg-1·d-1 with an upper CI of 240 mg·kg-1·d-1. 
Present recommendations for essential amino acid requirements by WHO/FAO/UNU 
(14) are estimated from the average intakes of breastfed infants. The accuracy of these 
estimations is complicated by many factors, including the change in milk composition 
over the course of lactation, the variation in milk composition between mothers, and the 
variation in milk intake between infants (27-28). The leucine intake of breastfed infants 
is estimated to be 166 mg·kg-1·d-1 (14). Estimated amino acid composition of human milk 
may provide some guidelines for the composition of infant formulas, but it may not 
necessarily reflect the amino acid needs of infants. Current study provides experimental 
evidence of leucine requirement for infants fed an elemental formula. 
In the present study, we observed a wide CI compared to the other amino acids studied 
thus far (17-18). Similar findings have been observed in the leucine requirement study by 
Snyderman et al. (13) in the 1960s. They attempted to estimate leucine requirement in 6 
infants up to 5 months of age using growth rate and nitrogen retention. After complete 
withdrawal of leucine in the diet, it was then stepwise reintroduced. Each infant received 
2-7 test intakes, and each for a period of ~1 week. They concluded that the requirement 
is in the range between 76 and 229 mg·kg-1·d-1, and also encountered a greater variation 
in the requirement for leucine than for any other amino acids they studied. In addition, 
they noticed a less obvious difference in nitrogen retention between inadequate and 
adequate periods. These findings might due to the potential interactions among BCAAs. 
BCAA use a common membrane-transport system and enzymes for their reversible 
transamination into α-ketoacids and irreversible oxidation into α-ketoacyl-CoA (1). A 
change in the dietary intake of leucine has been shown to decrease the plasma concen-
trations of valine and isoleucine (1, 29). However, whereas different BCAA ratios affect 
the requirement level for individual BCAA is not known. Studies by Pelletier et al. (30-31) 
observed no effect on valine oxidation at different leucine intakes, in addition, different 
valine-isoleucine ratios had no effect on leucine oxidation. Therefore, we speculate that 
different BCAA ratios have no effect on individual BCAA requirement. 
We determined the requirements for each BCAA separately, since it enables us to deter-
mine the ideal BCAA ratio. In addition, current study design has many advantages. First, 
we have the ability to vary in leucine intakes while keeping the other nutrients constant, 
including valine, isoleucine and the total nitrogen intake. Secondly, the intersubject 
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variability in nutrient intakes is minimized due to the strict control of formula intake. 
Thirdly, the IAAO method is more accurate and less invasive than using the growth rate 
and nitrogen balance technique. These factors all contribute to a more accurate require-
ment estimate. 
The efficiency of utilization of an elemental diet is less than a protein diet showed by 
a 20-35% higher oxidation rate by Metges et al. (32). Therefore, by postulating our 
estimate derived from infants fed an elemental infant formula to infants fed a protein 
formula may overestimate their requirement. 
To give a recommendation on the safe level of intake, a level that nearly meets the 
requirement of all individuals, data of individual distribution of leucine requirement are 
needed. However, the distribution of leucine requirement is unknown. The safe level of 
leucine intake can be calculated based on the assumption that the safe level of amino 
acid intake is the same as the safe level of protein intake proposed by WHO (33), which 
is 125% of the average protein requirement. The calculated safe level of leucine intake is 
140 mg·kg-1·d-1 (which is the mean requirement) when taking into account the less effi-
ciency of utilization rate (~25%) by the use of an elemental diet. Current infant formulas 
provide 195 - 345 mg leucine per kg per day at an intake of 150 mg·kg-1·d-1 (34), which is 
2-3 times our mean requirement. A higher amount than our mean requirement might be 
necessary with regards to the great individual variations in leucine requirement shown 
in the study by Snyderman et al. (13) and in the present study. Intakes above the require-
ment are well tolerated when an appropriate amount of protein with a balanced BCAA is 
consumed. So far, no evidence of toxicity was observed in human studies administering 
high dose of leucine (35-36). However, we have to be aware of the anabolic effect of 
leucine, which might contribute to the increase risk of obesity of formula fed infants 
later in life (37-38).
The current study determined the mean leucine requirement for infants up to one month 
of age to be 140 mg·kg-1·d-1. Current study provides more experimental evidence of 
amino acid needs for formula-fed infants, which is required to improve infant nutrition. 
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ABSTRACT
Introduction: Higher protein intake for infants that are fed formula may play a role in 
the development of the metabolic syndrome. Leucine may affect muscle protein turn-
over and stimulates insulin release and tissue sensitivity. Human milk protein contains 
a isoleucine-leucine-valine ( Ile:Leu:Val) ratio of 1: 1.74 : 1. Current recommendations of 
these branched-chain amino acids (BCAAs) for infants are based on this ratio. Different 
formulas use BCAAs in different ratios depending on the casein-whey ratio (milk-based 
formula: 1 : 1.6 : 1.1, whey-adapted formula: 1 : 2.3 : 1.1).
Objective: This review describes the requirement of the individual BCAAs and the 
optimal BCAA ratio in term neonates aged 0 to 1 month determined by the different 
methods and compares them with the mean requirement determined by using the 
indicator amino acid method. We compare these mean requirements with the amount 
of amino acids in current formulas and the current standards for infant formulas. 
Results: The advised intake for isoleucine, leucine and valine based on the IAAO method 
is 105, 140 and 110 mg∙kg-1∙d-1, respectively. The optimal Ile:Leu:Val ratio in enterally fed 
neonates aged 0 to 1 month, based on the IAAO method, is 1 : 1.3 : 1. This is comparable 
with the ratio in egg protein and with the ratio determined by Snyderman using the 
nitrogen balance and weight gain. 
Conclusion: Our result imply that, regarding the BCAA ratio, egg protein might be a 
better alternative protein than cow milk protein for infants aged 0 to 1 month. Some 
of the currently used formulas provide 2-3 times too much BCAAs and might provide 
suboptimal BCAA ratios.
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INTRODUCTION
It is becoming increasingly clear that the growth during the earliest stages of life can 
be an important determinant of an individual’s later health and risk of chronic disease 
(1). There is now substantial evidence that growth in the first 2 years of life, especially 
high early weight gain, is associated with adverse health outcomes later in life, including 
increased blood pressure (2), increased weight gain and body fat deposition (3-6) and 
increased risk of diabetes (7). Higher protein intake for infants that are fed formula may 
play a role in these health outcomes because formula-fed children reach a higher body 
weight and weight for length at one year of age compared to those fed breast milk (8, 
9). However, early nutrition (especially protein intake) correlates with improved neuro-
development in preterm infants (10, 11). Current understanding of the nutritional needs 
for early growth and development is fragmentary and inadequate to provide answers 
that are needed (12).
Different methods have been developed to determine requirements in infants and 
adults. Over fifty-five years ago, Snyderman and colleagues have determined amino acid 
requirements for infants by means of the nitrogen balance method and weight gain 
(13-16). Because limited data on human infants and children were available, experts 
proposed a factorial approach to define dietary indispensable amino acid requirements 
in infants and children > 6 months (17, 18). The obligatory losses are used as mainte-
nance requirement and the nutrients needed for growth are added to determine the 
requirement in children. The growth factor is calculated from the rate of protein mass 
gain in infants during the first two years of age as determined by Butte (19). Dewey et 
al. calculated the factorial approach for infants aged 0 to 1 month based on breast milk 
and implied that breast milk provided on average a 45% excess of indispensable amino 
acids at 0-1 month (20). They assumed that the average intake of breastfed infants does 
not approximate the mean requirement and stated that this would imply that half of the 
breastfed infants have deficient intakes. Because nearly all breastfed infants are meeting 
their protein intakes, their average intake should be above the safe level for protein 
intake, i.e. > 2 SD higher than the mean requirement. 
Current recommended requirements for infants aged 0 to 1 month are based upon the 
amino acid content of human milk. These recommendations are based on the average 
amino acid content of breast-milk protein and multiplied by the milk protein intake 
(which is 75% of crude protein) (21). Estimating true protein intakes from breast milk 
is difficult because of the high proportion of non-protein nitrogen in human milk. The 
extend of utilization of this non-protein nitrogen (for example urea) is not entirely under-
stood in any comparison of predicted requirements with human milk, and judgements 
of the amount of available nitrogen consumed as protein in breast milk must be made. 
These values also do not take into account that human milk shows remarkable variation 
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in protein and whey-casein ratio during different lactation stages and breastfed infants 
have a variable milk consumption rate (22-25). There might be a great variation in amino 
acid intake of breastfed children: they largely regulate the intake they require.
Recently it was shown by using stable isotopes that current Dietary Reference Intake 
(DRI) recommendations for protein intake in healthy school children determined by the 
factorial approach seems to underestimate the requirement by 71 and 63% (26). These 
results suggest that the IAAO method may be useful in re-evaluating amino acid and 
protein requirements in children and infants. This review describes the requirement of 
the branched-chain amino acids in term neonates 0-1 month determined by the dif-
ferent methods and compares them with the mean requirement determined using the 
indicator amino acid method. We compare these mean requirements with the amount 
of amino acids and protein in current formulas and the current standards for infant 
formula. Finally we will discuss which would be the new recommendations for infant 
formulas for infants aged 0 to 1 month. 
Branched-chain amino acids: isoleucine, leucine, and valine
The essential branched-chain amino acids (BCAAs) differ from most other essential ami-
no acids in that the enzymes initially responsible for their catabolism are found primarily 
in the extra-hepatic tissue. BCAAs account for 35-40% of the dietary essential amino 
acids found in body protein and 14% of the total amino acids in skeletal muscle. Their 
main metabolic fate is incorporation into body protein, although first pass utilization in 
neonates is also high (27). BCAAs are similar in structure and share common enzymes 
for transamination and oxidative decarboxylation. The BCAAs compete with other 
large neutral amino acids (LNAA), particularly tryptophan and tyrosine, for membrane 
transport. Although BCAAs do not act as direct precursors for neurotransmitters, they 
can affect the transport of certain LNAAs across the blood-brain barrier and thereby 
influence central nervous system concentrations of neurotransmitters (28, 29). BCAAs 
are both ketogenic and glucogenic, and their amino groups are used for the synthesis 
of alanine and glutamine in muscle, thereby providing a shuttle for the transfer of BCAA 
nitrogen from muscle to liver for urea formation. Among the BCAAs, leucine can act 
independently as a nutrient signal and stimulates protein synthesis via the activation of 
translation initiation factors (30). Leucine may affect muscle protein turnover (31) and 
stimulates insulin release and tissue sensitivity (32). High intakes of leucine by humans 
or animals enhances the activity of the branched-chain keto acid dehydrogenase in vari-
ous tissues (33, 34), thereby decreasing valine and isoleucine concentrations in blood. 
An excess of leucine increases the oxidation of isoleucine and valine, thus limiting their 
availability as substrates for protein synthesis (33, 35-37). 
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The requirement for isoleucine in infants aged 0 to 1 month:
There are no isotopic data for individual isoleucine requirements in humans or animals. 
In 1964, Snyderman et al. used the nitrogen balance method to determine the isoleucine 
requirement in six healthy male infants to be between 79 and 126 mg∙kg-1∙d-1 (14).
By using the factorial approach, Dewey et al. determined the isoleucine requirement in 
infants aged 0 to 1 month to be 59 mg∙kg-1∙d-1 by using the rate of body mass, adjusted 
for the percentage of deposition as fat from the data of Fomon et al (38). They implied 
that breast milk provided on average a 45% excess of indispensable amino acids at 0-1- 
month. Because of this and given that intakes of breast milk of a healthy well-nourished 
mother are considered to satisfy protein requirements in the first 6 months of life, breast 
milk content of amino acids to be considered as the best estimate of amino acid require-
ment for this group. The current recommended isoleucine requirement, based on hu-
man milk is 95 mg∙kg-1∙d-1 in infants aged 0 to 1 month (21). Using the IAAO method, our 
group recently determined the mean isoleucine requirement to be 105 mg∙kg-1∙d-1 (all 
shown in Table 1). Current formulas provide 97-194 mg∙kg-1∙d-1 isoleucine when an intake 
of 150 mL∙kg-1∙d-1 is given (39-42). Since we and Snyderman both used free L-amino acids 
in the study diet – rather than total proteins – the requirement might be overestimated. 
A 20-35% higher first pass oxidation rate was seen in adults when an amino acid based 
diet was used compared to intact protein (43), so at least 20% of our mean requirement 
should be subtracted to correct for the amino acid based formula. The ESPGHAN advises 
an increase in protein content of infants formulas of 1.25 fold when the proteins used 
are based on hydrolyzed proteins in stead of intact proteins to correct for potentially less 
digestibility and biologic value of the nitrogen content (44). We therefore correct 25% 
for the use of amino acids in stead of intact proteins. Thereby, we determined a mean 
Table 1: Previous studies using nitrogen balance techniques and current recommendations of the 
individual BCAA.
Requirement
mg∙kg-1∙d-1
Nitrogen
balance
Infants 
1-5 mo  
(13-15, 54)
Factorial
Approach
0-1 mo(20)
IAAO
0-1 mo
Current
Recomm
Infants
0-1 mo(21)
Current
Formulas
Per 150 mL∙kg-1∙d-1
(39-42)
Recomm
intake
Per 150 mL∙kg-1∙d-1
IAAO
Isoleucine 119
(79-126)
59 105 95 97-194 97
Leucine 150 
(76-229)
109 140 165 195-345 130
Valine 105
(85-105)
72 110 95 117-216 102
Ile:Leu:Val
Ratio
1 : 1.3 : 0.9 1 : 1.8 : 1.5 1 : 1.3 : 1 1 : 1.7 : 1 1 : 1.4 : 0.9-
1 : 2.3 : 1.2
1 : 1.3 : 1
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requirement and not a safe level of intake in which a correction is made for individual 
variance in requirement. A safe level of intake is calculated as the mean requirement plus 
2 SD of this mean requirement. Since the distribution of the amino acid requirement is 
not known, we use the safe level of protein intake as proposed by the WHO (21) which is 
125% of the average protein requirement. If we correct our mean requirement for these 
two factors an intake of 105 mg∙kg-1∙d-1 should be the advised intake for isoleucine in 
infants aged 0 to 1 month of age. The ESPGHAN recommends an isoleucine intake of 92 
mg ∙100 kcal-1 in infant formulas (44) which resembles our advised isoleucine intake of 
97 mg∙100 kcal-1 based on our study formula which contains 108 kcal when an intake of 
150 mL kg-1∙d-1 is given (Table 2).
The requirement for valine in infants aged 0 to 1 month 
In 1959, Snyderman et al. determined the valine requirement in five neonates to be be-
tween 85-105 mg∙kg-1∙d-1 using the nitrogen balance (13). Using the factorial approach, 
Dewey et al. determined the valine requirement in infants aged 0 to 1 month to be 72 
mg∙kg-1∙d-1 (20). The current recommended valine requirement, based on human milk is 
95 mg∙kg-1∙d-1 in infants aged 0 to 1 month (21). Our group determined the mean valine 
requirement in infants aged 0 to 1 month to be 110 mg∙kg-1∙d-1 using the IAAO method. 
Current formulas provide an intake of 117-216 mg∙kg-1∙d-1 valine when an intake of 150 
mL kg-1∙d-1 is given (39-41) (Table 1). Since we used an amino acid based formula and 
because amino acids derived from intact casein are utilized in a higher proportion for 
protein synthesis than those from an equivalent intake of free amino acids (43), the true 
value of the requirement would be lower than our mean estimation. If we correct the 
mean requirement for the hydrolyzed proteins and correct for the safe protein intake 
which is 125% of the mean intake, an intake of 110 mg∙kg-1∙d-1 should be the advised 
valine intake in infants aged 0 to 1 month. The ESPGHAN recommends an intake of 90 
mg∙100 kcal-1 (44) which is lower than our estimation of 102 mg∙100 kcal-1 based on our 
study formula which contains 108 kcal when an intake of 150 mL kg-1∙d-1 is given (Table 
2).
The requirement for leucine in infants aged 0 to 1 month
In 1961, Snyderman et al. determined the leucine requirement in 1 preterm and 5 term
infants to be 150 mg∙kg1∙d-1 by using the nitrogen balance and weight gain (range 79-
226 mg∙kg1∙d-1). Using a soy-isolate formula Fomon et al. determined the leucine 
requirement in normal female infants to be no greater than 132 mg∙100 kcal-1(45), lower 
intakes were not given . The factorial approach estimated the requirement for term 
neonates aged 0  month to be 109 mg∙kg1∙d-1 (20). The current recommended isoleucine 
requirement, based on human milk, is 165 mg∙kg-1∙d-1 in infants aged 0 to 1 month (21). 
Current formulas provide an intake of leucine of 195-345 mg∙kg-1∙d-1 when an intake of 
Femke Maingay-de Groof 15-8.indd   146 20-08-12   15:43
147
Enteral requirement for branched-chain amino acids in the neonate
150 mL kg1∙d-1 is given (39-42) (Table 1). At discussed earlier, Metges et al. compared 
leucine oxidation rate, non-oxidative leucine disposal and net protein synthesis rate in 
adults that were fed an amino acid mixture and an intrinsically [1-13C]leucine labelled 
casein (43). The oxidation rate was 22% higher, non-oxidative leucine disposal was 28% 
lower and the net protein synthesis rate was 35% lower in the amino acid mixture condi-
tion compared to the intrinsically labelled casein condition. Amino acid utilization might 
be lower from amino acid based or hydrolyzed formulas as also was shown in adults 
fed an elemental diet (46). The advised intake for leucine in infants aged 0 to 1 month 
based on the IAAO method corrected for hydrolyzed proteins and adapted for the safe 
level of protein is 140 mg∙kg-1∙d-1. The ESPGHAN recommends an intake of 169 mg ∙ 100 
∙ kcal-1 (44) which is higher than our estimation of 130 mg ∙100 kcal-1 based on our study 
formula, which contains 108 kcal when an intake of 150 mL kg-1∙d-1 is given (Table 2). 
This indicates that current formulas may provide too much leucine which might be not 
beneficial for the neonate since leucine induces insulin release and sensitivity in the 
tissues which might be associated with diabetes mellitus later in life.
The BCAA ratio
Considerable interaction has been reported in humans and animals in response to 
disproportional intakes of BCAAs. In rats, imbalanced BCAA concentrations result in 
impaired growth, and BCAA supplementation has negative effects on fetal brain growth 
(36). The difficulty about studying the different branched-chain amino acids is the 
potential interaction between the BCAA; by changing the intake of a single test amino 
acid, the dietary mixture may become imbalanced (47). Therefore different groups de-
termined the total BCAA requirement in stead of individual branched-chain amino acids. 
The BCAA pattern used in these studies is based on egg protein (which has a Ile:Leu:Val 
ratio of 1: 1.3: 1.1) to minimize the potential interaction of the BCAA on assessment of 
the requirement. The optimal proportion for protein synthesis in children is assumed to 
Table 2: The current recommendations for the BCAA in infant formulas in mg∙100 kcal-1 compared to the 
amount in regular infant formula. The third column describes the new recommendations based on the 
IAAO method
Human milk
(mg∙100 kcal-1) (59) (44)
Current 
Term formulas
(mg∙100 kcal-1)(41) (39, 42)
IAAO
(mg∙100 kcal-1)
Isoleucine 90-92 105-190 97
Leucine 166-169 167-338 130
Valine 88-90 106-213 102
Ile:Leu:Val Ratio 1 : 1.7 : 1 - 1 : 1.8 : 1 1 : 1.4 : 0.9 - 1 : 2.3 : 1.2 1 : 1.3 :1
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be that present in egg protein (48, 49) and the total BCAA requirement was determined 
to be the same as in healthy men (50). The concentrations of the BCAA in human milk 
varies from 1 : 1.8 : 1.3 (51), 1 : 1.6 : 1 to 1 : 2.0 : 0.9 (44). Human milk protein contains a 
Ile:Leu:Val ratio of 1: 1.74 : 1 (21). Current recommendations are based on this ratio that is 
based on the content of the branched-chain amino acids in human milk, since exclusive 
breastfeeding by a healthy mother is the feeding standard from birth to 6 months in 
healthy, term infants (21). Different formulas use BCAAs in different ratios depending on 
the casein-whey ratio (milk-based formula: 1 : 1.6 : 1.1, whey-adapted formula: 1 : 2.3 : 
1.1) (52). Milk protein contains a Ile:Leu:Val ratio of 1 : 1.6 : 1 (17), casein a Ile:Leu:Val ratio 
of 1 : 1.8 : 1.4 (39).
The difficulty in the development of infant formulas is that the amino acid content of 
cow milk proteins is different than that of human milk. Both milks are composed of two 
classes of proteins, casein or acid-preciptable proteins and whey or acid-soluble pro-
teins. The whey-casein ratio in colostrum is 80:20 and changes to 55:45 in mature milk 
(52). Casein dominant cow’s milk formulas are made with nonfat dry milk and contain 
about 82% bovine casein and 18% bovine whey proteins. During the manufacture of 
infant formulas whey is added to cow milk to obtain a whey-casein ratio of 60:40 which 
is more similar to human milk. However, human milk proteins differ from bovine proteins 
in concentrations and amino acid composition so adding bovine whey proteins does 
not make the formula identical to the amino acid composition of human milk. In casein-
dominant formula, especially methionine and tyrosine are elevated. In whey-dominant 
formula, methionine, threonine and lysine are elevated. The sum of the BCAAs is much 
higher in formulas than human milk: infants fed formula have higher concentrations of 
BCAA than human milk fed infants suggesting that levels of these amino acids are more 
closely related to protein quantity than protein quality (51).
Besides the differences between human milk protein and cow milk protein it is impor-
tant to note that the amino acid composition of human milk is not the same as that 
of body protein, and Dewey et al. stated in 1996 that the composition of human milk 
proteins is not necessary a definition of the biological amino acid requirement of the 
growing neonate (20). Whole body protein contains a Ile:Leu:Val ratio of 1 : 2.1 : 1.4 (53). 
Our group found an optimal Ile:Leu:Val ratio of 1 : 1.3 : 1 in neonates aged 0 to 1 month 
which is comparable with the ratio determined by Snyderman using the nitrogen bal-
ance and weight gain (13-15, 54). Our results imply that egg protein might be a better 
alternative protein regarding the BCAA ratio for infants aged 0 to 1 month than cow 
milk protein. Since egg proteins contain more sulfur amino acids than milk proteins, the 
concentration of methionine and cysteine should be monitored carefully.
The nutritional implications of these differences in amino acid content of different 
proteins or mixtures of proteins can be evaluated by comparing the amino acid com-
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position of the protein source with a suitable reference amino acid pattern by use of 
an amino acid scoring pattern. These scoring systems use the amino acid requirement 
in humans to develop reference amino acid patterns for purposes of evaluating the 
quality of food proteins or their capacity to efficiently meet both the nitrogen and in-
dispensable amino acid requirement of the individual (17). The scoring systems use the 
limiting essential amino acid in the test protein, divide it by the amount of amino acid 
in a reference protein and correct it for true digestibility. The indispensable amino acid 
composition of the specific protein source is compared to that of a reference amino acid 
composition profile. Earlier the amino acid composition of a good protein such as egg 
was used, which is regarded as being well balanced in amino acid content in relation 
to human needs (55). Later the amino acid content of human milk was used as refer-
ence pattern (56,57) because adequate growth and development are known to occur 
in infants provided human milk, and plasma amino acid profiles of infants have been 
shown to reflect the amino acid composition of human milk. The Life Sciences Research 
Office (LSRO) report concluded that the amino acid scoring pattern of human milk is an 
accurate and appropriate standard for assessing the protein quality of infants formulas 
(58). The difficulty in composing infant nutrition is that even if the amino acid composi-
tion of infant formulas could be made very similar to that of human milk, digestibility 
and absorption of amino acids and peptides would be quite different from that of breast 
milk, thus resulting in different plasma amino acid profiles. Hypothetically, one could 
develop an infant formula based on egg protein and determine the plasma amino acid 
profile in infants fed this formula to see if the plasma aminogram is more similar to that 
of breast-fed infants than normal formulas provide. 
Concluding, the requirement of valine and isoleucine determined by the IAAO method 
showed that the recommendations based on human milk are correct. The factorial
approach by Dewey et al. underestimates the requirement for all BCAAs. For leucine, the
IAAO showed a lower requirement for term infants than the human milk data. This
would imply that, based on the IAAO data, the optimal Ile:Leu:Val ratio in infant formula 
would be 1 : 1.3 : 1 which resembles the BCAA ratio of egg protein. Current formulas 
provide 2-3 times too much leucine which could be associated with the development of 
the metabolic syndrome later in life. The IAAO method should be used to determine the
requirement of the other essential amino acids to determine the protein reference to 
optimize infant nutrition.
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West meets East
INTRODUCTION
When you enter Shanghai, its immense structures that reflect the economic growth of 
the last 20 years force you to immediately realise you are in one of the cities of the world 
that matters. Economically, China has become a world power, while in other areas it is 
still a developing country. The Ping Pong diplomacy of Nixon in 1972 has led to China 
opening its doors to the world, with the organisation of The Olympic Games in 2008 as 
a major highlight. Several collaborations between China and the western world have 
developed in all types of fields. In our case, it led to a collaborative research program in 
the Children’s Hospitals of our two universities: Rotterdam meets Shanghai, West meets 
East.
President Hu Jingtao’s goal to be a superpower in medical research by 2020 has led to 
major investments in research and development. The Ministry of Health issued require-
ments for good clinical practice in 1999 that also included ethical review. The protection 
of human participants in international medical research collaborations in China, and 
in other developing countries, has been a focus of attention in the mass media and 
scientific literature of developed countries. The competition with China’s enormous 
economic success has in some cases led to questions about the integrity of research 
conducted in China, and led to the “ Declaration of Scientific Ideology” in 2006 by the 
Chinese Academy of Sciences (1). We collected our experiences from one year of medical 
research on a Neonatology Ward in China and exchanged them with our Chinese col-
leagues in an eastern view.
MEDICAL ETHICAL COMITTEE:
According to the World Medical Association’s (WMA) Declaration of Helsinki (2), all 
medical research projects involving human subjects must undergo ethical review. In a 
developing country, such as China, not all hospitals have an ethics committee. In the 
institutions that have an institutional or independent local research ethics committee, 
it is very important that there is sufficient capacity and expertise to meet participants’ 
needs.
In our hospital, a committee was formed during the preparation period of our research 
project. Although relatively inexperienced, the committee contributed many useful re-
marks. Three meetings in 6 months were required to have our protocol approved, which 
is similar to the time and process to obtain approval in the Netherlands.
 Informed Consent
A fundamental principle of research ethics is that a participant that agrees to take part 
in research should do so voluntarily and with sufficient knowledge and understanding 
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of the procedures, risks and benefits involved. This is usually ensured through oral con-
sultation and written consent, in our subjects, from one or both parents. In clinical trials, 
the International Conference on Harmonisation Guideline for Good Clinical Practice (3) 
is widely followed by both public and private sector researchers. These require detailed 
consent forms and a large amount of reading by the subjects or parents.
Because there was no experience in asking the parents at our Neonatology Department 
for consent, the informed consent process was a major challenge. Parents cannot visit 
their children because of the large number of patients per room and because of the 
supposed risk of infections. Parents have a telephone conversation with the doctor 
1-2 times a week to receive information about their child. This is the only moment in 
which we can ask the parents for informed consent. The relationship between parents 
and doctors is not always optimal, as we will describe later. Additionally, many parents 
have negative associations with research and reject participation as soon as they hear 
the word research. Additionally, Chinese society is based on individual autonomy rather 
than social harmony. As a result, the argument that other people can benefit in the future 
from their participation does not have the desired effect; when there is no direct benefit 
for the child, no consent is given. In an observatory period of 12 months, we asked 272 
parents for consent. In term neonates, 113 approved (58%) and 82 rejected. In preterm 
neonates, 43 parents approved (56%) and 34 rejected. These values are lower than the 
approval rates we obtain in the Netherlands, where almost 80% of parents approve for 
at least one study at our neonatal intensive care unit. Strikingly, in Shanghai, only fathers 
or grandfathers signed the informed consent form.
HEALTH CARE SYSTEM
Most developed countries have a universal health care system that provides partial or full 
compensation for medical costs depending on the system used. One of the major criti-
cisms of performing research in a country where healthcare is not provided to children 
for free is that it is not ethical to perform free-of-charge intervention studies in patients 
that cannot pay for their own treatment. Because every country has its own medical 
system with its particular benefits and disadvantages, we will discuss only the Chinese 
system and the ethical issues that we experienced while conducting our research.
Inequity
The introduction of the Health Care Market System in the early 1980s led to the dis-
appearance of universal, free basic healthcare in China. The responsibilities for the 
provision of health services have devolved to the provincial and county governments. 
Because only 10% of the people in rural sites are covered by the cooperative medical 
system, compared to 45% in the cities, this leads to significant urban/rural differences 
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and inequities in services between the rich and insured people and the poor people 
(4). In our daily practice, we observed patients not receiving optimal care or parents 
forced to stop treatment due to financial reasons. The government is aware of these 
problems and recently increased the health budget by 40.6%; the coverage percentage 
of the people of the rural sites has increased over the years. Thereby, inflation in medi-
cal costs that is greater than the economic growth will be banned to make health care 
more affordable in the future for all individuals (5). The mean cost for the treatment and 
hospitalisation of a term neonate is 4,235 RMB (440 euro). The mean cost for a preterm 
neonate is between 7,539 and 33,312 RMB (783-3,460 euro), depending on the gesta-
tional age and birth weight. These costs are almost 10 times lower than the costs in the 
Netherlands. Because the mean capital annual income in 2006 was 11,900 RMB (1,235 
euro), and the average annual household income in Shanghai in that year was 20,668 
RMB (2,148 euro) (6), these medical expenses are sometimes unaffordable and families 
are forced to abandon treatment. 
Hopefully the loss of treatable patients will not occur in the future because the govern-
ment’s goal is to achieve universal access to basic health insurance by 2020. As quoted in 
1999, “the Chinese experience shows that health development does not automatically 
follow economic growth”(7). 
Prepayment Fee
When you enter a hospital in China, the waiting line is the first thing you see. No treat-
ment is started before payment is received. This is the case for both outpatient and 
inpatient clinics. This situation disturbs the patient-doctor relationship; some parents do 
not trust doctors because their greatest concern appears to be the payment and not the 
patient. In 2007, the death of a boy led to protests against this so-called “Pay or Delay” 
system. Although the hospital was found not guilty of the accusations, statements blam-
ing the hospital for the death were made during (illegal) protests (8). 
One child policy:
To control the enormous population growth, the Chinese State of Council decided in 
1979 to launch the one child policy. Deng Xiaoping, the acknowledged architect of the 
economic system that has made China an economic world power, approved this system 
to drive economic development and to raise the standard of living. This policy did have 
its desired effect when compared to the improvement of living standards in a country 
such as India that does not control population growth. However, the policy did have 
other unwanted effects. Because China has a long tradition of favouring boys, the ratio 
of male to female births is approximately 1.2 to 1.0 (9). Part of this difference lies in the 
under-registration of female births because females are sometimes left with relatives, 
given up for adoption or abandoned at orphanages (10). Sex ratios are further skewed 
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by widespread abortion, which 1 of 4 women in their twenties undergo, and 55% of 
them more than once (11). This occurs despite the fact that conducting an ultrasound to 
identify fetal sex is illegal in China.
In the clinical practice, our department admission rate in 2008 was 3376 patients per 
year, with 2096 males and 1280 females. Of these babies, 2236 were term, 65 were post-
term and 1075 were preterm neonates. The male-to-female admissions ratio of Shanghai 
residents is 1.36 to 1. The ratio for infants that come from other provinces is 1.8 to 1. This 
large difference results most likely from the fact that ill or premature females are more 
frequently left untreated. We observed a tendency to abandon impaired babies by leav-
ing them behind in the hospital. We also observed the male-to-female ratio difference 
in our study results; the first study we conducted in term infants did not contain one 
female after the inclusion of the first 15 patients.
OTHER ISSUES
Communication
What strikes you the most upon entering China is the fact that you cannot be understood 
if you do not speak Chinese. Even in a city such as Shanghai, most of the people do not 
speak any English. In the hospital, some of the doctors and nurses do speak English, but 
usually only the younger generation. To start clinical medical research in this country, a 
Chinese (-speaking) researcher is necessary, not only for communication with parents 
but especially for giving directions to avoid errors in your research setting. 
Number of patients
Among the main reasons to perform research in China is the quantity of patients. There 
were 160 patients in our neonatology ward, which is 3-5 times higher than the western 
average. However, the numbers of nurses, doctors and nurse-assistants are similar to 
those in western hospitals. This results in medicine based on efficiency because every 
nurse has to take care of 15-20 babies and every neonatologist supervises 5 residents 
and is in charge of treatment for 55 patients. All procedures are performed at fixed time 
points in all patients at the same time. For research purposes, you must find a system that 
does not require individual handling by nurses or nurse-assistants to avoid mistakes. If 
individual handling is needed, you must have enough manpower to do it yourself. 
Study requirements
One problem we experienced and did not expect before we went to China was the 
importation of our study materials. Because China has an enormous amount of exports, 
but few imported products and the regulations in China are based on forms and stamps, 
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importing items requires advanced preparation. The required forms must be prepared 
with the correct stamps from the government of the country where the products are 
produced. Because the list of required forms is not easy to acquire, at times the required 
forms are missing, the products are delayed in the customs process; this situation may 
take months to resolve. In our case, it took 4 months to pass the study formulas through 
customs, with help from a formula-producing company in China. It is also expensive to 
import items because the tax is 30%. 
In short, to start up a medical research project in China takes time to learn about the 
culture and habits of the people and to become familiar with the logistics system; there-
fore, a Chinese-speaking researcher is a must. After all of the preparations are finished 
and all of the approvals and requirements are acquired, the amount of patients and the 
working spirit of the Chinese provide a stimulating research environment. The Chinese 
can learn from our ethical perspectives and our experience in asking for informed con-
sent, whereas we can learn to manage large amounts of patients and learn from the 
Chinese efficiency. This is a win-win situation in a collaboration that has a large capacity 
for growth, which provides the opportunity to bring medical health care to a higher 
level in both eastern and western populations.
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INTRODUCTION
In January 2008, a Sino-Dutch research project started at the Children’s Hospital of Fu-
dan University in Shanghai. The aim of this research project was to determine essential 
amino acid requirements in Chinese neonates. It began in 2006, when I (Ying Huang, 
paediatric gastroenterologist of Fudan Children’s Hospital) went to the Netherlands for 
an educational visit for 3 months. This was my first encounter with the neonatal nutri-
tional studies by Prof. dr. van Goudoever. As a gastroenterologist, I view nutrition as one 
of the most important research fields. Due to the improvements in neonatal life support 
over the past decades, neonatal survival rates have increased tremendously, and the 
role of early nutrition is essential for this outcome. 
WHY A COLLABORATION?
China is continually boosting its research potential. One of the opportunities to improve 
its innovativeness is through international collaborations. Erasmus MC-Sophia Children’s 
Hospital, where Prof.dr. van Goudoever works, is one of the top institutions in the field 
of nutritional studies. To start the research project, two Dutch PhD students came to 
China for 1.5 and 3 years. They were assisted by a Chinese PhD student, several Dutch 
and Chinese medical students. The Chinese PhD student benefited from training during 
the design, implementation, and ethics of the trial and will perform her PhD defence 
according to the Dutch standards. 
THE VALIDITY OF THE STUDY
As shown by WHO’s new growth charts, given a healthy environment, children born in 
different regions of the world have the potential to grow and develop within the same 
range of height and weight for age (1). Therefore, the results from our research project 
(the essential amino acid requirements) performed in Chinese infants should be repre-
sentative for infants across the world. This assumption is supported by the amino acid 
requirement studies performed in Canadian and Indian children (2-3). Therefore, we can 
make a contribution to optimising infant nutrition around the world. 
Femke Maingay-de Groof 15-8.indd   169 20-08-12   15:43
Chapter 10
170
CHILDREN’S HOSPITAL OF FUDAN UNIVERSITY
Fudan University is one of the nation’s leading medical educational institutions; it 
represents the top level of clinical research in China. The neonatal department of the 
Children’s Hospital of Fudan University is equipped with 50-70 neonatal intensive care 
unit beds and 200 medium-care beds, which makes our neonatal ward the largest in 
China. The hospital discharge rate of the neonatal ward is 4500 cases per year. Over 85% 
of the neonatologists and one-third of the nurses have been trained abroad. 
RESEARCH ETHICS IN CHINA
In addition to the rapid development of medical technology in China, great progress has 
been made in the area of medical research ethics as well.
Medical research ethics is a relatively recent phenomenon in China. The basis of medical 
ethical committees has been imported from abroad. The development of ethical com-
mittees has been placed on a fast track. Since the acknowledgement of medical research 
ethics in 1987, 80 medical ethical committees were set up over 5 years. In 1998, China’s 
Ministry of Health announced the establishment of “biomedical research ethics commit-
tees involving human subjects”. Different steps have been taken to regulate the medical 
ethical committees across the country. By 2007, there were more than 400 institutional 
review boards across the country. During this process, the member composition and 
the legislation were improved. The Chinese guidelines for medical research ethics are 
greatly influenced by Euro-American medical ethics, especially by the US National Insti-
tutes of Health. The composition of ethical boards has been standardised. The institu-
tional review board of the Children’s Hospital of Fudan University includes 7 members: 1 
lawyer, 1 ethicist, 2 administrators and 3 medical experts (a doctor of internal medicine, 
a surgeon and a pharmacist). The board’s meetings are held once every 1-2 months.
For the current research project, additional focus has been placed on safety matters, 
the reasons behind setting up a study in China, and whether the same type of research 
has been performed in Europe. Additional documents, such as the review process 
documents from the Dutch institutional review board were required. Because there is 
no insurance company that offers insurance for studies which involve human subjects in 
China, a deposit from the research budget was needed for insurance funds.
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INFORMED CONSENT
Informed consent is a cornerstone of ethics in medicine. In China, informed consent in 
medical handling has existed for a few decades. Parents must approve medical proce-
dures and medical costs by written consent. Written consent improves human rights 
and the communication between patients and doctors.
Informed consent for research purposes is another developing area of medical ethics in 
China. Before the Sino-Dutch program started at the neonatal ward, there was not much 
experience in asking for informed consent for clinical studies in the NICU. This is not 
rare in China; at the time we started our collaboration in 2008, after studying all clinical 
trials published in the Chinese Journal of Pediatrics, informed consent procedures were 
mentioned in only 20% of the published clinical studies. A similar percentage was re-
ported for randomised controlled trials conducted in 2004 (4). This amount is expected 
to increase in the near future because the majority of Chinese journals require ethics 
committee approval and informed consent from the participants.
In our studies, written informed consent was obtained from at least one of the parents 
by a Chinese-speaking researcher. Most Chinese informed consent forms are 1-2 pages 
in length. Therefore, we summarised the Dutch informed consent form of 8 pages into 
1 page in Chinese. Low literacy among some of the parents and mistaking research 
for routine health care are common problems (5). An explanation of the research by a 
Mandarin-speaking researcher is necessary. The consent rate was approximately 50%, 
which is much lower than the 80% agreement rate observed in the Netherlands for 
nutritional studies in the neonatal intensive care unit. 
MEDICAL INSURANCE
China has a high internal rural to urban migration rate. This rate is expected to increase 
in the coming decades. Migrants in Shanghai are largely excluded from urban services, 
including access to public health and public medical insurance. In general, the socio-
economic status of the migrants is below that of the urban population. Over 50% of 
the admissions at the neonatal ward of the Children’s Hospital of Fudan University are 
new-borns of migrants (6). Of these 50%, the majority are new-borns of workers with 
low socioeconomic status who have to pay out-of-pocket for their new-born’s medical 
services. In some cases, the unaffordable medical cost makes it necessary to take the sick 
infant to a rural hospital for further treatment. Shanghai residents have basic insurance 
that covers approximately 50% of medical costs. Since September 2011, certain funds 
exist for non-Shanghai household-registered patients who have incomes less than 100, 
000 Renminbi per year per household.
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The Chinese government is starting to focus on medical insurance coverage as a basic 
requirement for all citizens. In March 2009, an announcement made by the Chinese gov-
ernment brought hope for a national child insurance system. The proposal is to develop 
a national child insurance system to ensure that every child has the right to receive 
medical care. Moreover, the country has recently embarked on major health reform to 
achieve universal coverage of primary health services by 2020 (7).
Part of a doctor’s duties is to inform parents about the admission and treatment costs 
for their new-borns. The doctor-patient relationship is not what it should be; mistrust of 
doctors and researchers is a common phenomenon.
USE OF ExTERNAL SUPPORT
The main logistical problem during the Sino-Dutch research program was the importa-
tion of study formulas. All sorts of issues had to be resolved to receive clearance from 
customs to import the study formulas to China. The main issues were the required import 
licenses and the continuously changing customs legislation, which made it impossible 
for a hospital to import study formulas directly. Industry sponsors, in our case Danone 
and Dumex China, were required to facilitate the transportation, but excessive costs 
were incurred to import the study formulas.
CONCLUSION
China has the largest scientific workforce in the world and has just started to bloom in 
the scientific field (8). The clinical research publication output has increased impressively 
at an average rate of 22% each year between 2000-2009 (9). The Chinese government in-
vested approximately 1 billion Renminbi (EUR €100 million) in medical research in 2010 
(10). This enormous boost is meant to make China’s medical research more competitive 
internationally. There is enormous potential for collaborative scientific research work 
with China. As described in this article, there are many differences between conducting 
research in China and in a western country. However, the ethical principles for good 
clinical practice are universal. To achieve success in a Sino-European research collabora-
tion, we should first follow the Western and Chinese ethical standards, and have co-
investigators who can speak Mandarin and English and possess knowledge regarding 
the cultural settings. 
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ABSTRACT
Background: The essential amino acid methionine can be used for protein synthesis, 
but also serves as precursor for homocysteine and cysteine. 
Objective: The objective was to determine the minimal obligatory methionine require-
ment for infants in presence of excess cysteine (91 mg·kg-1·d-1) using the indicator amino 
acid oxidation (IAAO) method with L-[1-13C]phenylalanine as the indicator.
Design: Fully enterally fed term infants less than one month of age were randomly as-
signed to methionine intakes ranging from 3 to 59 mg·kg-1·d-1, as part of an elemental 
formula. After 1 d adaptation to the test diet, [13C]bicarbonate and L-[1-13C]phenylala-
nine tracers were given enterally. Breath samples were collected at baseline and during 
isotopic plateaus. Mean methionine requirement was determined by using a biphasic 
linear regression crossover analysis on the fraction of 13CO2 recovery from L-[1-
13C]phe-
nylalanine oxidation (F13CO2). Data are presented as mean ± SD. 
Results: Thirty-three neonates (gestational age 39 ± 1 wk) were studied at 13 ± 6 d. With 
increasing methionine intakes, F13CO2 decreased until a methionine intake of 38 mg·kg
-
1·d-1; additional increases in methionine intake did not affect F13CO2. Mean methionine 
requirement was determined at 38 mg·kg-1·d-1 and the upper and lower CIs were 48 and 
27 mg·kg-1·d-1, respectively (p < 0.0001, r2 = 0.59).
Conclusions: Although the current recommended methionine intake of 28 mg·kg-1·d-1 
is within the CIs of our study, the estimated mean requirement is substantially higher. 
However, most of the infant formulas provide a methionine intake of 49 to 80 mg·kg-1·d-1, 
which is above the upper CI of our study.
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INTRODUCTION
Methionine is an essential amino acid required for protein synthesis. It is also needed for 
the biosynthesis of carnitine, which is essential for fatty acid metabolism (1). Methionine 
is the major methyl donor in mammalian cells and a precursor for polyamine synthesis 
(2). Transmethylation of methionine leads to homocysteine synthesis. Homocysteine 
can be remethylated to form methionine or catabolized via the transsulfuration path-
way to form cysteine. Cysteine can be incorporated into protein and it is also involved 
in the production of glutathione, taurine, coenzyme A and inorganic sulfur. Cysteine, 
glutathione and taurine play a role in the defense mechanism against oxidative stress. 
Deficient intake of methionine not only impairs growth, but has also an impact on the 
sulfur metabolic pathways in the synthesis of its key metabolic intermediates. In contrast, 
methionine is known as the most toxic amino acid in animals when supplemented in 
excess (3-4). Hypermethioninemia and hyperhomocysteinemia were observed in infants 
consuming methionine fortified formula with methionine content of 788 mg/L or a high 
protein formula providing 9 g protein per kg per d (5-6). Extreme hypermethioninemia 
may cause cerebral edema (5). Hyperhomocysteine is found to be associated with an 
increased risk for neonatal stroke (7). Because both a deficient and excess intake of me-
thionine have detrimental effects, it is therefore important to determine the methionine 
requirement to optimize infant nutrition.
Experimental evidence for methionine requirement of enterally fed infants is scarce. In 
earlier studies with relatively small number of infants (n = 7 -13), methionine requirement 
was estimated to be between 27 and 49 mg·kg-1·d-1 (8-11). Since breast milk is considered 
to be the optimal nutrition for infants up to 6 months of age, the joint WHO/FAO/UNU 
expert consultation recommended a methionine intake of 28 mg·kg-1·d-1, based on the 
average intake of breastfed infants (12). Human milk is known to vary in protein content 
while the volume ingested varies as well on a daily basis. These factors all contribute 
to the difficulty of providing an accurate estimation of the intake of a breastfed infant. 
The indicator amino acid oxidation (IAAO) method is minimally invasive and therefore 
suitable for determining the essential amino acid requirements in vulnerable popula-
tions including infants (13-14).
The aim of this study was to determine the minimal obligatory methionine requirement 
with excess intake of cysteine for term infants using the IAAO method.
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SUBJECTS AND METHODS
Subjects
Thirty-three neonates admitted to the Neonatal Ward in the Children’s Hospital of Fudan 
University participated in the study. Each subject was selected for study by the following 
criteria: fully enterally fed infants with a gestational age of ≥ 37 weeks, birth weight ≥ 
2500 g, and clinically stable with a weight gain rate ≥ 5 g·kg-1·d-1 in the preceding 3 d. 
Subjects were excluded if they had congenital anomalies, gastrointestinal pathology or 
sepsis. 
The study was approved by the Institutional Review Boards of the Children’s Hospital 
of Fudan University, and a statement of no objection was obtained from the Erasmus 
Medical Centre-Sophia Children’s Hospital, Rotterdam. Written consent was obtained 
from at least one of the parents of each subject by a Chinese speaking researcher. 
Study formula
The study formula used was an elemental formula that was based on free amino acids. 
The amino acids, fat, carbohydrates, and energy content of the study formula are shown 
in Table 1. The composition was the same as Neocate (SHS International) except for the 
methionine, phenylalanine and alanine content. Methionine, which was completely 
withdrawn from the study formula, was separately added in the form of L-methionine to 
obtain different amounts of intake. The formula provided a cysteine intake of 91 mg·kg-
1·d-1. This amount was considered to be in excess, since it is more than 3 times the intake 
of a breastfed infant (12). This amount should minimize the amount of methionine 
that is metabolized to cysteine via the transsulfuration pathway, which enables us to 
determine the minimal obligatory methionine requirement. The phenylalanine intake 
was kept constant during the study by separately adding L-phenylalanine during the 24 
h adaptation period to obtain the same amount as in the Neocate (SHS International), 
and this amount of phenylalanine was given as stable isotope L-[1-13C]phenylalanine on 
the tracer infusion day. The phenylalanine intake during the study was 166 mg·kg-1·d-1, 
which was above the recommended amount of 72 mg·kg-1·d-1 (12). A generous amount 
of tyrosine (166 mg·kg-1·d-1) was provided to ensure that the newly formed [1-13C]tyro-
sine hydroxylated from [1-13C]phenylalanine would be directly channeled to oxidation 
into 13CO2, which can be measured in expired air (15). This amount of tyrosine was almost 
twice the recommended intake (12). The nitrogen intake was kept constant for all sub-
jects by the substitution of L-alanine for the methionine that was withdrawn. The caloric 
intake was kept constant during the study period in all infants.
The minerals and trace elements supplied in 100 g formula were as follows: iron 7.0 mg, 
calcium 325 mg, phosphorus 230 mg, magnesium 34 mg, sodium 120 mg, chloride 290 
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mg, potassium 420 mg, manganese 0.38 mg, iodine 47 µg, selenium 11 µg, copper 380 
µg, and zinc 5.0 mg.
The vitamin content of 100 g formula was as follows: vitamin A 528 µg retinol equivalent, 
vitamin D 8.5 µg, vitamin E 3.3 mg α-tocopherol equivalent, vitamin K 21 µg, thiamin 390 
µg, riboflavin 600 µg, niacin 4.5 mg, vitamin B6 520 µg, vitamin B12 1.3 µg, pantothenic 
acid 2.3 mg, folic acid 38 µg, vitamin C 40 mg, and biotin 26 µg. 
Experimental design
The study design is based on the minimally invasive IAAO method (13), which is recently 
modified to apply in enterally fed infants (14). The advantages of this method are the 
short adaptation period to the test intake (1 d), the enterally delivered isotopes, and the 
sampling of expired air without sampling of the amino acid enrichments in plasma or 
urine. The IAAO method is based on the concept that when the test amino acid intake 
Table 1. Energy, carbohydrates, fat, and amino acids content of the study formula.
Component Per 100 g formula
Energy (kcal) 475
Carbohydrates (g) 54
Fat (g) 23
Total amino acid (g) 13
L-Alanine (g) 1 ≥ 0.61
L-Arginine (g) 1.08
L-Asparagine (g) 1.01
L-Cyst(e)ine (g) 0.4
Glycine (g) 0.95
L-Histidine (g) 0.62
L-Isoleucine (g) 0.95
L-Leucine (g) 1.63
L-Lysine (g) 1.11
L-Methionine (g) 2 0
L-Phenylalanine (g) 3 0.20 
L-Proline (g) 1.16
L-Serine (g) 0.71
L-Threonine (g) 0.8
L-Tryptophan (g) 0.32
L-Tyrosine (g) 0.73
L-Valine (g) 1.04
L-Carnitine (g) 0.01
Taurine (g) 0.03
L-Glutamine (g) 1.34
1  Variable levels of L-alanine were added to the diet depending on the test methionine level of each infant to 
maintain an isonitrogenous diet. The study formula contained at least 0.61 g L-alanine per 100 g formula.
2 L-methionine was added separately, depending on the test methionine level.
3  0.53 g L-phenylalanine per 100 g formula was added to the study diet on day 1. Equivalent amount of 
L-phenylalanine (0.52 g per 100 g formula) was given as isotope on day 2. 
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is insufficient to meet the requirement, protein synthesis will be limited and all of the 
amino acids will be oxidized, including the indicator amino acid, which is labelled with 
a stable isotope. As the dietary intake of the test amino acid increases, the oxidation 
rate of the indicator will decrease until the requirement of the test amino acid is met. 
Once the requirement of the test amino acid is met, an additional increase in its intake 
will have no further influence on the oxidation rate of the indicator amino acid. The 
oxidation of the indicator amino acid can be measured in expired air as 13CO2. 
During the study, all of the infants received a fluid intake of ~150 mL·kg-1·d-1, a caloric 
intake of 108 kcal·kg-1·d-1 and an amino acid intake equal to the protein intake of ~2.96 
g·kg-1·d-1. Infants were randomly assigned to one of the graded test intakes of methio-
nine, which ranged from 3 to 59 mg·kg-1·d-1. To maximize the power of the breakpoint 
analysis used in our method, a wide range of methioinine intakes with approximately 
equal number of intakes above and below the expected breakpoint was chosen (16). 
Since the methionine requirement was expected to approximate the methionine 
content in human milk, we therefore studied an equal number of intakes above and 
below the expected requirement of 28 mg·kg-1·d-1 (12). Each study took place over a 31-h 
period whereby each infant received one of the test intakes. After 24 h of study formula 
consumption, the tracers were administered on day 2 for 7 h. Infants were bottle fed 
every 3 h during the adaptation period. Subsequently, the feeding regimen changed 
to hourly bottle feeding during the tracer infusion until the end of the study. On the 
tracer day, a nasogastric tube was placed for tracer infusion. Infants received a primed 
(14 µmol·kg-1) continuous (9 µmol·kg-1·h-1) enteral infusion of [13C]bicarbonate (sterile 
pyrogen free, 99% 13C APE; Cambridge Isotopes, Woburn, MA) for 3 h to quantify indi-
vidual CO2 production rates (17). Phenylalanine was used as the indicator. After the [
13C]
bicarbonate infusion was stopped, a primed (34 µmol·kg-1) continuous (27 µmol·kg-1·h-1) 
enteral infusion of L-[1-13C]phenylalanine (99% 13C APE; Cambridge Isotopes) was started 
and lasted for 4 h. Syringes were weighted before and after the study to determine the 
exact amount of the tracers that were given to the infants. The tracer infusion day is 
depicted in Figure 1. 
Figure 1.  
[13C]Bicarbonate Tracers 
Feeding 
Time 
(min) 
Breath 
samples 
[1-13C]phenylalanine 
  0                             180                                                     420    
Figure 1. Schematic overview of tracer infusion day. Triangles indicate time that bolusfeeding was given. 
Arrows indicate times that breath samples were taken.
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Sample collection and analysis
Breath samples were obtained by using the direct nasopharyngeal sampling method 
described by van der Schoor et al. (18). Briefly, a 6F gastric tube (6 CH Argyle; Sherwood 
Medical, Tullamore, Ireland) was placed 1 to 1.5 cm into the nasopharynx and the end-
tidal breath was taken slowly with a syringe. Collected air was transferred into 12 mL 
sterile, non-silicon-coated evacuated glass tubes (Van Loenen Instruments, Zaandam, 
the Netherlands) and was stored at room temperature until analysis. Two duplicated 
baseline samples were obtained before the start of tracer infusion. Duplicated breath 
samples were obtained at 15 min intervals during isotopic plateau of [13C]bicarbonate 
between 105 and 180 min. Seven duplicated samples were obtained every 10 min dur-
ing isotopic plateau of L-[1-13C]phenylalanine between 360 and 420 min (Figure 1). 
13C isotopic enrichment in the breath samples was analyzed by an infrared isotope 
analysis technique (Helifan, Analytic Fischer Instruments, Leipzig, Germany) (19). The 13C 
enrichment was expressed as the atom percent excess above baseline (APE). 
Calculations
The isotopic steady state was represented by plateaus in 13CO2. Plateaus were deter-
mined by visual inspection and were confirmed by regression analysis as a slope not 
significantly different from zero.
The estimated body CO2 production rate (mmol·kg
-1·h-1) was calculated as described 
previously (14, 17).
The fraction of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) in % was 
calculated with the following equation (20):
F13CO2 = [IEPHE x iB ] / [ iPHE x IEB] x 100%
where IEPHE is the 
13C isotopic enrichment in expired air during [1-13C]phenylalanine infu-
sion (APE), iB is the infusion rate of [
13C]bicarbonate (µmol·kg-1·h-1), iPHE is the infusion rate 
of L-[1-13C]phenylalanine (µmol·kg-1·h-1) and IEB is the 
13C isotopic enrichment in expired 
air during [13C]bicarbonate infusion. 
Phenylalanine flux was not obtained. As shown in our previous study, test amino acid 
intake has no effect on the phenylalanine flux (14). 
Statistical analysis
Descriptive data are expressed as means ± SD. Determination of the methionine require-
ment, the breakpoint, was performed using a biphasic linear regression crossover model 
(21). With the biphasic linear regression analysis, the regression equation was split into 
two parts. For the first part an intersept and slope were estimated, while for the second 
part, the slope was restricted to zero. Therefore, the estimated intercept of the second 
Femke Maingay-de Groof 15-8.indd   183 20-08-12   15:43
Chapter 11
184
line is equal to the breakpoint. The model with the best fit, based on the highest r2 was 
selected. The 95% confidence intervals were calculated. A value of p < 0.05 was taken as 
significant. The analyses were performed in STATA version 11. 
The power analysis cannot be performed. We aimed to study 20 to 35 infants, more than 
studies in parenterally fed infants using the same approach with intravenous adminis-
tration of the tracer (22-24).
RESULTS
Subject characteristics
Thirty-three term neonates participated in the study. The neonates were studied at a 
methionine intake that ranged between 3 and 59 mg·kg-1·d-1. Subject characteristics are 
summarized in Table 2. All subjects were growing well before entering the study. The 
mean (± SD) weight gain rate 3 d before the study was 13 (± 5) g∙kg-1∙d-1. The mean (± SD) 
energy intake was 109 ± 1 kcal·kg-1·d-1. The nitrogen intake was equivalent to a protein 
intake of 3.0 ± 0.1 g·kg-1·d-1. The infants were clinically stable and considered healthy 
because they were discharged on the study day or the day after. The primary reasons for 
admissions were unconjugated hyperbilirubinemia (n = 15), pneumonia with a negative 
blood culture (n = 6), asphyxia (n = 4), infection suspicion with a negative blood culture 
(n = 5), wet lung (n = 1), observation due to uterine bleeding (n = 1) and pending results 
of TORCH (toxoplasmosis, other agents, rubella, cytomegalovirus, herpes simplex virus) 
(n = 1), which were negative. Intravenous antibiotics (penicillins and/or cephalosporins) 
were given to 28 of the 33 infants. 
Table 2. Subject characteristics, and protein and energy intake prior to the study of infants who 
participated in the study (n = 33).
Values
Birthweight (kg) 3.3 ± 0.4
Gestational age (wk) 39 ± 1
Age on study day (d) 13 ± 6
Weight on study day (kg) 3.5 ± 0.4
Weight gain before study (g·kg-1·d-1) 13 ± 5
Sex (F:M) 9:24
Protein intake prior to the study (g·kg-1·d-1) 2.5 ± 0.4 
Energy intake prior to the study (kcal·kg-1·d-1) 108 ± 14
All values are means ± SDs. 
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13CO2 enrichments during [
13C]bicarbonate infusion
The baseline 13CO2 enrichment was -17.04 ± 0.94 pee dee belemnite (PDB). The mean 
13CO2 enrichment at isotopic plateau during [
13C]bicarbonate infusion was 0.0380 ± 
0.032 APE. The corresponding mean CO2 production rate was 23.44 ± 2.04 mmol·kg
-1·h-1. 
The mean 13CO2 enrichment at isotopic plateau and their corresponding CO2 produc-
tion rate of each infant were plotted against the methionine intake (Figure 2A and 2B 
respectively). 
Figure 2a.  
Figure 2b.  
C
O
2 p
ro
du
ct
io
n 
ra
te
 
(m
m
ol
·k
g-
1 ·h
-1
) 
M
ea
n 
en
ric
hm
en
t d
ur
in
g 
[13
C
]b
ic
ar
bo
na
te
 (A
PE
)
Methionine intake (mg·kg-1·d-1) 
Methionine intake (mg·kg-1·d-1) 
Figure 2A. Mean 13CO2 enrichment at isotopic plateau during enteral [
13C]bicarbonate infusion of each 
infant plotted against the methionine intake (n=33). APE, atom percent excess. 
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Figure 2B. The CO2 production rate of each infant plotted against the methionine intake (n=33). 
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L-[1-13C]phenylalanine oxidation
The mean 13CO2 enrichment at isotopic plateau during L-[1-
13C]phenylalanine infusion 
was 0.0198 ± 0.032 APE. These 13CO2 enrichment values and the F
13CO2 are plotted 
against methionine intakes in Figure 3A and 3B . As the methionine intake increased, 
F13CO2 decreased. This negative correlation was shown between F
13CO2 and methionine 
intakes up to 38 mg·kg-1·d-1; additional increases in methionine intake did not affect the 
F13CO2. Using a biphasic linear regression crossover model, mean methionine require-
Figure 3a.  
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Figure 3A. Mean 13CO2 enrichment at isotopic plateau during enteral L-[1-
13C]phenylalanine infusion of 
each infant plotted against the methionine intake (n=33). APE, atom percent excess.
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Figure 3B. The fraction of 13CO2 recovery from L-[1-
13C]phenylalanine oxidation (F13CO2) during the 
isotopic plateau at different methionine intakes (n = 33). Each infant received a different methionine 
intake. With the use of a biphasic linear regression crossover model, the breakpoint was estimated to be 
38 mg·kg-1·d-1 (p < 0.0001, r2 = 0.59). The upper CI was 48 mg·kg-1·d-1 and the lower CI was 27 mg·kg-1·d-1. 
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ment was determined to be 38 mg·kg-1·d-1 (p < 0.0001, r2 = 0.59). The upper CI was 48 
mg·kg-1·d-1 and the lower CI was 27 mg·kg-1·d-1.
DISCUSSION
The minimal obligatory methionine requirement for enterally fed term infants is esti-
mated to be 38 mg·kg-1·d-1 using the IAAO method. This value is comparable with the 
estimates of 32 to 49 mg·kg-1·d-1 determined by Snyderman et al. (8). In their study, the 
methionine requirement was determined in 7 infants with postnatal age between 2 
weeks and 2 months using weight gain rates and the nitrogen retention. The study diet 
used by Snyderman et al. (8) was an elemental diet providing a cysteine intake of 64 
mg·kg-1·d-1. Fomon et al. (9-11) reported a series of studies with soy protein formulas 
with or without a methionine supplement fed to infants over a period of several months. 
Eight to thirteen infants were included in each study diet. Adequacy of the diet and 
thus adequacy of sulfur amino acids intakes was estimated by measurement of growth, 
serum chemical indices and nitrogen retention. They concluded that for female infants 
a diet with methionine content of 35 mg/100 kcal was considered adequate, however a 
methionine intake of 39 mg/100 kcal failed to meet the requirement of male infants un-
der the age of 56 d. Although our study was not designed to detect gender differences 
in methionine requirement, the average requirement estimates by Fomon et al. (9-11) 
are consistent with our results. The limitations of earlier studies were the relative small 
number of subjects studied and the method used. Growth rates and nitrogen balance 
might not be the most sensitive and accurate methods for estimating the amino acid 
requirements.
Recently, Courtney-Martin et al. (22) determined the methionine requirement in par-
enterally fed postsurgical neonates using the IAAO method to be 49 mg·kg-1·d-1. The 
diet was devoid of cysteine. To compare their estimates with ours, the route of nutrition 
intake and the sparing effect of cysteine on methionine requirement need to be taken 
into account. Experiments with human fetal tissues demonstrated the lack of activity 
of cystathionase (25-26), the enzyme involved in the final step in the cysteine synthesis 
pathway. However, recent clinical studies showed the capability of transsulfuration of 
methionine to cysteine in (pre)term neonates (27-29) and thereby support the evidence 
of cysteine having a sparing effect on methionine requirement. The level of cysteine for 
sparing the dietary methionine requirement is ~33% in infants (30), ~55% in school-
aged children (31), 60-89% in adults (32-33), ~40% in piglet studies (34). In a series of ex-
periments, Shoveller et al. (34-35) compared the methionine requirement and cysteine 
sparing capacity in piglets that were parenterally and enterally fed. They showed that 
the parenteral methionine requirement was ~70% of the enteral requirement and the 
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dietary cysteine reduces the methionine requirement by equal proportion in both feed-
ing routes of ~40%. Using these fractions, the parenteral methionine requirement of 49 
mg·kg-1·d-1 with a diet devoid of cysteine in neonates determined by Courtney-Martin et 
al. (22) can be converted to enteral methionine requirement with excess of cysteine as in 
our study. The predicted requirement would be 42 mg·kg-1·d-1. This amount is nearly the 
same as our estimated requirement of 38 mg·kg-1·d-1.
The current essential amino acid recommendations are based on the average intake of 
an exclusive breastfed infant (12). The estimated methionine intake in the first month of 
life is 28 mg·kg-1·d-1, which is lower than our estimated mean requirement. At least four 
explanations might contribute to this finding.
First, a part of the difference may be caused by the elemental formula we used, while 
the recommendations are not discriminating between whole protein based formulas, 
partially hydrolyzed or elemental formulas. All these formulas are on the market for 
infants. A recent report demonstrated that an elemental diet provides in average 17% 
less protein substrate per gram of free amino acids than does a protein bound diet. This 
is due to the release of a water molecule when a peptide bond is formed (36). 
Secondly, amino acids utilization and therefore retention were shown to be different de-
pending on the protein/ amino acids digestion rates (37-38). Metges et al. (37) showed 
that the oxidation rate was 22% higher and the non-oxidative disposal is 38% lower 
when free amino acids are ingested compared to a protein diet. Therefore, we might 
overestimate the actual requirement. However, using a diet based on free amino acids 
provides us the ability to vary in test amino acid intake while keeping the other amino 
acid intakes constant. Future studies with an intrinsically labelled protein are required 
to evaluate this issue. 
Thirdly, human milk composition shows remarkable variation, it is influenced by many 
factors, such as the gestational age at parturition, stage of lactation, nutritional status of 
the mother, etc. The protein content in human milk declines remarkably during lactation 
(39-40). The recommendations do take into account the decline in protein intake by the 
breastfed infant, but not for the change in whey-casein ratio and thus the change in 
amino acid composition (41).
Lastly, the protein digestibility and amino acid bioavailability in human milk are differ-
ent from that in the formula. Therefore, the gross amino acid composition of human milk 
may not necessarily reflect the amino acid requirement profile of infants consuming 
infant formula. An ESPGHAN coordinated international expert group stated that “the 
composition of human milk can provide some guidance for the composition of infant 
formulae, but gross compositional similarity is not an adequate determinant or indicator 
of the safety and nutritional adequacy of infant formulae” (42). The results of our current 
study provide more scientific knowledge of amino acid needs of infants fed an infant 
formula, which is necessarily to improve infant nutrition.
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A limitation of our study is that we performed the study in hospitalized infants. Although 
the infants were recovered from their illnesses, 11 out of 33 infants were in a (possible) 
post-infectious state. Since inflammation along with increased oxidative stress might 
deplete liver glutathione pool by increase glutathione usage, the liver glutathione 
pool might be depleted in these infants. The liver glutathione pool can be restored by 
increasing the cysteine content in the diet (43). We therefore assume that the current 
health status will not affect the estimated methionine requirement significantly because 
cysteine was supplied in excess and glutathione synthesis depends mainly on the avail-
ability of cysteine (44). 
Another issue in our study is the extensive antibiotic use in our study population. Antibi-
otic treatment has a major impact on the bacterial flora in the gastrointestinal tract (45), 
and it is possible that the requirement is met not only by the diet but also by the de novo 
synthesis by the gastrointestinal bacterial flora (46). However, the bacterial contribution 
to amino acid requirements is still unclear. Therefore, the impact of antibiotic use on the 
estimated requirement is unknown.
The minimal obligatory methionine requirement is determined to be 38 mg·kg-1·d-1 of 
term neonates fed an amino acid based formula provided with an excess of cysteine. 
Current infant formulas provide excess methionine (49-80 mg·kg-1·d-1) when 150 mL·kg-
1·d-1 is consumed (47). The results of our current study provide more scientific knowledge 
of amino acid needs for infants fed an infant formula, which is necessarily to improve 
infant nutrition.
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INTRODUCTION
Birth and adaptation to extrauterine life involve major shifts in the protein and energy 
metabolism of the human newborn. These include a shift from a state of continuous sup-
ply of nutrients including amino acids from the mother to cyclic periodic oral intake and 
a change in the mobilization and use of substrates. It is associated with marked surges in 
several hormones, lipolysis and initiation of endogenous glucose production. Although 
a vast majority of neonates’ transition to the extrauterine environment uneventfully, a 
number of infants, in particularly those born prematurely, develop significant problems 
(1). Major advances in the care of these infants, such as ventilatory support, surfactant 
replacement therapy, and ante-partum glucocorticoids, have markedly improved their 
survival. At the same time it made their nutritional care a challenge for the physician; 
extremely low birthweight infants (ELBWI, birthweight < 1000 gram) survivors have 
an increased risk of growth failure (2, 3). The improvement in survival for ELBWI has 
not been accompanied by proportional reduction in the incidence of disability in this 
population (4, 5). In addition, many infants born with a weight between 1000 and 1500 
g become growth restricted as well with parameters below the 10th percentile by 36 
weeks’ postconceptional age (6-8), and many remain small into childhood and adoles-
cence (9, 10). The growth failure is attributable, at least in part, to inadequate nutrition 
in the first weeks of life. There is accumulating evidence that malnutrition during periods 
of vulnerability alters the growth of the developing brain and may have permanent 
negative consequences (11-13). A clear association between early enteral intake and 
neurodevelopmental outcome has been demonstrated in larger preterm infants. Lucas 
et al. demonstrated higher cognitive and motor scores at 18 months’ corrected age, 
higher verbal IQs and lower rates of cerebral palsy at 7.5 to 8 years of age in preterm 
infants fed preterm formula versus term formula in the first 4 weeks of life (14, 15). More 
recently, Stephens et al. showed that increased first week protein and energy intakes are 
associated with higher mental developmental index (MDI) scores and lower likelihood of 
length growth restrictions at 18 months in ELBWI (16). In addition to the benefits, there 
may be adverse long-term effects of increased early protein and energy intake. Preterm 
infants randomly assigned to human milk versus formula, just for 4 weeks, have marked 
benefits 13-16 years later for lipid profile (17), blood pressure (18), leptin resistance (19) 
and insulin resistance (20). For the latter, a diet of human milk or standard formula was 
beneficial compared with nutrient-enriched formula (20). 
In term neonates, weight gain in the first 1-2 years of life is associated with adverse 
health outcomes later in life, including increased blood pressure (21), increased weight 
gain and body fat deposition (22-25) and an increased risk of diabetes (26). The higher 
protein intake in infants who are fed formula may play a role with these health outcomes 
because formula-fed infants reach a higher body weight and weight for length at one 
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year of age compared with infants who are fed breast milk (27). Thus, protein intake 
should be strictly regulated early in life to result in the best possible neurodevelopment 
while reducing the risk of obesity.
METHODOLOGICAL ISSUES
Adaptation to the study diet
A decrease in the intake of protein or a specific indispensable amino acid intake results 
in a reduced rate of amino acid oxidation (28-31) and consequently a decrease in the 
rate of body-N loss (30). When intakes of energy and other nutrients are adequate but 
the protein level is very low, this decline in N-excretion reaches, within a few days to 1 
week, a new, lower and relatively steady state (32). Harper (33) described the enzymatic 
changes that occurred after ingestion of a protein-low and protein-high intake. Enzymes 
involved in the metabolism of dispensable amino acids responded to the amount of 
protein consumed, whereas enzymes involved in the catabolism of indispensable amino 
acids adapted to changes in protein intake (and indispensable amino acid intake) in 
relation to the amino acid needs of the body. So the capacity to degrade amino acids 
depends to a considerable extent on the diet. A change in the intake of an amino acid 
is promptly, at least within a few hours accompanied by a parallel change in its oxi-
dation rate (34, 35). Our study indicates that a period is necessary to adapt to the 13C 
level of the study formula before a requirement study in infants can be performed, this 
adapts within 24 hours (chapter 2). Secondly, no differences were observed in fractional 
oxidation rates between day 2 and 4. However, and very interestingly, we did observe 
a significantly decrease in indicator oxidation rate after five days of adaptation. This 
coincided with a lower weight gain rate observed after a period of 6 days. These results 
can be interpreted in two ways. First, at least five days of adaptation to a study diet is 
necessary in IAAO studies determining the amino acid requirements in preterm infants. 
Secondly, the body adapts to a reduced essential amino acid intake to lower growth rate 
which again is reflected by a new equilibrium. In the new equilibrium, a lower require-
ment of essential amino acids is needed since e.g. growth is reduced. So a requirement 
determined under those circumstances would not reflect the optimal intake. If this 
theory is true, this would reflect the remarkable flexibility of the human body to adapt 
to changed circumstances. 
In the minimally invasive protocol of Bross et al., subjects are adapted to a protein intake 
for 2 days followed by a study day adaptation to the test amino acid intake for 4 hours. 
Recently it was shown that adaptation to the study diet for 7 days, 3 days or 8 hours did 
not influence the oxidation of the indicator in healthy men (36) after a 2 day adaptation 
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to the protein intake. Duncan et al. showed no difference in lysine requirement in adults 
adapted to 2 different protein intakes (37). These studies indicate that 4 hours adaptation 
to the study intake should be sufficient to determine amino acid requirements using the 
IAAO method. The IAAO method is based on partitioning of the indicator amino acid in 
either protein synthesis or oxidation which occurs primarily at the acyl-t-RNA level. The 
adaptation needed does not relate to the urea pool which needs 7 days to achieve a 
equilibrium but does relate to the turnover of acylated t-RNA’s, which adapts in less than 
four hours (38). Since the Michaelis-Menten constant (Km) for various amino acid degrad-
ing enzymes are relatively high and not saturated under the physiological range of 
plasma or tissue amino acid concentrations, the oxidation will respond quite rapidly to a 
change in intracellular amino acid concentration (33). Whether amino acid requirement 
for growth and maintenance have already changed in these few hours is not known but 
it seems not likely. As mentioned above, the IAAO method is based on partitioning of 
the indicator amino acid in either protein synthesis or oxidation which occurs primarily 
at the acyl-t-RNA level which adapts in less than four hours. No conclusive evidence 
has been generated as how long an adaptation to a deficent diet should last. To solve 
this question the requirement of a test amino acid should be determined after 5 days 
adaptation to the study diet and compared to the requirement after 1 day adaptation 
to the study diet but this should be performed in the range of the requirement to avoid 
growth restrictions in these infants. 
Sampling of air
To avoid unnecessary invasive handling, non-invasive methods have been incorporated 
into the stochastic model for the study of protein and amino acid metabolism. An oral or 
intra-gastric infusion of isotope was used in infants (39) and an urine analysis of isotope 
enrichment was used in infants to measure amino acid kinetics (40). An excellent cor-
relation was found between plasma and urinary amino acid enrichment in both infants 
and adults (40, 41). The measurement of 13CO2 in breath has shown to be a well method 
to determine the requirement without sampling the plasma pool in healthy adult males 
(37, 42). A minimally invasive protocol was developed which used oral tracers and de-
termined isotopic enrichment in urine and breath. It was used to determine amino acid 
requirements in school-aged children and in parenterally fed neonates (46-48). 
In Chapter 4 we determined the lysine requirement in enterally fed infants. The require-
ment of lysine determined in air was identical to that determined in urine and plasma. 
We also showed that our short-period tracer protocol of 400 minutes is valid for deter-
mining amino acid requirements in enterally fed infants. 
The use of an indicator amino acid to estimate protein synthesis and amino acid oxida-
tion is the basic concept of the IAAO method. The IAAO is selected specifically because 
it has a carboxyl group that is irreversibly removed and excreted as carbon dioxide in 
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the earliest stage of degradation. The key concept behind the indicator amino acid 
method is the fact that due to the dietary change in the test amino acid from deficient 
to excess, the flux of the indicator does not change. The dietary concentration of the 
indicator remains constant with graded concentrations of the test amino acid, so there is 
no change in dilution of the tracer. In our lysine study, no correlation was found between 
urinary phenylalanine flux and lysine intake or plasma phenylalanine flux and lysine 
intake as was earlier shown in human adults (42). We thereby showed phenylalanine to 
be a good indicator in term infants. In the IAAO technique, oxidation of the indicator is 
inversely related to its uptake for protein synthesis, which in turn is determined by the 
concentration of the limiting amino acid. The effectiveness of all tracer studies depends 
upon an accurate assessment of the specific activity of the amino acid in the precursor 
pool. For phenylalanine, the specific activity of the liver free phenylalanine pool in pigs 
receiving phenylalanine in excess of their requirement, was not influenced by the supply 
of histidine, methionine, lysine and threonine in the diet (43, 44). The size of free phe-
nylalanine pools in liver and plasma is closely regulated. Plasma phenylalanine showed 
the smallest change of the indispensable amino acids when piglets were fasted or fed 
protein-free diets. These data indicate that the size of the liver phenylalanine free amino 
acid pool is well controlled compared to other amino acids, thus making it a good choice 
as an amino acid indicator (45). Because phenylalanine hydroxylation occurs primarily 
in the cytosol of the hepatocytes, sampling the hepatic intracellular enrichments of 
amino acids might be more accurate in determining amino acid requirements than the 
plasma enrichments; plasma is not the true precursor pool from which protein synthesis 
takes place. In healthy young adults a well correlation was shown between F13CO2 and 
apo-B100, a hepatic export protein which is synthetized from intra-hepatocytic amino 
acids (46). Therefore, the use of F13CO2 circumvents the complex issue of measuring the 
true precursor pool enrichment in humans during routine studies where relative rates 
are being compared (47). Concluding, our results imply that in infants, sampling of 13CO2 
in expired air is sufficient to estimate amino acid requirements and our short protocol is 
valid to determine amino acid requirements.
Background adaptation and tracer washout time
Every diet differs in naturally enriched 13C. The natural abundance of 13C in nature is 
approximately 1.1% 13C. Atmospheric abundance differs: European breath CO2 has a 
different percentage of natural abundance 13C than North American breath CO2 (48).
 13C 
abundances of formula differ dependent on the constituents: for example the source of 
protein, the source of lipids and carbohydrates all vary in 13C abundance (48). Therefore, 
a period is necessary to allow background adaptation to the experimental diet. Since 
we used European formulas which might be based on different sources of carbohydrate 
and protein than the Chinese formulas the infants received before the adaptation day, 
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we determined the time needed to reach a stable background enrichment in the first 
8 patients of the valine requirement study (chapter 6). We found the time to obtain a 
stable background enrichment was two bottles of formula (when given every 3 hours) or 
4.7 hours. These results are comparable to the study of Bross et al., who showed a stable 
background enrichment in breath between 225 and 255 minutes in adult humans fed 
hourly meals, and suggested that 5 hourly mails are required to achieve a constant 13CO2 
enrichment (49). This means that our protocol in which we adapt 24 hours to the study 
formula is sufficient to allow background enrichment to adapt to the new formula.
The possibility of isotope not clearing the body between two infusion studies and thus 
interfering with baseline isotope enrichment is an unwanted effect in tracer studies. 
Previous studies showed that the carry-over effect of the isotope did not affect the 
background enrichment after 2 days (50). Most studies used a latency of 2 days (51, 
52) or 7 days (53, 54) between 2 measurements. We determined a tracer washout time 
of 7.5 hours (chapter 2). This makes it possible to measure the same patient on two 
consecutive study days, as we did in our adaptation study. The estimated body CO2 
production did not significantly differ between the different adaptation days; i.e. energy 
expenditure is remarkable stable over a period slightly less than a week. 
AMINO ACID REQUIREMENTS IN TERM NEONATES
We will describe the requirement of the essential amino in term neonates 0 to 1 month 
of age determined by the different methods and will compare them with the mean re-
quirement determined using the IAAO method. We compare these mean requirements 
with the amount of amino acids and in current formulas and the current standards for 
infant formula. An overview of all these studies is shown in Table 1 and 2 (pages 207 and 
208).
Isoleucine requirement for infants 0 to 1 month of age
In 1964, Snyderman et al. (55) determined the isoleucine requirement in 6 healthy male 
infants to be between 79 and 126 mg∙kg-1∙d-1 based on the nitrogen balance method 
and weight gain.
The current recommended isoleucine requirement, based on human milk is 95 mg∙kg-
1∙d-1 in infants aged 0 to 1 month (56). Using the factorial approach, Dewey et al. deter-
mined the isoleucine requirement in infants aged 0 to 1 month to be 59 mg∙kg-1∙d-1 (57). 
Using the IAAO method, we determined the mean isoleucine requirement to be 105 
mg∙kg-1∙d-1 (chapter 5). Current formulas provide 97-194 mg∙kg-1∙d-1 isoleucine when an 
intake of 150 mL∙kg-1∙d-1 is given (58-61) (Table 1). Because we and Snyderman both used 
free L-amino acids in the study diet – rather than total proteins – the requirement might 
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be overestimated. A 20-35% higher first pass oxidation rate was seen in adults when an 
amino acid based diet was used compared to intact protein (67), so at least 20% of our 
mean requirement should be subtracted to correct for the amino acid based formula. 
The ESPGHAN advises an increase in protein content of infants formulas of 1.25 fold 
when the proteins used are based on hydrolyzed proteins in stead of intact proteins to 
correct for potentially less digestibility and biologic value of the nitrogen content (68). 
We therefore correct 25% for the use of amino acids in stead of intact proteins. Thereby, 
we determined a mean requirement and not a safe level of intake in which a correction 
is made for individual variance in requirement. A safe level of intake is calculated as the 
mean requirement plus 2 SD of this mean requirement. Since the distribution of the 
amino acid requirement is not known, we use the safe level of protein intake as pro-
posed by the WHO (56) which is 125% of the average protein requirement. If we correct 
our mean requirement for these two factors an intake of 105 mg∙kg-1∙d-1 should be the 
advised intake for isoleucine in infants aged 0 to 1 month. The ESPGHAN recommends 
an isoleucine intake of 92 mg ∙100 kcal-1 in infant formulas (62) which resembles our 
advised isoleucine intake of 97 mg∙100 kcal-1 based on our study formula which contains 
108 kcal when an intake of 150 mL kg-1∙d-1 is given (Table 2).
Valine requirement for infants 0 to 1 month of age
In 1959, Snyderman et al. determined the valine requirement in five neonates to be be-
tween 85-105 mg∙kg-1∙d-1 using the nitrogen balance (63). Using the factorial approach, 
Dewey et al. determined the valine requirement in infants aged 0 to 1 month to be 72 
mg∙kg-1∙d-1 (57). The current recommended valine requirement, based on human milk is 
95 mg∙kg-1∙d-1 in infants aged 0 to 1 month (56). We determined the mean valine require-
ment in infants aged 0 to 1 month to be 110 mg∙kg-1∙d-1 using the IAAO method (chapter 
6). Current formulas provide an intake of 117-216 mg∙kg-1∙d-1 valine when an intake of 
150 mL kg-1∙d-1 is given (58-60) (Table 1). Since we used an amino acid based formula 
and because amino acids derived from intact casein are utilized in a higher proportion 
for protein synthesis than those from an equivalent intake of free amino acids (67), the 
true value of the requirement would be lower than our mean estimation. If we correct 
the mean requirement for the hydrolyzed proteins and correct for the safe protein intake 
which is 125% of the mean intake, an intake of 110 mg∙kg-1∙d-1 should be the advised 
valine intake in infants aged 0 to 1 month. The ESPGHAN recommends an intake of 90 
mg∙100 kcal-1 (62) which is lower than our estimation of 102 mg∙100 kcal-1 based on our 
study formula which contains 108 kcal when an intake of 150 mL kg-1∙d-1 is given (Table 
2).
Leucine requirement for infants 0 to 1 month of age
In 1961, Snyderman et al. determined the leucine requirement in 1 preterm and 5 term 
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infants to be 150 mg∙kg1∙d-1 using the nitrogen balance and weight gain (range 79-226 
mg∙kg1∙d-1) (64). By using a soy isolate formula Fomon et al. determined the leucine 
requirement in normal female infants to be no greater than 132 mg∙100 kcal-1 (65), lower
intakes were not given. The factorial approach estimated the requirement for term 
neonates 0 to 1 month of age to be 109 mg∙kg1∙d-1 (57). We determined the mean leu-
cine requirement in infants 0 to 1 month to be 140 mg∙kg-1∙d-1 using the IAAO method 
(chapter 7). The current recommended leucine requirement, based on human milk is 
165 mg∙kg-1∙d-1 in infants aged 0 to 1 month (56). Current formulas provide an intake of 
leucine of 195-345 mg∙kg-1∙d-1 when an intake of 150 mL kg1∙d-1 is given (58-61) (Table 
1). As discussed earlier, Metges et al. compared leucine oxidation rate, non-oxidative 
leucine disposal and net protein synthesis rate in adults that were fed an amino acid 
mixture and an intrinsically [1-13C]leucine labelled casein (66). The oxidation rate was 
22% higher, non-oxidative leucine disposal was 28% lower and the net protein synthesis 
rate was 35% lower in the amino acid mixture condition compared to the intrinsically la-
belled casein condition. Amino acid utilization might be lower from amino acid based or 
hydrolyzed formulas as also was shown in adults fed an elemental diet (67). The advised 
intake for leucine in infants aged 0 to 1 month based on the IAAO method corrected 
for hydrolyzed proteins and adapted for the safe level of protein is 140 mg∙kg-1∙d-1. The 
ESPGHAN recommends an intake of 169 mg ∙ 100 ∙ kcal-1 (62) which is higher than our 
estimation of 130 mg ∙100 kcal-1, which is based on our study formula which contains 
108 kcal when an intake of 150 mL kg-1∙d-1 is given (Table 2). This indicates that current 
formulas may provide 2-3 times too much leucine which might not be beneficial for the 
neonate. During feeding, leucine enhances the insulin sensitivity of protein synthesis, 
inducing a stimulation of muscle protein synthesis (68). Very high levels of leucine have 
the capacity to stimulate protein synthesis and inhibit protein degradation skeletal 
muscle in rats. This effect on protein synthesis may be enhanced by the transient but 
small increase in serum insulin that is induced by the insulin dose. A role for leucine 
as enhancer of insulin sensitivity also implies the possibility that prolonged very high 
intakes of leucine might lead to insulin resistance, in a similar way to insulin resistance 
resulting from prolonged hyperglycemia (68). A high protein intake in excess of meta-
bolic requirements may enhance the secretion of insulin-like growth factor I (IGF-I) and 
insulin. High insulin and IGF-I levels can enhance growth during the first 2 years of life 
(69, 70) and adipogenic activity and adipocyte differentiation (71). More over, high pro-
tein intakes may also lead to decreased human growth hormone secretion and hence 
to reduced lipolysis. Epidemiological studies found that high protein intakes in early 
childhood, as opposed to high intakes of energy, fat or carbohydrates, was predictive 
of an early occurrence of the adiposity rebound and a high BMI in childhood corrected 
for parental BMI (72-75). Thus, the higher protein intake in infant formula feeding, as 
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compared to the protein supply in breastfed babies, may play a role in predisposing 
infants to an increased obesity risk later in life (the early protein hypothesis) (76).
Lysine requirement for the term infant
Only a few studies have been performed in infants to determine enteral lysine require-
ments. Snyderman et al. determined the mean requirement for lysine in enterally fed 
infants to be between 90 and 105 mg∙kg-1∙d-1(77). The factorial approach estimated the 
requirement for term neonates 0 to 1 month of age to be 116 mg∙kg1∙d-1 (57). Current 
recommendated lysine intake based on human milk for infants 0 to 1 month is 119 
mg∙kg-1∙d-1 (78). We determined the mean lysine requirement in infants 0 to 1 month to 
be 130 mg∙kg-1∙d-1 using the IAAO method (chapter 4). Current formulas provide 158-
244 mg∙kg-1∙d-1 when an intake of 150 mL kg1∙d-1 is given (58-61). The advised intake for 
lysine in infants aged 0  month, based on the IAAO method, corrected for hydrolyzed 
proteins and adapted for the safe level of protein is 130 mg∙kg-1∙d-1. The ESPGHAN rec-
ommends an intake of 114 ∙ 100 ∙ kcal-1 (62) which is comparable with our estimation of 
120 mg ∙100 kcal-1 that is based on our study formula which contains 108 kcal when an 
intake of 150 mL kg-1∙d-1 is given (Table 2). Because the main metabolic fate of lysine is 
protein synthesis, supplying sufficient intake of lysine is important in infants for growth. 
A deficient intake of lysine in infants limits protein synthesis and causes weight loss (77).
Methionine requirement for the term infant
Experimental evidence for the methionine requirement is scarce. Previous studies per-
formed by Snyderman et al. determined a methionine requirement between 27 and 49 
mg∙kg-1∙d-1 (79). Fomon et al. studied the effects on growth, nitrogen balance and serum 
chemical values of soy isolated based formulas and concluded methionine to be the 
limiting nutrient in soy protein (65, 80, 81). Current recommendated methionine intake 
based on human milk for infants aged 0 to 1 month is 28 mg∙kg-1∙d-1 (78). We determined 
the mean methionine requirement in infants aged 0 to 1 month to be 38 mg∙kg-1∙d-1 
using the IAAO method (chapter 11). Current formulas provide 43-89 mg∙kg-1∙d-1 when 
an intake of 150 mL kg1∙d-1 is given (58-61). The advised intake for methionine in infants 
0 to 1 month of age, based on the IAAO method, corrected for hydrolyzed proteins and 
adapted for the safe level of protein is 38 mg∙kg-1∙d-1. The ESPGHAN recommends an in-
take of 24 mg ∙ 100 ∙ kcal-1 (62) which is lower than our estimation of 35 mg ∙100 kcal-1 that 
is based on our study formula which contains 108 kcal when an intake of 150 mL kg-1∙d-1 
is given (Table 2). This might be partially explained by the fact that our patients might 
be in a postinfectious state in which inflammation might deplete the liver glutathione 
pool, although cysteine was given in excess which should restore the glutathione pool 
(82). Methionine is known as the most toxic amino acid in animals when supplemented 
in excess (83, 84). Hypermethioninemia and homocysteinemia were observed in infants 
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who consumed a methionine-fortified formula or a high protein formula (85, 86). High 
levels of homocysteine are associated with stroke (87), increased levels of methionine 
can cause cerebral edema (85). We postulate that there is no need to supply intakes 
above our mean requirement of 35 mg ∙100 kcal-1.
OVERVIEW OF ALL STUDIES
Table 1: The requirement for the essential amino acids in mg∙kg-1∙d-1 in term neonates 0 to 1 month of 
age determined by the different methods, and compared to the intake in term neonates when given 150 
mL∙kg-1∙d-1. The last column discribes the new recommendations for infant formulas in mg∙100 mL-1
Requirement Nitrogen
balance*
Infants 
1-5 mo 
(36, 37, 66, 91)
Factorial
Approach*
0-1 mo60)
IAAO*
Enterally fed 
infants
(EAR)
Current
Recomm*
Infants (AI)
0-1 mo(59)
Current
Formulas* per 
150 mL∙kg-1∙d-1 
(61-64)
IAAO
Recomm**
(RDA) 
Isoleucine     119
(79-126)
59 105 95 97- 194 70
Leucine     150 
(76-229)
109 140 165 195- 345 93
Valine     105
(85-105)
72 110 95 117- 216 73
Lysine     103
(90-105)
116 130 119 158- 244 87
Methionine          45
(27-49)
38  43- 89 25
Sulfur  AA 64 57
Threonine        87
(45-87)
63 76 113- 173
Phenylalanine         90
(63-91)
77- 143
Aromatic AA 114 162
Histidine         34
(17-35) -
36 47- 85
Tryptophan        22
(15-22)
22 15 29 28- 68 10
Ile:Leu:Val
Ratio
1 : 1.3 : 0.9 1 : 1.8 : 1.5 1 : 1.3 : 1 1 : 1.7 : 1 1 : 1.4 : 0.9-
1 : 2.3 : 1.2
1 : 1.3 : 1
* mg∙kg-1∙d-1
** mg∙100 mL-1
Aromatic amino acids: phenyalanine and tyrosine
Sulfur amino acids: methionine and cysteine
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RECOMMENDATIONS FOR INFANT FORMULAS AGED 0 TO 1 MONTH
The optimal BCAA ratio in infants. 
Considerable interaction has been reported in humans and animals in response to 
disproportional intakes of BCAAs. In rats, imbalanced BCAA concentrations result in 
impaired growth, and BCAA supplementation has negative effects on fetal brain growth 
(91). The difficulty about studying the different branched-chain amino acids is the 
potential interaction between the BCAA; by changing the intake of a single test amino 
acid, the dietary mixture may become imbalanced (92). Therefore different groups 
determined the total BCAA requirement in stead of individual branched-chain amino 
acids. The BCAA pattern used in these studies is based on egg protein (which has a 
Ile:Leu:Val ratio of 1: 1.3 : 1.1 (93) to minimize the potential interaction of the BCAAs on 
assessment of the requirement. The optimal proportion for protein synthesis in children 
is assumed to be that present in egg protein (94, 95) and the total BCAA requirement 
was determined to be the same as in healthy men (96). The concentrations of the BCAA 
in human milk varies from 1 : 1.8 : 1.3 (97), 1 : 1.6 : 1 to 1 : 2.0 : 0.9 (62). Human milk protein 
contains a Ile:Leu:Val ratio of 1 : 1.74 : 1 (56). Current recommendations are based on this 
ratio that is based on the content of the branched-chain amino acids in human milk, 
Table 2: The current recommendations for infant nutrition in mg∙100 kcal-1 compared to the amount 
in regular infant formulas. The third column describes the new recommendations based on the IAAO 
method.
Current Recomm based on 
Human milk (AI)
(mg∙100 kcal-1) (92) (65)
Current 
Term formulas
(mg∙100 kcal-1)(63) (63, 66)
IAAO
(mg∙100 kcal-1)
(RDA)
Isoleucine 90-92 105-190 97
Leucine 166-169 167-338 130
Valine 88-90 106-213 102
Lysine 113-114 165-243 120
Methionine 23-24 43-89 35
Threonine 77 99-170
Phenylalanine 81-83 71-140
Histidine 40-41 45-85
Tryptophan 32-33 22-67 14
Ile:Leu:Val Ratio 1 : 1.7 : 1 - 1 : 1.8 : 1 1 : 1.4 : 0.9 - 1 : 2.3 : 1.2 1: 1.3 : 1
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since exclusive breastfeeding by a healthy mother is the feeding standard from birth to 
6 months in healthy, term infants (56). Different formulas use BCAAs in different ratios 
depending on the casein-whey ratio (milk-based formula: 1 : 1.6 : 1.1, whey-adapted 
formula: 1 : 2.3 : 1.1) (98).
Besides the differences between human milk protein and cow milk protein it is impor-
tant to note that the amino acid composition of human milk is not the same as that 
of body protein, and Dewey et al. stated in 1996 that the composition of human milk 
proteins is not necessary a definition of the biological amino acid requirement of the 
growing neonate (57). Whole body protein contains a Ile:Leu:Val ratio of 1 : 2.1 : 1.4 (99). 
Milk protein contains a Ile:Leu:Val ratio of 1 : 1.6 : 1 (100), casein a Ile:Leu:Val ratio of 
1 : 1.8 : 1.4 (58). We found an optimal Ile:Leu:Val ratio of 1 : 1.3 : 1 in neonates 0 to 1 
month of age (chapter 8), which is comparable with the ratio determined by Snyder-
man using the nitrogen balance and weight gain (55, 63, 88, 89). Our results imply 
that, regarding the BCAA ratio, egg protein might be a better alternative protein than 
cow milk protein for infants aged 0 to 1 month. Since egg proteins contain more sulfur 
amino acids than milk proteins, the concentration of methionine and cysteine should be 
monitored carefully. Thereby, in parenteral fed infants, the use of egg protein as nitro-
gen source showed higher concentrations of phenylalanine and tyrosine compared to 
an alternative with an amino acid profile more similar to breast milk (101). In parenteral 
fed piglets, the optimal BCAA ratio has been shown to be 1: 1: 1 (102), i.e. concentrations 
of amino acids in parenterally fed infants cannot be compared to enterally fed infants. 
The other essential amino acid requirements should be determined in term neonates to 
see whether modified egg protein could be an alternative for infant nutrition. 
WEST MEETS EAST/ EAST MEETS WEST
One of the main reasons to start a collaborative study project in Shanghai is the high 
amount of infants admitted at the Neonatal Intensive Care Unit (NICU) in the Fudan 
Children’s Hospital. The admission rate is 3376 patients per year, 2096 males and 1280 
females. Of these babies 2236 are term, 65 post-term and 1075 were preterm neonates. 
There is a difference in male to female admissions: the ratio of Shanghai residences is 
1.36 to 1, the ratio from infants that come from other provinces is 1.8 to 1. This big dif-
ference is probably a result of the fact that ill or premature females will be left untreated 
more frequently; at first because parents are allowed to have only one child because of 
the one child policy, and secondly because of the high costs of the medical treatment; 
parents have limited or no medical insurance. Research is still in a developing state, 
medical ethical committees are being formed and at the NICU in the Fudan Children’s 
Hospital there was no experience in asking informed consent of the parents. We de-
scribe the western view of the European researchers who lived and worked 1.5-3 years 
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in Shanghai in chapter 9, and the eastern/Chinese view of the collaborative researchers 
in chapter 10.
INFANT FORMULAS COMPOSITION
The difficulty in the development of infant formulas is the fact that the amino acid 
content of cow milk proteins differs from that of human milk. Both milks are composed 
of two classes of proteins, casein or acid-preciptable proteins and whey or acid-soluble 
proteins. The whey-casein ratio in colostrum is 80:20 and changes to 55:45 in mature 
milk (98). Casein dominant cow’s milk formulas are made with nonfat dry milk and con-
tain about 82% bovine casein and 18% bovine whey proteins. During the manufacturing 
process of infant formulas, whey is added to cow milk to obtain a whey-casein ratio of 
60:40, which is more similar to human milk. However, human milk proteins differ from 
bovine proteins in concentrations of the proteins present, and in amino acid compo-
sition of these proteins. So adding bovine whey proteins does not make the formula 
identical to the amino acid composition of human milk. In casein-dominant formula, es-
pecially methionine and tyrosine are elevated. In whey-dominant formula, methionine, 
threonine and lysine are elevated. The sum of the BCAAs is much higher in formulas 
than human milk: infants fed formula have higher concentrations of BCAAs than human 
milk fed infants suggesting that levels of these amino acids are more closely related to 
protein quantity than protein quality (97).
In studies of protein quality, the assessment of the protein and amino acid compositions 
of various formula preparations is usually conducted by comparing them to human milk. 
This assessment must consider that cow milk formula contains more protein per volume 
than human milk and that there are differences in the composition of both whey and 
casein from the two species (103). Whey-dominant infant formula produces concentra-
tions of plasma free amino acids that are more like those in infants fed pooled human 
milk than does casein-predominant formula (104). According to Polberger et al., the 
standard for protein quality should be such that reflects the plasma amino acid pattern 
of optimally growing LBW infants fed only human milk proteins (103, 105). One could 
argue whether other standards like amino acid composition of human milk or plasma 
amino acid levels of healthy breast-fed term neonates should be the standard and that 
functional outcome measurements like neurodevelopmental outcome and develop-
ment of metabolic syndrome should be taken more into account. 
The nutritional implications of the differences in amino acid content of different proteins 
or mixtures of proteins can be evaluated by comparing the amino acid composition of 
the protein source with a suitable reference amino acid pattern by use of an amino acid 
scoring pattern. These scoring systems use the amino acid requirement in humans to 
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develop reference amino acid patterns for purposes of evaluating the quality of food 
proteins or their capacity to efficiently meet both the nitrogen and indispensable amino 
acid requirement of the individual (100). The scoring systems use the limiting essential 
amino acid in the test protein, divide it by the amount of amino acid in a reference pro-
tein and correct it for true digestibility. The indispensable amino acid composition of the 
specific protein source is compared to that of that of a reference amino acid composition 
profile. Earlier the amino acid composition of a good protein such as egg was used, 
which is regarded as being well balanced in amino acid content in relation to human 
needs (106). Later the amino acid content of human milk was used as reference pat-
tern (107,108) since adequate growth and development are known to occur in infants 
provided human milk, and plasma amino acid profiles of infants have been shown to 
reflect the amino acid composition of human milk. The LSRO report concluded that the 
amino acid scoring pattern of human milk is an accurate and an appropriate standard for 
assessing the protein quality of infant formulas (109). The difficulty in composing infant 
nutrition is that even if the amino acid composition of infant formula could be made 
very similar to that of human milk, digestibility and absorption of amino acids and pep-
tides could be quite different from that of breast milk, thus resulting in different plasma 
amino acid profiles. Hypothetically, one could develop an infant formula based on egg 
protein and determine the plasma amino acid profile in infants fed such a formula to 
see if the plasma aminogram is more similar to that of breast-fed infants than normal 
formulas provide. 
Concluding, we speculate that current formulas provide too much protein and do not 
contain the optimal amino acid composition. We postulate that formulas may contain 
lower amounts of protein if the quality of the milk protein can be modified. The require-
ment of histidine and phenylalanine are currently determined in term infants. If all 9 es-
sential amino acids are studied in term infants, new recommendations can be made for 
term infant formula. The effect on growth and plasma aminogram of alternative proteins 
like egg protein could be studied in pigs. Optimizing the amino acid composition might 
result in a decrease in protein intake in formula fed infants which might decrease the risk 
of the metabolic syndrome later in life.
FUTURE PERSPECTIVES 
Most currently available infant formulas provide intakes of protein that markedly ex-
ceed the requirement and exceed the protein intakes from human milk in breast-fed 
infants. For example, the measured daily protein intake in infants aged 0 to 1 month 
is 1.7 – 2.09 g∙kg-1∙d-1 which declines to 0.9 – 1.0 g∙kg-1∙d-1 at 5-6 months (97, 110). Term 
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neonates fed a formula with a protein content of 1.6 g ∙dL-1 received a protein intake 
of 2.5 g∙kg-1∙d-1 at 12 weeks (111) which is much higher than the intake of a breastfed 
infant at 3 months of age (0.9 – 1.2 g∙kg-1∙d-1 ) (97, 110) . The amino acid composition of 
the nutritionally available proteins from human milk differs from that found of bovine 
proteins (97). This results in different plasma amino acid profiles in formula fed infants 
compared to breastfed infants. For example, the concentrations of threonine, valine and 
total branched-chain amino acids are significantly higher in formula fed children fed a 
whey-dominant formula than in breastfed infants at 3 months of age (112) . At 6 months 
of age, children fed a casein-dominant formula which contained 2.7 g ∙dL-1 of protein, the 
concentrations of phenylalanine, methionine, leucine, valine and proline and isoleucine 
were more than 2 fold the values found in breastfed infants (113). Because high levels 
of BCAA interfere with the transport of tryptophan (a serotonine precursor) and other 
large neutral amino acids (tyrosine) across the blood brain barrier, they influence central 
nervous system concentrations of neurotransmitters (114, 115). Current formulas might 
not contain the optimal amino acid composition and may provide too much protein 
which might be detrimental for the neonate.
Regarding the decrease in protein intake in human milk in the first months of life, 
one could question the use of one formula for infants 0 to 6 month of age. The larg-
est difference in growth in a breastfed infant compared to a formula fed infant are 
observed between 3 and 6 months of life (27). The benefits of breastmilk for long term 
obesity might be due to a slower pattern of growth in breastfed infants compared to 
formula-fed infants, i.e. the growth acceleration hypothesis (116). This proposes that 
faster postnatal growth programmes components of the metabolic syndrome includ-
ing insulin resistance, higher low-density lipoprotein cholesterol concentration, higher 
blood pressure and obesity (116). Most infant formulas have a slightly higher energy 
density than typical human milk, and energy intakes per kilogram of body weight in 
formula-fed infants aged 3-12 mo were reported to be 10-18% higher than those of 
breastfed infants (117). Even much larger is the difference in protein supply per kilogram 
of body weight, which is 55-80% higher in formula fed infants than breastfed infants 
(118). Protein requirements of infants 3-4 month of age are more similar to those of 
older infants than to those of infants less than 3 mo of age (110). The use of one high 
protein formula for 0-6 months is questionable. A formula for infants 3-6 months could 
be developed which might contain less proteins. Infants with a lower protein intake will 
use more of the protein for growth regardless of feeding mode (117). In the DARLING 
study, a formula with a reduced protein content normalized the weight gain during the 
first 24 months of age, making it more similar to breast-fed children (117). 
Basing values for desirable amino acid intakes of preterm infants on values from the 
composition of preterm human milk is unadvisable. First, the absorption of amino acids 
present in human milk may be incomplete because of non-uniform hydrolysis of various 
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proteins by the preterm infant. Secondly, the total amino acid content of preterm milk 
is limiting for preterm infants after the first 2 weeks of life (103). For preterm infants, 
current recommendations are based on the factorial approach. A minimum and maxi-
mum protein intake is multiplied by the amount present in 1g of human milk protein 
(103). As discussed in chapter 5, the factorial approach underestimates the amino 
acid requirements in term infants. Optimizing early nutrition has been shown to effect 
neurodevelopmental outcome in preterm infants (15). Determining the requirements in 
this group is of high priority, especially because catch-up growth is associated with the 
development of metabolic syndrome later in life (20, 116). Based on their studies, Lucas 
et al. concluded that the first 2 weeks of life in the preterm infant may represent a critical 
growth window during which nutrition may have its greatest beneficial and adverse 
effects (15). To optimize infant nutrition in the first month of life, we recently started a 
study in the High Care Centers of the Erasmus MC-Sophia to determine the threonine 
requirement in preterm infants (chapter 3). This study will be the first to be conducted 
in a research program that will define the requirement of all 9 essential amino acids 
in preterm infants. These can be compared to the current recommendations based on 
the factorial approach and compared to what current preterm formulas provide. New 
recommendations can be made for preterm infant formulas like this thesis provides for 
term infant formulas.
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English Summary
Growth during the earliest stages of life is an important determinant of an individual’s 
later health and risk of chronic disease. Substantial evidence shows that growth in the 
first 2 years of life, especially high early weight gain, is associated with adverse health 
outcomes later in life, including increased blood pressure, increased weight gain and 
body fat deposition, and increased risk of diabetes. Higher protein intake for infants who 
are formula fed may play a role in these health outcomes because formula-fed children 
reach a higher body weight and weight for length at one year of age compared to those 
fed breast milk, resulting in a higher body mass index (BMI). In preterm infants, however, 
a higher protein intake in the first month of life correlates with improved neurodevelop-
ment. The goal in feeding preterm neonates is to provide the quantity and quality of 
protein needed to achieve foetal rates of tissue growth and nitrogen accretion. This goal 
should be accomplished in the context of physiological and metabolic development 
of the infant in order to avoid accumulation of potentially harmful protein metabolic 
products. 
Because intakes of breast milk from a healthy well-nourished mother are considered to 
satisfy protein requirements for the first six months of life, current recommendations 
from the World Health Organization are based on the breast milk contents. Breastfed 
infants, however, have a variable milk consumption rate, which makes it difficult to 
provide an accurate estimation of the amino acid intake. Consequently, other methods 
were needed to validate these requirements. Over fifty-five years ago, Snyderman and 
colleagues have determined individual amino requirements of infants by means of the 
nitrogen balance method and weight gain. A limitation of this method is the need for 
a 7 day adaptation time to the diet. Thereby they studied only 5-6 infants per amino 
acid. More recently, the indicator amino acid method (IAAO) was developed. Isotopically 
labelled tracers are used to determine the metabolic rate of an amino acid at varying 
dietary intakes. In adults it was demonstrated using isotopic labelled amino acids that 
the nitrogen balance method underestimated the requirements of adults by 2 to 3 fold. 
No studies have been performed using stable isotope techniques to determine essential 
amino acid requirements for enterally fed neonates. 
The major findings presented in this thesis will be discussed next. The thesis is divided 
into 6 parts. Part I describes the introduction and aims of the study. Part II describes 
the studies performed to validate our study protocol and the study design of the study 
recently started in the Netherlands. Part III describes the requirement of the branched-
chain amino acids in term neonates. These are 3 amino acids that are similar in structure 
and share common degrading steps in metabolism. Part IV is a western versus eastern 
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view regarding the Sino-Dutch research program. Part V describes the requirement of 
another essential amino acid, methionine, in infants aged 0 to 1 month. Part VI provides 
the general discussion and reviews the requirements determined by the different meth-
ods. These are compared with the mean requirement determined in our studies using 
the indicator amino acid method. We compare these values with the current recom-
mendations for infant formulas and the amount of amino acids in these formulas. Finally 
the new recommendations will be discussed for infant formulas for infants aged 0 to 1 
month and what will be the future perspectives for further research.
In Chapter 2 we determined whether the period of adaptation to a study diet with 
decreased intake of leucine has effect on the oxidation of the indicator amino 
acid [1-13C]phenylalanine to F13CO2. To avoid accumulation of the tracer we determined 
the minimal time needed to perform the next tracer study by determining the tracer 
washout time. Our study indicates that a period up to 24 h is necessary to adapt to the 
13C level of the study formula. Furthermore, if adaptation to a specific deficient diet has 
occurred, a tracer study as described here can be performed at daily intervals. Regarding 
the time needed to adapt to the study formula, no difference was found in metabolism 
between day 2 and day 4. At day 6 significant changes were found in F13CO2 , probably 
as a result of a protein sparing adaptive response. No conclusive evidence has been 
generated as how long an adaptation period on a deficient diet should last. To solve 
this question a study should be performed to compare the requirement of an essential 
amino acid after 1 and 5 days adaptation to the study diet but this should be performed 
within the range of the amino acid requirement to avoid growth restrictions in these 
infants.
In Chapter 3 we describe the study protocol of the study we recently started in the 
High Care Centers of the Erasmus MC-Sophia in the Netherlands. We will determine the 
threonine requirement in preterm infants using the IAAO method. This study will be 
the first to be conducted in a research program a research program that will define the 
requirement of all 9 essential amino acids in preterm infants. These can be compared to 
the current recommendations based on the factorial approach and compared to what 
current preterm formulas provide. New recommendations can be made for preterm 
infant formulas like this thesis provides for term infant formulas.
In Chapter 4 we showed that our short-period tracer protocol of 400 min is valid for 
determining amino acid requirements in enterally fed infants. The requirement of lysine 
in air was identical to that determined in urine and plasma. This implies that in both 
infants and adults, sampling of 13CO2 in expired air is sufficient to estimate amino acid 
requirements. No correlation was found between urinary phenylalanine flux and lysine 
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intake or plasma phenylalanine flux and lysine intake as was earlier shown in human 
adults. We thereby showed phenylalanine to be a good indicator in term infants.
The requirement for lysine in term neonates determined by the IAAO method (130 
mg∙kg-1∙d-1) corresponded well with the current recommendation based on human milk 
(119 mg∙kg-1∙d-1).
Part III: The branched-chain amino acid requirement in term neonates 
In Chapter 5 we determined the isoleucine requirement in term neonates 0 to 1 month 
of age. The mean requirement determined by the IAAO method (105 mg∙kg-1∙d-1) cor-
responded well with the current recommended isoleucine requirement, based on 
human milk (95 mg∙kg-1∙d-1). This was also the case for the requirement for valine that 
was determined in chapter 6 (IAAO method: 110 mg∙kg-1∙d-1, current recommendation: 
95 mg∙kg-1∙d-1). This value was also similar to the mean requirement determined by the 
nitrogen balance method in the 1950s by Snyderman et al. (105 mg∙kg-1∙d-1). In chapter 
7 we determined the requirement for leucine using the IAAO method. This was found 
to be lower than current recommendation (IAAO method: 140 mg∙kg-1∙d-1, current rec-
ommendation: 165 mg∙kg-1∙d-1, respectively) but corresponded well with the nitrogen 
balance method (150 mg∙kg-1∙d-1). This indicates that current formulas may provide 
2-3 times too much leucine which might not be beneficial for the neonate. Prolonged 
very high intakes of leucine might lead to insulin resistance, in a similar way to insulin 
resistance resulting from prolonged hyperglycemia. A high protein intake in excess of 
metabolic requirements may enhance the secretion of insulin-like growth factor I (IGF-I) 
and insulin. High insulin and IGF-I levels can enhance growth during the first 2 years 
of life and adipogenic activity and adipocyte differentiation. More over, high protein 
intakes may also lead to decreased human growth hormone secretion and hence to 
reduced lipolysis. Epidemiological studies found that high protein intakes in early child-
hood, as opposed to high intakes of energy, fat or carbohydrates, was predictive of an 
early occurrence of the adiposity rebound and a high BMI in childhood corrected for 
parental BMI. Thus, the higher protein intake in infant formula feeding, as compared 
to the protein supply in breastfed babies, may play a role in predisposing infants to an 
increased obesity risk later in life (the early protein hypothesis). 
Different formulas use BCAAs in different ratios depending on the casein-whey ratio. We 
determined an optimal isoleucine-leucine-valine (Ile:Leu:Val) ratio of 1 : 1.3 : 1 in neo-
nates 0 to 1 month of age (chapter 8) which is comparable with the ratio determined 
by the group of Snyderman using the nitrogen balance method and weight gain. Our 
results imply that egg protein might be a better alternative protein regarding the BCAA 
ratio for infants aged 0 to 1 month of than cow milk protein. Since egg proteins contain 
more sulfur amino acids than milk proteins, the concentration of methionine and cyste-
ine should be monitored carefully. The other essential amino acid requirements should 
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be determined in term neonates to see whether egg protein could be an alternative for 
infant nutrition.
Part IV: West meets east/ East meets West
One of the main reasons to start a collaborative study project in Shanghai is the high 
amount of infants admitted at the NICU in the Fudan Children’s Hospital. The admission 
rate during our studies in 2008 was 3376 patients per year, nowadays 4500 patients per 
year. Research is still in a developing state, medical ethical committees are being formed 
and at the NICU there was no experience in asking informed consent of the parents. We 
describe the western view of the Dutch researchers who lived and worked respectively 
1.5 and 3 years in Shanghai in chapter 9, and the eastern view of the collaborative re-
searchers in chapter 10.
Part V
In Chapter 11 we determined the mean methionine requirement in infants 0 to 1 month 
of age to be 38 mg∙kg-1∙d-1 using the IAAO method (chapter 11) which is higher than 
current recommendations (25 mg∙kg-1∙d-1). Some of the current formulas, however, 
provide almost twice the recommended intake. This could be not beneficial for the 
neonate because methionine is known as the most toxic amino acid in animals when 
supplemented in excess. 
Part VI: 
In the general discussion, Chapter 12, the requirements determined by the different 
methods are compared with the requirements determined by our studies using the 
IAAO method. We compare these mean requirements with the amount of amino acids 
in current formulas. These results are summarized in Table 1 and Table 2 (pages 207 and 
208). The current recommendations based on human milk seem to be correct for most of 
the essential amino acids. We speculate that current formulas provide too much protein 
and do not contain the optimal amino acid composition. We postulate that formulas 
may contain lower amounts of protein if the quality of the milk protein can be modified. 
The requirement of threonine, histidine and phenylalanine are currently determined in 
term infants. If all 9 essential amino acids are studied in term infants, new recommenda-
tions can be made for term infant formula. The use of egg protein as alternative protein 
for infant nutrition has to be studied. Optimizing the amino acid composition might 
result in a decrease in protein intake in formula fed infants which might decrease the risk 
of metabolic syndrome later in life.
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Voeding speelt een belangrijke rol bij pasgeborenen. Te vroeg geboren (preterme) kin-
deren hebben een betere neurologische ontwikkeling als ze meer eiwitten in hun voe-
ding krijgen in de eerste levensweken. Adequate groei is hierbij van groot belang; het 
doel is de kinderen volgens dezelfde groeicurve te laten groeien als ze in de baarmoeder 
zouden doen. De keerzijde hiervan is dat er een verband bestaat tussen inhaalgroei en 
de ontwikkeling van het metabool syndroom op latere leeftijd; hieronder vallen een 
hoge bloeddruk, suikerziekte, overgewicht en een verhoogd cholesterol. 
Bij op tijd geboren (à terme) pasgeborene lijkt er een verschil in groei te bestaan afhan-
kelijk van de soort voeding. Flesgevoede kinderen zijn op de leeftijd van 1 jaar zwaar-
der maar niet per se langer dan borstgevoede kinderen. Dit veroorzaakt een hogere 
body mass index (BMI) wat een risicofactor is voor het ontwikkelen van het metabool 
syndroom. De oorzaak van dit verschil in groei tussen flesgevoede kinderen en borstge-
voede kinderen zou kunnen liggen in het feit dat flesvoeding meer eiwitten bevat dan 
borstvoeding. De huidige aanbevelingen voor à terme kinderen zijn gebaseerd op de 
hoeveelheid eiwitten in borstvoeding. Hierbij is de samenstelling van de aminozuren 
in borstvoeding als leidraad genomen; dit zijn de bouwstenen waaruit eiwitten zijn 
opgebouwd. Of deze aanname correct is, is nooit onderzocht. De enige studies naar 
de behoefte aan aminozuren van pasgeborenen (neonaten) dateren uit 1950-1965. Ze 
zijn gedaan door de groep van Snyderman in 5 tot 6 kinderen per aminozuur. Er werd 
gekeken naar groei en stikstofbalans bij verschillende hoeveelheden aminozuren in de 
voeding. Het nadeel van deze methode is dat de kinderen 7 dagen op een bepaald dieet 
moesten staan om een effect te kunnen meten. Recent is er een nieuwe methode ont-
wikkeld om naar de behoefte aan aminozuren te kijken door het meten van de stofwis-
seling. Dit wordt gedaan door de kinderen verschillende hoeveelheden aminozuren in 
een voeding te geven met “een vlaggetje” eraan, waarvan het effect op de stofwisseling 
gemeten kan worden in uitademingslucht. Deze methode heet de indirecte aminozuur 
oxidatie methode, afgekort IAAO methode. Met deze methode kan je de behoefte aan 
essentiële aminozuren meten, dit zijn aminozuren die het lichaam zelf niet kan maken 
en dus in het dieet moeten zitten.
Het proefschrift is opgebouwd uit 6 delen. Deel I is de inleiding met het doel van het 
onderzoek. Deel II beschrijft de onderbouwing van de methode bij à terme en preterme 
neonaten. Deel III beschrijft de behoefte aan vertakte keten aminozuren in de eerste le-
vensmaand van à terme neonaten. Dit zijn 3 essentiële aminozuren die vergelijkbaar zijn 
in structuur en een gezamenlijk omzettingssysteem hebben. Deel IV is een West versus 
Oost uiteenzetting: het onderzoek is verricht als onderdeel van een Chinees-Nederlands 
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samenwerkingsproject en beide partijen geven hun visie op deze samenwerking. Deel 
V is de beschrijving van de behoefte aan een ander essentiëel aminozuur, methionine. 
In deel VI wordt het onderzoek samengevat in de discussie en worden er nieuwe aan-
bevelingen gedaan voor voeding voor à terme neonaten in de eerste levensmaand. 
Hieronder zullen we kort bespreken wat de belangrijkste uitkomsten waren van onze 
studies.
In Hoofdstuk 2 hebben we gekeken naar het aanpassen aan het studiedieet bij preter-
me neonaten. Deze kinderen kregen 6 dagen een voeding met een lagere hoeveelheid 
leucine en op dag 2, dag 4 en dag 6 keken we naar de stofwisseling met behulp van de 
IAAO methode. We zagen dat het lichaam tijd nodig heeft om te wennen aan het dieet 
zelf, dit gebeurt binnen 24 uur. Als het lichaam eenmaal aan de dieetvoeding is gewend 
kan je dagelijks een meting doen aangezien de isotopen na gemiddeld 7.5 uur uit het 
lichaam verdwenen zijn. Daarbij was er geen verschil in stofwisseling tussen dag 2 en 
dag 4. Echter op dag 6 was er een lagere stofwisseling vergeleken met dag 2 en dag 4. 
Dit is waarschijnlijk het gevolg van het feit dat het lichaam in een nieuw evenwicht komt 
om zoveel mogelijk eiwitten te sparen. Er is geen duidelijke conclusie te trekken over 
hoe lang het lichaam van een neonaat zich moet aanpassen aan het dieet in de IAAO 
methode. Dit zou je kunnen onderzoeken door de behoefte aan een aminozuur op dag 
2 te vergelijken met dag 6, hierbij moet de groei wel gewaarborgd blijven door de intake 
rondom de behoefte te houden.
Hoofdstuk 3 beschrijft de studie die we recent zijn gestart in de High Care Centers van 
het Erasmus MC-Sophia naar de threonine behoefte bij te vroeg geborenen. Dit is de 
eerste van de 9 essentiële aminozuren die onderzocht gaat worden. Het doel is om, net 
als in deze dissertatie gedaan is voor à terme pasgeborenen, nieuwe aanbevelingen te 
maken voor voeding voor de preterme neonaten.
In Hoofdstuk 4 beschrijven we de studie bij à terme neonaten naar de behoefte aan lysine 
gemeten in uitademingslucht versus urine versus bloed. We zagen dat de behoefte aan lysine 
die je op de verschillende manieren meet niet verschilt. Het meten van alleen uitademings-
lucht is dus voldoende voor het bepalen van de behoefte aan een aminozuur. Het protocol 
van 400 minuten geeft hetzelfde resultaat als het 960 minuten protocol. De gebruikte tracer 
is een goede indicator gebleken bij à terme neonaten. De hoeveelheid lysine die een à terme 
pasgeborene nodig heeft volgens de IAAO methode (130 mg∙kg-1∙d-1) komt goed overeen 
met de huidige aanbeveling gebaseerd op borstvoeding (119 mg∙kg-1∙d-1).
In Hoofdstuk 5 bepalen we de behoefte aan isoleucine in à terme neonaten. De waarde 
die we vinden met de IAAO methode (105 mg∙kg-1∙d-1) komt goed overeen met de hui-
dige aanbevelingen gebaseerd op borstvoeding (95 mg∙kg-1∙d-1). Dit geldt ook voor de 
behoefte aan valine in de eerste levensmaand ( IAAO methode: 110 mg∙kg-1∙d-1, huidige 
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aanbevelingen 95 mg∙kg-1∙d-1) zoals wordt beschreven in Hoofdstuk 6. Deze waarde 
komt ook goed overeen met de stikstofbalans studies van Snyderman zo’n 60 jaar ge-
leden (105 mg∙kg-1∙d-1). Echter, de behoefte aan leucine bepaald met de IAAO methode 
(140 mg∙kg-1∙d-1) is lager dan de huidige aanbevelingen (165 mg∙kg-1∙d-1) maar is wel 
vergelijkbaar met de stikstofbalans methode (150 mg∙kg-1∙d-1) (Hoofdstuk 7). Huidige 
voedingen voor kinderen van 0-1 maand bevatten mogelijk 2-3 maal te veel leucine. Een 
langdurig hoge leucine intake kan resulteren in een hoge insuline spiegel in het bloed. 
Bij langer bestaande hoge insuline spiegels kan de gevoeligheid voor insuline in de 
weefsels afnemen. Hypothetisch zou de hoge leucine intake negatieve effecten kunnen 
hebben bij de pasgeborene. Het zou een rol kunnen spelen bij het onstaan van insuline 
ongevoeligheid wat later in het leven een kans op suikerziekte zou kunnen geven. In 
Hoofdstuk 8 wordt een overzicht gegeven van de verhouding tussen de vertakte keten 
aminozuren en wordt de optimale verhouding van deze aminozuren besproken. Op 
basis van de IAAO methode zou een vertakte keten aminozuurverhouding met minder 
leucine ten opzichte van isoleucine en valine, beter kunnen zijn voor pasgeborenen 
(isoleucine-leucine-valine (Ile:Leu:Val) verhouding: 1: 1.3 : 1 in plaats van 1: 1.7: 1 in 
de huidige aanbevelingen). De stikstofbalans methode vond zestig jaar geleden ook 
een verhouding van 1: 1.3 : 1. De Ile:Leu:Val verhouding gevonden in kippeneiwit komt 
dichter bij deze optimale verhouding voor een pasgeborene dan die in koemelkeiwit. 
Indien de behoefte van alle 9 essentiële aminozuren bepaald is, kan er gekeken worden 
of kippeneiwit als alternatief voor babyvoeding overwogen kan worden.
Een van de redenen om de Chinees-Nederlandse samenwerking te starten is het feit dat 
er in China veel meer pasgeborenen zijn opgenomen op de Intensive Care Neonatologie 
dan in Nederland: ten tijde van het onderzoek in 2008 werden er bijna 3400 kinderen 
opgenomen; in 2011 was dit bijna 4500. Aangezien China nog in ontwikkeling is op het 
gebied van informed consent en medisch ethische regelgeving is er voor beide partijen 
veel te leren en te doen. We beschrijven de westerse en oosterse visie op het samenwer-
kingsverband en bespreken de ervaringen van respectievelijk 1.5 jaar en 3 jaar Shanghai 
in Hoofdstuk 9 en Hoofdstuk 10: West meets East, East meets West.
In Hoofdstuk 11 bespreken we de behoefte aan methionine bij à terme neonaten. De 
behoefte aan methionine gevonden door middel van de IAAO methode (38 mg∙kg-1∙d-1) 
is hoger dan de huidige aanbevelingen gebaseerd op borstvoeding (25 mg∙kg-1∙d-1). 
Echter, sommige voedingen voor kinderen van 0-1 maand bevatten toch 2 maal de 
aanbevolen hoeveelheid methionine. De hoeveelheid methionine zou beperkt moeten 
worden gezien het feit dat in dierstudies methionine een van de meest toxische amino-
zuren is gebleken indien het in te hoge hoeveelheden gegeven wordt.
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Hoofdstuk 12 geeft een overzicht van de belangrijkste onderwerpen en conclusies 
van deze dissertatie. De belangrijkste conclusies zijn dat de huidige aanbevelingen 
gebaseerd op borstvoeding grotendeels lijken te kloppen. Sommige voedingen blijken 
te veel aminozuren te bevatten en niet de optimale verhouding van deze aminozuren. 
De rol van kippeneiwit als alternatief voor babyvoeding zal onderzocht moeten worden. 
Hypothetisch zou, indien de verhoudingen aan aminozuren beter op elkaar afgestemd 
worden, er minder eiwit in deze voedingen nodig zijn. Dit zou gunstig kunnen zijn 
voor de pasgeborene, aangezien de hogere eiwitinname van flesgevoede kinderen kan 
leiden tot het ontwikkelen van het metabool syndroom later in het leven. Tabel 1 (blad-
zijde 207) geeft een overzicht van alle methoden en de huidige aanbevelingen voor 
neonaten en vergelijkt deze met de behoeften aan de verschillende aminozuren die wij 
gevonden hebben met de IAAO methode. Tabel 2 (bladzijde 208) geeft de nieuwe aan-
bevelingen voor babyvoeding voor à terme neonaten van 0-1 maand oud. Afsluitend 
worden er aanbevelingen gedaan voor toekomstig onderzoek, zoals het bepalen van 
de behoefte aan de essentiële aminozuren van preterme neonaten met als doel om ook 
nieuwe aanbevelingen te maken voor deze groep kinderen.
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Het is al weer 4.5 jaar geleden dat we naar China vertrokken, wat een avontuur met 
een baby van 6 maanden! Alle positieve herinneringen staan nog vol op het netvlies, 
de wat minder leuke ervaringen zijn al lang weggezakt... Qua onderzoek was het een 
leerzame tijd en vooral een enorme uitdaging, sociaal gezien was het in eerste instantie 
moeizaam maar uiteindelijk onvergetelijk... En dan nu ineens een proefschrift klaar en 
een fellowship afgerond! Er op terug kijkend waren het tropenjaren... Natuurlijk doe je 
het allemaal niet alleen en zijn er vele mensen die mij door de jaren heen begeleid en 
gesteund hebben.
Als eerste wil ik mijn promotor “Professor Hans” bedanken voor het bieden van zoveel 
kansen. Zowel in het onderzoek als op de werkvloer creeёr je een enorm positieve 
leeromgeving waarin je mensen enorm stimuleert zonder dat er druk op lijkt te liggen. 
Jouw positieve instelling en drive is bewonderingswaardig! Dat we überhaubt naar 
China gegaan zijn, is omdat je Gijs op een Sophia bedrijfshockeyavond enthousiast 
gekregen hebt voor het plan waar ik toen nog niet heel veel oren naar had. In China 
waren we qua onderzoek erg op ons zelf aangewezen maar gelukkig gaf je altijd hoge 
prioriteit aan onze mailtjes en hadden we direct een antwoord bij alle problemen. Heel 
erg gezellig was het met Lisha en jou in Sanya en in Shanghai, wat een lol hebben we 
gehad. Ik denk dat er weinig promovendi zijn die zo zelfstandig hebben kunnen werken, 
dank voor al het vertrouwen.
Prof. dr. van der Heijden, beste Bert, in 1992 ben ik als ANIOS door je aangenomen, 
vervolgens AIOS geworden met jou als opleider en in China ben je meerdere malen 
komen kijken hoe het onderzoek verliep. Dank voor een goed leertraject en een mooie 
afronding van 10 jaar Sophia. Dank voor het beoordelen van het manuscript en het 
plaatsnemen in de promotiecommissie. Prof.dr. Bos, beste Bert, we hebben elkaar enkele 
malen in China ontmoet. Dank voor beoordelen van het manuscript, het positieve com-
mentaar en het plaatsnemen in de commissie. Prof.dr. Reiss, beste Irwin. Heel erg fijn dat 
je mijn promotie zo hebt gesteund en ervoor gezorgd hebt dat ik uit de kliniek kon om 
alles af te ronden. Dank voor het beoordelen van het manuscript en het deelnemen in 
deze promotiecommissie. 
Prof.dr. Hokken-Koelega, beste Anita, ooit begon ik als student in een project waar jij 
medeverantwoordelijk voor was, dank voor het deelnemen in deze promotiecommissie. 
Prof.dr. Boehm, thanks for coming over and taking part in the defense commission. Dr. 
Vermes, beste Andras, dank voor het deelnemen in deze promotiecommisie en voor 
je hulp bij het bereiden en regelen van de isotopen. Prof.dr. Chen, Prof.dr. Ying, thanks 
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for all your efforts and trust in the research project, I believe your efforts contributed in 
making the project to a success. Unfortunately you can’t join us today.
Dr. Joosten, beste Koen, al weer 12 jaar geleden was je de begeleider van mijn afstudeer-
project. Heel fijn dat ik door de jaren heen van je steun en adviezen gebruik heb mogen 
maken. Zeker ook leuk dat we tijdens mijn IC stage als collega’s hebben samengewerkt. 
Dank voor het plaatsnemen in de promotiecommissie, hopelijk verliezen we elkaar niet 
uit het oog nu ik het Sophia verlaat... 
特别感谢:
感谢所有参与实验的婴儿和他们家长的配合.
感谢上海复旦大学儿科医院的所有医生, 护士, 营养室的同事和喂奶的阿姨们对我的
帮助
Dan het massaspec-lab: Henk, Gardi en Kristien, veel dank voor al jullie hulp, kennis en 
steun. Het opsturen en bepalen van monsters vanuit Shanghai bleek best een uitdaging 
en gelukkig waren jullie er altijd om ons bij te staan en dingen te organiseren. Dank 
voor al jullie tijd en moeite! Piet Dollee, dank voor al je hulp rondom het bereiden van 
de studievoedingen. Hester en Denise, veel dank voor al jullie adviezen en hulp bij alle 
onderzoekszaken, veel succes de komende ronde!
De studenten in Shanghai: Waheeda, Carmen, Lodi, heel veel dank voor jullie hulp en 
gezelligheid in Shanghai, hopelijk vonden jullie het net zo geslaagd als wij. Ineke, dank 
voor alle hulp bij het opstarten van het onderzoek. En natuurlijk heel erg leuk en be-
wonderingswaardig dat je ons kwam versterken in Shanghai, in eerste instantie alleen, 
later met de rest van de familie. Annelies, dank voor al je hulp bij het opzetten van de 
Nederlandse studie, wat een gedoe was het, maar wel uiteindelijk alle toestemmingen 
rond, nu de inclusies nog! Fleur en Nicole, het opzetten van het onderzoek in Nederland 
kost veel energie, positivisme en doorzettingsvermogen. Hopelijk kijken jullie terug 
op een tijd waarin je veel geleerd hebt, en voor Celine: we gaan ervoor! Beste mede-
onderzoekers in de High Care centra, dank voor alle tijd en energie, hopelijk wordt de 
Nederlandse studie een succes.
Lisha, wij gingen samen naar China zonder dat we elkaar ooit ontmoet hadden. Ik denk 
dat in ons geval gold: 1 + 1 = 3. Zonder jou was het voor mij een kansloos project in 
Shanghai, dat jij de taal sprak en de ouders, verpleegkundigen en voedingsassistenten 
kon spreken en instrueren was zo belangrijk voor het slagen van het onderzoek. Daarbij 
waren we elkaars sparring partners en hebben we het onderzoek op een hoger niveau 
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getild toen we eenmaal in Shanghai waren en de voedingen vast stonden bij de douane. 
Wat een werksfeer hebben we samen gecreëerd! Fijn dat je nu mijn paranimf bent! Ik 
wens je heel veel succes met Li, Owen en alle toekomstplannen die je hebt.
Lieve vrienden uit Shanghai, wat een fantastische tijd hebben we gehad. De TGIF-
borrels, “girls night out”, Olympische Spelen en hockey avonden waren onvergetelijk en 
we kijken er met veel plezier op terug, Gelukkig zien we velen van jullie nog steeds 
regelmatig!
Xiao Lio, Julie, Mecah, as a working mother I can only say you made our life so much 
easier. Your presence have made our girls feel happy and safe when I was not around; 
your roles have been so important for us as a family and I thank you all for your help in 
the last years. 
Lieve collega’s op de ICN, lieve André, Daan, Jeroen, Ronny, Nikk, René, Monique, Marijn, 
Rogier, Liesbeth, Cynthia, Renate, Nynke, Paul en Irwin, dank voor alle opleidingsjaren 
die ik met jullie heb door mogen brengen. Ik vond het altijd een heel fijn en warm 
leerklimaat. Dank voor alle begrip en steun in de laatste maanden zodat ik aan dit proef-
schrift kon werken. Karin en Wendy, veel dank voor jullie hulp! Odile, George, Monique, 
Ilke, Evelien, Bas, Roland, Heleen, heel erg leuk dat ik het begin van jullie opleiding nog 
heb meegemaakt en jullie heb zien groeien tot verpleegkundig specialisten. Ik vind het 
een mooie en zeer bijdragende functie die jullie nu hebben! Lieve mede-fellows Leo, 
Willemijn, Janine, Ellen en Sinno, wat een hoop hebben we samen meegemaakt, het 
leven van een fellow gaat niet altijd over rozen! Maar heel veel gezelligheid, borrels, 
cursussen en niet te vergeten veel steun van jullie allen, ik ga jullie missen!!! Lieve col-
lega’s uit het Sophia en ieder die door de jaren heen is uitgewaaid, we hebben altijd fijn 
samen gewerkt, veel dank voor de gezellige tijd! Lieve Jessie, als maatje en fijne collega; 
heel veel dank voor het meelezen, succes met de voedingslijn binnen het Sophia! Lieve 
arts-assistenten, verpleging en secretaresses, tegen velen van jullie heb ik de laatste 
maanden heerlijk mogen uitweiden over alle levenskeuzes, onderzoeksstress en ga zo-
maar door. Ik vond het heel fijn met jullie samen te werken, dank!!! Aanstaande collega’s 
in Alkmaar, fijn dat ik bij jullie mag komen werken, ik heb er zin in!
Lieve vrienden, buurt- en hockeygenoten. De laatste maanden was het een beetje 
mager qua gezelligheid maar dit was ook wel topdrukte. Door de jaren heen hebben 
we zoveel gezelligheid en vriendschap opgebouwd dat deze maanden afzien en onze 
verhuizing naar Alkmaar/Bergen hier niet gaan tussen komen. Dank voor jullie begrip en 
steun en tot de volgende BBQ!!!
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Lieve Kermits en Foolhousers, wat een fijne vriendinnen heb ik en wat fijn dat jullie zo 
goed begrijpen hoe ik in elkaar zit! Het maakt niet uit of we elkaar veel of weinig zien 
maar de basis is goed, heel fijn dat alles altijd zo relaxed en soepel gaat, dank voor alle 
gezellige jaren!
Lieve Frank&Fely, Menno&Linda, Bas&Annechien. Heel fijn om jullie als schoonfamilie 
te hebben, niet alleen voor de gezelligheid maar ook omdat jullie ons altijd enorm 
steunen. Ik voel me echt thuis in de familie Maingay! Lieve familie Bruinsma en familie 
de Groof/De Win, altijd betrokken en geїnteresseerd, fijn om een onderdeel van zo’n 
hecht geheel te zijn.
Lieve Marieke&Dirk, Floor&Wouter, Karien&Deyan. Wat een warm gezin hebben we en 
wat een geweldige zussen heb ik! Heel veel dank dat ik kan zijn wie ik ben! Alle opbeu-
rende gesprekken en bezorgde telefoontjes van de afgelopen maanden hebben me er 
zeker doorheen geholpen, ik denk dat wat wij als zussen samen hebben heel bijzonder 
is. Karien, heel fijn dat je mijn paranimf bent, als mede-Rotterdammer, mede-RVSV-ster, 
mede-studiegenoot, mede-hockeyfanaat hebben we denk ik heel veel gemeen ondanks 
ons leeftijdsverschil. Ik bewonder je standvastigheid en keuzes, dank voor het meelezen, 
heel fijn dat je naast me staat als paranimf!
Lieve pa en ma. Ik denk dat er niemand op de wereld is die zo supportive, lief en betrok-
ken is als jullie samen. Al op de middelbare school gold bij ons thuis “ een slimme meid 
is op haar toekomst voorbereid” en jullie hebben ons alle 4 altijd enorm gestimuleerd en 
gesteund. Ik ben heel trots dat jullie mijn ouders zijn, veel dank voor alles, heel mooi te 
zien hoeveel jullie voor onze kinderen betekenen!
Lieve Ella en Fleur. Wat een geweldige dochters zijn jullie en wat een geduld hebben 
jullie moeten opbrengen de laatste maanden. Heel veel tijd die normaal naar jullie zou 
gaan zit nu in dit boek. Ik kan niet wachten om weer heerlijk onbezonnen en zonder 
drukte in mijn hoofd een boekje met jullie te lezen of een spelletje te doen. Als jullie 
maar altijd weten: “ Ik hou van jou, en ook van jou...”
Lieve Gijs, nu al 18 jaar samen, time flies when you are having fun! Na 18 jaar gaan we 
onze basis Rotterdam verlaten en een nieuwe avontuur aan in Alkmaar/Bergen. Heel fijn 
hoe jij me stimuleert en me steunt in mijn keuzes. Heel lief en fijn dat je me de laatste 
maanden uit de wind gehouden hebt zonder een moment te klagen, en dat terwijl onze 
keuze voor Alkmaar voor jou ook heel veel consequenties heeft... Ik denk dat wat we 
samen hebben heel bijzonder is en hopelijk komen er wat rustigere tijden aan waarin 
het wat meer om jou gaat draaien. Heel gelukkig ben ik met jou, Ella& Fleur, love you!
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AI adequate intake 
APE atom percent excess
BCAA branched-chain amino acid
BCAT branched-chain aminotransferase 
BCKAs branched-chain keto-acids 
BCKAD branched-chain keto-acid dehydrogenase
BMI body mass index
BUN blood urea nitrogen
BW birth weight 
CI confidence interval
DAAO direct amino acid oxidation 
24-h DAAB  24h direct amino acid balance
DRI Dietary Reference Intake
EAR estimated average requirement 
ELBWI extremely low birthweight infants 
GA gestational age 
IAAO indicator amino acid oxidation
IAAB indicator amino acid balance
IGF-I insulin-like growth factor I 
KIC ketoisocaproate 
KIV ketoisovalerate
KMV keto-β-methylvalerate 
Ile : Leu : Val ratio isoleucine-leucine-valine ratio
LNAA large neutral amino acids 
MDI mental developmental index
MPE mole percent excess 
NICU Neonatal Intensive Care Unit
PDB pee dee belemnite
RDA recommended dietary allowance 
STDH serine/threonine dehydratase 
TCA tricarboxylic acid cycle 
TDH threonine dehydrogenase 
TORCH  Toxoplasmosis, Other agents, Rubella,  
Cytomegalovirus, Herpes virus
UL tolerable upper intake level
WHO World Health Organization
WMA World Medical Associaton
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Femke Maingay-de Groof was born on December 20th, 1975 in Eindhoven, the Nether-
lands. She received secondary education at the St. Joriscollege in Eindhoven and com-
pleted this in 1994. She started her medical training in 1994 at the Erasmus University 
in Rotterdam. In 1999 she participated in a project at the Pediatric Intensive Care Unit 
of the Erasmus MC- Sophia, Rotterdam and determined the Growth Hormone/ IGF-I axis 
in children with a meningococcal septic shock, supervised by Dr. K.F.M. Joosten and 
Prof. dr. A.C.S. Hokken-Koelega. After obtaining her medical degree in 2001, she worked 
as a pediatric resident (ANIOS) in the Albert Schweitzer Hospital in Dordrecht and the 
Maasstad Hospital in Rotterdam. She started as a pediatric resident (AIOS) in 2003 under 
supervision of Prof. dr. A.J. van der Heijden, Dr. M. de Hoog and Prof. dr. A.M. Oudesluys-
Murphy. In the last year of her training (2008) she moved to Shanghai for 1.5 years to 
start up the research project “Essential amino acid requirement in term and preterm 
neonates” at the Fudan University Children’s Hospital in Shanghai, China together with 
Lisha Huang, under supervision of Prof. dr. J.B. van Goudoever, Prof.dr. Y. Huang and Prof.
dr. C. Chen. She started as a fellow Neonatology in 2009 under supervision of Prof. dr. J.B. 
van Goudoever and finished her fellowship last May 2012 under supervision of Prof. dr. 
I.K.M. Reiss. In this fellowship she started the research project in the High Care centers 
of the Sophia Children’s Hospital for the “Threonine requirement in preterm infants” 
and after finishing her fellowship she worked on her dissertation “ The Branched-Chain 
Amino Acid Requirement in Neonates”. In August 2012 she started as a pediatrician-
neonatologist in the Medisch Centrum Alkmaar. Femke is married to Gijsbert Wouter 
Maingay and they have 2 daughters Ella Josephine and Fleur Susanne. 
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Summary of PhD training and teaching
Name PhD student: Femke Maingay-de Groof
Erasmus MC department: Neonatal Intensive Care Unit
Research school: Erasmus MC
PhD period: 2008-2012 
Promotor: Prof.dr. J.B. van Goudoever
1. PhD training
Year Workload (hrs)
General courses
Basiscursus Regelgeving Klinisch Onderzoek, Erasmus MC 2012 20
Biostatistics for Clinicians, NIHES, Erasmus MC 2012 20
Specific Courses
ESN Course, Neonatal Respiration, Hamburg
ESN Course , Neonatal Neurology, Hamburg  
Neonatal Update, Imperial College, London
ESN Course, Resuscitation and Stabilization of Preterm Infants, Kopenhagen
ESN Course, Neonatal Gastroenterology and Nutrition, Kopenhagen
Ipokrates, Neonatal Hemodynamics, Bratislava, Slovakia
ESN Course, Neonatal Infection, New Castle
ESN Course, Neonatal Circulation, New Castle
Newborn Life Support, Dutch foundation for Emergency Medical Care for Children, Riel
2009
2009
2009 
2010
2009 
2011 
2011 
2011 
2011
6
6
20
6
6
12.5
6
6
6
Seminars and workshops
Hands On Course Pediatric Echocardiography, Great Ormond Street Hospital, London
Dutch Neonatal Fellow Day, Groningen 
Research Bespreking Moeder en Kind Centrum, Erasmus MC Rotterdam
Fellowdagen neonatologie 
Interklinische en refereeravonden Erasmus MC
2011
2011
2010-2012
2010-2011 
2011-2012 
12.5
7
10
23
12
International Conferences
Young Investigator Meeting, Sanya, China
European Academy of Paediatric Societies, Kopenhagen 
European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Sorrento 
2009
2010
2011
12.5
20
20
Oral presentations
Leucine Requirement in the Enteral Fed Asian neonate,Young Investigator Meeting, 
Sanya, China 
New insights in the methodological issues of the IAAO method in preterm neonates, 
Fudan University, Shanghai, China
BCAA requirement in enterally fed term infants: Basis Isotopen Congres, Arnhem
East meets West, Grand Round, Erasmus MC Sophia, Rotterdam
BCAA requirement in term neonates, EAPS Kopenhagen
BCAA behoefte in terme neonaten, interklinische avond Erasmus MC Sophia, Rotterdam
BCAA behoefte in neonaten, Fellow Researchdagen Groningen
BCAA requirement in term infants, ESPGHAN Sorrento
2009
2009 
2010 
2010
2010
2010
2011
2011
30
30
30
60
60
30
30
60
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Lecturing activities
ZO Onderwijsmodule “ voeding bij neonaten” 3e jaars studenten Erasmus Universiteit
“Necrotising enterocolitis” training paediatric residents IC Neonatology
“Nutrition” training paediatric residents IC Neonatology
Training nurses 
AKTE medical students Erasmus MC 
Supervising Master Theses
Waheeda Joemai, medical student Erasmus MC
Carmen Hau, medical student Erasmus MC
Lodi Roksnoer, medical student Erasmus MC
Fleur van der Meide, medical student Erasmus MC
Nicole Schrier, medical student Erasmus MC
2010
2009-2012 
2009-2012 
2010
2010
2009
2009
2010
2012
2012
40
150
150
12
20
25
25
25
25
25
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